Saab Offers World Class Sensor Package for Indian Tejas LCA

Saab, in partnership with Indian industry, offers a solution that will bring the required Active Electronically Scanned Array (AESA) Fighter radar and Electronic warfare capability to India and the Indian Air Force. Thanks to our extensive technology development Saab can offer the latest technology, on time for the LCA Mk 1A needs, at low risk. The AESA fighter radar is developed by Saab with antenna technology based on the latest technologies using Gallium Nitride (GaN) and Silicone Carbide (SiC) substrates in combination with the latest generation of exciter/receiver and processor technology, giving optimum installed performance in a dense signal environment. The radar has a complete mode suite which includes air-to-air, air-to-ground and air-to-sea capabilities. A built-in memory provides a tool to record a large amount of data from performed flights. Integration in the LCA Mk1A fighter aircraft is enabled by the limited space, power and cooling required. The EW suite consists of sensors and transmitters developed by Saab and is a highly capable and extremely compact solution that provides essential situational awareness and self-protection. The heart of the suite is an electronic warfare receiver which is connected to a front end receiver and fin tip antennas inside the aircraft. Included is also an external AESA jammer pod. The radar warning system is based on ultra-wideband digital receivers and has very high probability of intercept, very good sensitivity and very high selectivity for handling the complex signal environment of today. The AESA jammer pod is small in size, low on weight and drag. Self-protection is based on Wideband Digital RF Memory (DRFM) that provides advanced jamming techniques and arbitrary combination of jamming waveforms. Transmission is performed by using GaN-based AESA:s. The EW suite also includes ground support systems and recording capability for advanced mission planning and post flight analysis. Saab’s solutions are based on the latest state-of-the-art technologies and COTS (commercial-off-the-shelf) available. The AESA fighter radar and electronic warfare units have no ITAR-restricted (Internationally Traffic in Arms Regulations) components, due to the high degree of Saab in-house developed and manufactured building blocks. Using contemporary technology provides the adaptability and growth potential needed to stay ahead. Technologies are re-used between variants and platforms in order to minimize Life Cycle Cost (LCC). “In our partnership, the transfer of technology will secure an indigenous Indian capability for series production, maintenance, repair and overhaul capability. Testing and development of the fighter sensor package will have synergies with the systems developed for Gripen,” says Anders Carp, head of Saab business area Surveillance. Saab has a proven background in tailoring systems to customer needs. This brings extensive experience from having open relations with customers when adapting advanced systems to new platforms. “Saab is a world leading company in the sensor area and has equipped some 4500 fighter aircraft with radar and electronic warfare systems. This has given us wide experience of successful sensor system integration, testing, and evaluation of radar and EW systems on fighter aircraft,” says Anders Carp. For further information, please contact:Saab Press Centre,+46 (0)734 180 018presscentre@saabgroup.com Regional contactVineet Khunger+91 98710 17080 www.saabgroup.comwww.saabgroup.com/YouTubeFollow us on twitter: @saab (http://www.saabgroup.com/YouTube) Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Catena Media Year-end report January–December 2016

Fourth quarter of 2016 · Revenues totalled EUR 12.29 million (5.90), an increase of 108 percent compared with the same quarter for the previous year. · Adjusted operating profit excluding non-recurring IPO and bond expenses amounted to EUR 6.18 million (3.62), corresponding to an adjusted operating margin of 50 percent (61). Operating profit increased to EUR 5.75 million (2.90), corresponding to an operating margin of 47 percent (49). · Adjusted profit before tax excluding non-recurring IPO and bond expenses totalled EUR 4.87 million (3.62), whilst profit before tax amounted to EUR 4.44 million (2.90). · New depositing customers (NDCs) totalled 67,023 (24,779), an increase of 170 percent compared with the same quarter for the previous year and an increase of 19 percent when compared to the previous quarter. · Earnings per share amounted to EUR 0.079 (0.063). Year 2016 · Revenues totalled EUR 40.05 million (14.94), an increase of 168 percent compared to the previous year. · Adjusted operating profit excluding non-recurring IPO and bond expenses amounted to EUR 21.03 million (10.15), corresponding to an adjusted operating margin of 53 percent (68). Operating profit increased to EUR 18.65 million (8.98), corresponding to an operating margin of 47 percent (60). · Adjusted profit before tax excluding non-recurring IPO and bond expenses totalled EUR 19.89 million (10.16), whilst profit before tax amounted to EUR 17.51 million (9.00). · NDCs totalled 204,633 (69,331), an increase of 195 percent compared with the previous year. · Earnings per share amounted to EUR 0.319 (0.199).  Comment from Robert Andersson, CEO Another year of success with strong growth and solid results 2016 was the most eventful and successful year to date for Catena Media with continued strong growth and solid results. Looking back at what we have accomplished over the last twelve months is rather impressive. We have completed and integrated seven strategic acquisitions, entered three new markets, and concurrently broadened our offering, reached over 204,000 NDCs and increased the number of employees from 70 to 190. Moreover, we achieved two important milestones with the successful listing of Catena Media´s shares on Nasdaq First North Premiere and the issue of a three-year secured bond loan. Another successful quarter The fourth quarter was the company´s strongest ever with a top line growth of 108 percent when compared to the same quarter last year, coupled with a solid operating margin of 50 percent. As a result of the heavy investment in Paid media, as well as our investments in technology and the recruitment of new employees, our margin declined slightly. This is a natural consequence of our current strategy, which is focused on growth and increase in market share. Given the pace at which Catena Media is growing, being at the forefront of technology is an absolute necessity. We have therefore decided to invest further in technical development by reinforcing our Technical department with two outsourced teams in Budapest. While making two strategic acquisitions in the UK, we further advanced our market presence in the biggest iGaming market in Europe. Through the acquisition of SBAT, Catena will strengthen its focus on sports, as well as its social media know-how, and through Casinouk.com we have the opportunity to expand our offering in Paid media and Search. In terms of new markets, we entered the US in January by acquiring regulated affiliate assets targeting the Poker and Casino markets in New Jersey and Nevada. Following the acquisition, Catena Media adds three new verticals to its business. In addition to Poker, we also acquired websites targeting eSports and Daily Fantasy Sports. We are very excited about this opportunity, which makes Catena Media the largest regulated casino affiliate in the US, and puts us in pole position to take advantage of further re-regulation in what has the potential to become the world’s largest iGaming market.  Following this acquisition, about 50 percent of Catena Media´s revenue will derive from regulated markets.  We are also very pleased to note continued growth in our acquired assets and in the Sportsbook segment that we entered earlier this year. In addition, during December, we reached a record of 24,000 NDCs in one single month on our different sites. Looking forward I am highly positive and confident as we enter 2017. Our move to the Nasdaq Mid Cap list is progressing as planned and we aim to finalize the transition within the first half of 2017. As previously, our focus remains on delivering in line with our financial targets and on continuing to grow in the same successful way both through organic growth and through acquisitions across existing and new geographic markets. To conclude, I am really proud of what we have achieved in 2016. Catena Media is an extraordinary company with extraordinary people and together we will continue this exciting journey towards becoming the world´s number one provider of high-value iGaming leads. This information is information that Catena Media PLC is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on 15 February 2017, at 07:00 a.m. CET. 

Notice to Stockmann’s Annual General Meeting

STOCKMANN plc, Notice to general meeting 15.2.2017 at 8:00 EET Notice is given to the shareholders of Stockmann plc to the Annual General Meeting to be held on Thursday 23 March 2017 at 14:00 at Finlandia Hall in Helsinki (address: Mannerheimintie 13). The reception of participants who have registered for the meeting and the distribution of voting tickets will commence at 12:30. A. At the General Meeting, the following matters will be considered: 1. Opening of the Meeting 2. Calling the Meeting to order 3. Election of persons to confirm the minutes and to supervise the counting of votes 4. Recording the legality of the Meeting 5. Recording the attendance at the Meeting and adoption of the list of votes 6. Presentation of the Annual Accounts, the report by the Board of Directors and the Auditor’s report for the year 2016Review by the CEO 7. Adoption of the Annual Accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividendThe Board of Directors proposes that no dividend be paid for the financial year 2016. 9. Resolution on the discharge from liability of the members of the Board of Directors and the CEO 10. Resolution on the remuneration of the members of the Board of DirectorsThe Shareholders’ Nomination Board proposes that the annual remuneration of the members of the Board of Directors remain at the present level and that the net amount of the remuneration after taxes be paid in shares. The Chairman of the Board of Directors is proposed to be compensated EUR 76 000, the Vice Chairman EUR 49 000 and other members EUR 38 000 each for the term of office ending at the closing of the 2018 Annual General Meeting. Additionally, it is proposed that the Chairman of the Board be paid EUR 1 000 and each Board member be paid EUR 500 as a meeting remuneration for each meeting of the Board of Directors, the Chairman of the Audit Committee be paid EUR 1 000 and each member be paid EUR 700 as a meeting remuneration for each meeting of the Audit Committee, and the Chairman and each member of the Compensation Committee be paid EUR 500 as a meeting remuneration for each meeting of the Compensation Committee. Stockmann plc is responsible for the statutory social security and pension costs of non-Finnish members of the Board in accordance with the applicable national law. 11. Resolution on the number of members of the Board of DirectorsThe Shareholders’ Nomination Board proposes that the number of members of the Board of Directors remains eight (8). 12. Election of members of the Board of DirectorsThe shareholders’ Nomination Board proposes that the present members of the Board of Directors, Kaj-Gustaf Bergh, Jukka Hienonen, Susanne Najafi, Leena Niemistö, Michael Rosenlew, Per Sjödell and Dag Wallgren, all having given their consents, be re-elected for the term of office continuing until the end of the next Annual General Meeting. Board member Torborg Chetkovich has informed that she will no longer be available as member of the company's Board of Directors. The Nomination Board proposes that LL.M, M.Sc.(Econ.) Esa Lager with his consent, be elected new Board members for the term of office stated above. Esa Lager (b. 1959, Finnish citizen) is professional Board member and he has earlier had several management positions in the Outokumpu Group, e.g. as deputy to CEO and CFO. Biographical details of Esa Lager, as well as an evaluation regarding his independence, are available on the company’s website www.stockmanngoup.com. 13. Resolution on the remuneration of the auditorThe Audit Committee of the Board of Directors proposes that the auditors to be elected be reimbursed as per invoice approved by the Board of Directors. 14. Election of auditorThe Audit Committee of the Board of Directors proposes that Henrik Holmbom, Authorized Public Accountant and Marcus Tötterman, Authorized Public Accountant, be elected as auditors, both having given their consents. It is proposed that KPMG Oy Ab, a firm of Authorized Public Accountants, be elected as deputy auditor. 15. Appointment of the Shareholders’ Nomination BoardThe Board of Directors proposes that the Annual General Meeting resolves to appoint a permanent Shareholders’ Nomination Board to yearly prepare proposals on the composition and remuneration of the Board of Directors to the Annual General Meeting, and if necessary to an Extraordinary General Meeting, in accordance with the following. The Shareholders’ Nomination Board would consist of representatives appointed by each of the four largest shareholders. In addition, the Chairman of the Board of Directors would serve as an expert member. The right to appoint a representative belongs to the four shareholders who hold the largest share of voting rights in the company based on their shareholdings registered in the shareholders’ register maintained by Euroclear Finland Ltd on the first working day of September preceding the Annual General Meeting. Should a shareholder not wish to exercise his/her nomination right, the right shall be transferred to the next largest shareholder who otherwise would not be entitled to nominate a member. The Shareholders’ Nomination Board will be convened by the Chairman of the Board of Directors and it will elect a chairman from among its members. The Nomination Board is established to exist and serve until the Annual General Meeting decides otherwise. The members shall be nominated annually and their term of office shall end when new members are nominated to replace them. 16. Closing of the Meeting B. Documents of the General Meeting The proposals for the decisions on the matters on the agenda of the General Meeting as well as this notice are available on Stockmann plc’s website at www.stockmanngroup.com. The Annual Report, the report of the Board of Directors and the Auditor’s report of Stockmann plc, will be available on the above-mentioned website no later than 2 March 2017. The proposals for decisions and other documents mentioned above will also be available at the Meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the Meeting will be available on the above-mentioned website as from 6 April 2017. C. Instructions for the participants in the General Meeting 1. Shareholders registered in the shareholders’ registerEach shareholder who is registered on 13 March 2017 in the shareholders’ register of the company kept by Euroclear Finland Ltd is entitled to participate in the General Meeting. A shareholder whose shares are registered in his/her personal Finnish book-entry account is registered in the shareholders’ register of the company. A shareholder, who is registered in the shareholders’ register of the company and who wants to participate in the General Meeting, shall register for the Meeting no later than 17 March 2017 at 16:00 by giving a prior notice of participation to be received by the company no later than on the above-mentioned date. Such notice can be given: a) on the company’s website www.stockmanngroup.com;b) by telephone + 358 20 770 6891 (Euroclear Finland Ltd); orc) by regular mail to the following address: Stockmann plc, Annual General Meeting, P.O. Box 220, 00101 Helsinki, Finland. In connection with the registration, a shareholder shall state his/her name, personal identification number, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data provided to Stockmann plc is used only in connection with the General Meeting and the processing of related registrations. 2. Holders of nominee registered sharesA holder of nominee registered shares has the right to participate in the General Meeting by virtue of such shares, based on which he/she, on the record date of the General Meeting, i.e. on 13 March 2017, would be entitled to be registered in the shareholders’ register of the company kept by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered in the temporary shareholders’ register kept by Euroclear Finland Ltd no later than on 20 March 2017 at 10:00 am. As regards nominee registered shares this constitutes due registration for the General Meeting. A holder of nominee registered shares is advised to request, without delay, necessary instructions regarding the registration in the temporary shareholder’s register of the company, the issuing of proxy documents and registration for the General Meeting from his/her custodian bank. The account management organization of the custodian bank will register a holder of nominee registered shares, who wants to participate in the General Meeting, in the temporary shareholders’ register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorneyA shareholder may participate in the General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the General Meeting. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares in different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting. Possible proxy documents should be delivered in originals to Stockmann plc, Annual General Meeting, P.O. Box 220, 00101 Helsinki, Finland before the last date of registration. 4. Other instructions and informationPursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the Meeting. On the date of this notice to the General Meeting, 15 February 2017, Stockmann plc has a total of 30 530 868 Series A shares and 41 517 815 Series B shares representing 305 308 680 votes attached to Series A shares and 41 517 815 votes attached to Series B shares. Free parking is available in Q-Park Finlandia for participants in the Annual General Meeting. The venue’s doors will open at 12:30. Helsinki, 15 February 2017 STOCKMANN PLCThe Board of Directors Further information:Jukka Naulapää, Director, Legal Affairs, tel. +358 9 121 3850 www.stockmanngroup.com STOCKMANN plc Lauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

Stockmann Group's Financial Statement Bulletin 2016

STOCKMANN plc, Financial Statement Release 15.2.2017 at 8:00 EET October-December 2016:- Consolidated revenue was EUR 388.4 million (EUR 420.0 million).- Revenue in continuing product areas and businesses was down by 6.5 per cent.- Gross margin was up, to 53.5 per cent (51.0 per cent).- Adjusted operating profit was EUR 36.5 million (EUR 18.5 million).- Reported operating profit was EUR 33.8 million (EUR 4.3 million). January-December 2016:- Consolidated revenue was EUR 1 303.2 million (EUR 1 434.8 million).- Revenue in continuing product areas and businesses was down by 4.1 per cent.- Gross margin was up, to 53.4 per cent (50.6 per cent).- Adjusted operating profit was EUR 20.2 million (EUR -28.5 million).- Reported operating profit was EUR 17.6 million (EUR -52.5 million).- Reported earnings per share were EUR -0.33 (EUR -1.24). - Hobby Hall, which was divested on 31 December 2016, is included in the 2016 income statement in the Stockmann Retail segment.- Department store operations in Russia have been classified as discontinued operations. The comments in the report refer only to continuing operations. The Board of Directors will propose no dividend to be paid on the 2016 result. Outlook for 2017:Stockmann expects the Group’s revenue for 2017 to decline due to changes in the store network and product mix. Adjusted operating profit is expected to improve, compared with 2016. Due to normal seasonal variation, the first-quarter operating result will be negative. CEO Lauri VeijalainenI’m encouraged by the financial development achieved in 2016. The Group’s adjusted operating result improved by nearly EUR 50 million, producing a positive operating result after two years of heavy losses. Our improved profitability has reinforced our confidence that we are on the right path. The department stores’ offering is now focused on fashion, beauty, food and home products, and complemented by cafés, products and services from numerous attractive partners. Lindex continued to be the Group’s most profitable division in 2016. Its operating profit was up by EUR 10 million to EUR 55 million and it achieved its best ever sales for the first half of the year. Real Estate continued its positive development and increased its operating profit and also the fair value of Stockmann’s properties improved. Also, Stockmann Retail’s operating result improved significantly, by around EUR 20 million, but was still negative. The department stores improved their results, particularly in the last quarter of the year which ended up with a solid operating profit of EUR 14 million. Operating costs were down significantly due to the efficiency programme, and the improved gross margin. There is still a lot of work to be done to make the department store business profitable by the end of 2018, but I am confident that this target can be reached as planned. Stockmann will open a totally new department store in Tapiola in March. We will focus on offering inspirational customer experiences, appealing high-quality selections with dozens of new brands and excellent customer service. The speed will be increased further to achieve the turnaround and to redeem our promises to our customers, as well as to provide more reasons to visit our stores. Key figures Continuing operations 10-12/ 10-12/ 1-12/ 1-12/ 2016 2015 2016 2015Revenue, EUR mill. 388.4 420.0 1 303.2 1 434.8Gross margin, per cent 53.5 51.0 53.4 50.6Operating result, EUR mill. 33.8 4.3 17.6 -52.5Adjustments to operating 2.6 14.2 2.6 24.0result*, EUR mill.Adjusted operating result 36.5 18.5 20.2 -28.5(EBIT), EUR mill.Adjusted operating result before 51.9 37.9 79.4 43.4depreciation (EBITDA), EUR mill.Net financial costs, EUR mill. 9.1 7.2 23.1 21.2Result before tax, EUR mill. 24.7 -2.9 -5.5 -73.7Result for the period, EUR mill. 22.4 -19.1 -18.2 -88.9Earnings per share, undiluted, 0.29 -0.27 -0.33 -1.24EURPersonnel, average 8 422 10 151 9 006 10 763 Continuing and discontinued 1-12/operations 2015Net earnings per share, 0.36 -1.26 -0.12 -2.43undiluted, EURCash flow from operating 96.1 97.0 41.5 17.2activities, EUR mill.Capital expenditure, EUR mill. 14.7 16.5 44.2 53.4Equity per share, EUR 14.99 14.53Net gearing, per cent 68.3 72.1Equity ratio, per cent 48.3 46.1Number of shares, undiluted, 72 049 72 049weighted average, 1 000 pcReturn on capital employed, 1.8 -7.6rolling 12 months, per cent * Adjustments affecting operating result were EUR 2.6 million in 2016 and they were mostly related to ICT outsourcing (2015: EUR 24.0 million, relating to Academic Bookstore, Seppälä, Oulu store closing and other restructuring costs). Adjustments affecting tax and financial costs were EUR 9.7 million (EUR 21.8 million). Stockmann has revised the terminology used in its reporting due to the new guidelines of the European Securities and Market Authority (ESMA). Alternative Performance Measures are used to better reflect the operational business performance and to facilitate comparisons between financial periods. Starting from the second quarter of 2016, the previously used term “excluding non-recurring items” has been replaced with the term “adjusted”, and, as a consequence, “operating profit (EBIT) excluding non-recurring items” has been replaced with the term “adjusted operating profit (EBIT)”. Correspondingly, “adjusted EBITDA” is calculated from adjusted operating profit excluding depreciation. Stockmann uses the term “continuing product areas and businesses” which refers to operations excluding Russian retail operations (Stockmann and Lindex), Seppälä, Hobby Hall, Stockmann Beauty, the airport store and the product areas the company has withdrawn from in department stores (electronics, books, sports equipment, toys and pet supplies). Gross profit and gross margin are also used as alternative performance measures. Gross profit is calculated by deducting the costs of goods sold from the revenue, and gross margin is calculated by dividing gross profit by the revenue as a percentage. StrategyThe Stockmann Group is focusing on developing retail operations and real estate business in its department store properties in Finland and the Baltic countries, as well as the development and expansion of the Lindex fashion chain. The Stockmann Retail and Real Estate divisions cooperate closely, while Lindex is being developed as an independent part of the Group. In line with its strategy, Stockmann withdrew from several unprofitable business operations and merchandise areas during 2016 and reduced its department store network and retail space. The divestment of the Russian department store business was completed in February and Hobby Hall at year-end. Stockmann is considering divesting the Nevsky Centre shopping centre in St Petersburg. Investigation of this possibility is in progress. Stockmann is updating its selection that is focused on fashion, beauty, food and home products, improving services and investing in the renewal of its department store premises, in order to offer an improved customer experience. A new department store in rental premises in Tapiola, Finland, will be opened in March 2017. The new Stockmann online store was launched in the fourth quarter of 2016. The online store operates on a new platform and will gradually gain several new features, such as online availability of the goods in the brick-and-mortar stores and new delivery points. A new Crazy Days online store was launched in October 2016 when the campaign was taking place. Transition to more digital marketing based on customer data and development of digital services to support omnichannel shopping continued during the year. Risk factorsStockmann is exposed to risks that arise from the operating environment, risks related to the company’s own operations and financial risks. The general economic situation is affecting consumers’ purchasing behaviour and purchasing power in all of the Group’s market areas. Consumers’ purchasing behaviour is also influenced by digitalisation, increasing competition and changing purchasing trends. Rapid and unexpected movements in markets may influence the behaviour of both the financial markets and consumers. Uncertainties related to purchasing power and behaviour are considered to be the principal risks that could affect Stockmann during 2017. The operating environment may also affect the operations of Stockmann’s tenants and consequently may have a negative impact on rental income and the occupancy rate of Stockmann’s properties. These, particularly if related to the biggest tenants of the properties, may have an effect on the fair value of the real estate Fashion accounts for over two thirds of the Group’s revenue. An inherent feature of the fashion trade is the short lifecycle of products and their dependence on trends, the seasonality of sales and the susceptibility to abnormal changes in weather conditions. Responsible management of the supply chain is important for the Group’s brands in order to retain customer confidence in Stockmann. The Group addresses these factors as part of its day-to-day management of operations. The Group’s operations are based on flexible logistics and efficient flows of goods and information. Delays and disturbances in logistic and information systems as well as uncertainties related to the logistics partners can have an adverse effect on operations. Every effort is made to manage these operational risks by developing appropriate back-up systems and alternative ways of operating, and by seeking to minimise disturbances to information systems. Operational risks are also met by taking out insurance cover. The Group’s revenue, earnings and balance sheet are affected by changes in exchange rates between the Group’s reporting currency, which is the euro, and the Swedish krona, the Norwegian krone, the US dollar, the Russian rouble and certain other currencies. Currency fluctuations may have an effect on the Group’s business operations. Financial risks, mainly risks arising from interest rate fluctuations due to the Group’s high level of debt may have an effect on the financial costs and the financial position. Interest rate fluctuations may also impact the yield related to the properties owned by the Group, and thus to the fair value of these assets. Financial risks are managed in accordance with the risk policy confirmed by the Board of Directors. Outlook for 2017In the Stockmann Group’s largest operating country, Finland, the economy has slowly begun to recover. GDP and retail market are expected to grow slightly in 2017. Consumers’ purchasing power is, however, not expected to increase and purchasing behaviour is changing due to digitalisation and increasing competition. The Swedish economy remained stable in 2016 and the GDP growth estimate for 2017 remains on a higher level than in Finland. The steady growth in the fashion market stagnated in 2016, and the growth rate is expected to remain at the same level in 2017. In the Baltic countries, GDP growth is estimated to continue. The outlook for these countries is expected to be better than that for the Stockmann Group’s other market areas. The Russian economy is expected to recover gradually, but purchasing power of Russian consumers remains low. Stockmann will continue its turnaround by improving the Group’s long-term competitiveness and profitability. The efficiency programmes, launched in 2015 and continued in 2016, will be fully visible in the 2017 operating costs. Improvements in the operating result in 2017 are estimated to come mainly from the Stockmann Retail division, which is still loss-making, while Lindex and Real Estate are expected to continue their stable performance. Capital expenditure for 2017 is estimated to be approximately EUR 45-50 million, which is less than the estimated depreciation for the year. Stockmann expects the Group’s revenue for 2017 to decline due to changes in the store network and product mix. Adjusted operating profit is expected to improve, compared with 2016. Due to normal seasonal variation, the first-quarter operating result will be negative. Financial Statements Bulletin 2016This company announcement is a summary of the Stockmann Financial Statements Bulletin 2016 and includes the most relevant information of the bulletin. The complete bulletin is attached to this release as a pdf file and is also available on the company's website at stockmanngroup.com (http://www.stockmanngroup.com). Annual General Meeting 2017The Annual General Meeting of Stockmann plc will be held on Thursday 23 March 2016 at 2 p.m. at Finlandia Hall in Helsinki, Finland (address: Mannerheimintie 13). Notice of the Annual General Meeting which includes proposals to the meeting is published as a separate stock exchange release on 15 February 2017. Financial releases in 2017Stockmann's report by the Board of Directors, financial statements, audit report, CSR review, Corporate Governance Statement and an electronic version of the Annual Review will be published in the week starting on 27 February 2017. The 2017 interim reports will be released on 28 April 2017, 16 August 2017, and 27 October 2017. Stockmann will not publish monthly sales releases of its merchandise sales in 2017. Press and analyst briefingA press and analyst briefing in Finnish will be held today, on 15 February 2017 at 9:15 a.m. in Fazer’s À la Carte restaurant on the 8th floor of Stockmann's Helsinki city centre department store, Aleksanterinkatu 52. WebcastCEO Lauri Veijalainen will host a webcast in English today, on 15 February 2017, at 11:00 a.m. EET presenting the financial statements. To participate in the webcast, please dial one of the numbers below 5–10 minutes before the webcast begins. The presentation can be followed by this link (https://stockmann.videosync.fi/2017-02-15-q4/register) or on the address stockmanngroup.com. (http://www.stockmanngroup.com) The recording and presentation material are available on the company's website after the event. Finland: +358 9 7479 0361Sweden: +46 8 5033 6574United Kingdom: +44 330 336 9105United States of America: +1 719 457 1036 Confirmation code: 9962578 Further information:Lauri Veijalainen, CFO, tel. +358 9 121 5062Nora Malin, Director, Corporate Communications, tel. +358 9 121 3558 www.stockmanngroup.com STOCKMANN plc Lauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

Clas Ohlson increase sales in January 2017

Sales increase by 4 per cent in January to 578 MSEK (558). In local currencies, sales is unchanged versus previous year. Compared with the same month previous year, the net store portfolio was expanded by 8 stores. At the end of the period, the total number of stores was 213. Sales in January were distributed as follows: +-------------------------+-------+-------+-----------------+------------------+|Countries, MSEK |January|January|Percentage change|Percentage change,|| |2016/17|2015/16| |local currency |+-------------------------+-------+-------+-----------------+------------------+|Sweden |253 |259 |-2 |-2 |+-------------------------+-------+-------+-----------------+------------------+|Norway |235 |209 |+13 |+3 |+-------------------------+-------+-------+-----------------+------------------+|Finland |67 |63 |+6 |+4 |+-------------------------+-------+-------+-----------------+------------------+|Outside Nordic countries*|22 |27 |-19 |-12 |+-------------------------+-------+-------+-----------------+------------------+| |578 |558 |+4 |0 |+-------------------------+-------+-------+-----------------+------------------+ *Effected by store optimization in the UK.  Total sales during the first nine months of the fiscal year (May 2016 to January 2017) increased by 5 per cent to 6,415 MSEK (6,098). In local currencies, sales increased by 4 per cent. The third quarter interim report 2016/17 will be published at 07:00 CET on Wednesday 15 March 2017. The report will be presented on the same day at 08:30 CET in Clas Ohlson’s store at Drottninggatan 53 in Stockholm, Sweden. For more information, please contact:Sara Kraft Westrell, Director of Information and Investor Relations, phone +46 247 649 13  This is information that Clas Ohlson AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:00 am CET on 15 February 2017.

Nel ASA: Fourth quarter 2016 results

(Oslo, 15 February 2017) Nel ASA (Nel) reported revenues in the fourth quarter 2016 of NOK 50.6 million, compared to NOK 35.6 million in the same quarter in 2015. The company is on-track and well-positioned for the Californian market, both related to fueling stations and renewable hydrogen production. ”The fourth quarter was a strong period for Nel, with record high revenue growth, cash preservation and high business development activity in different key markets. We see increased interest in the field of hydrogen from multiple markets far outside our home base, and believe we are well positioned to take advantage of these opportunities”, says Jon Andrè Løkke, Chief Executive Officer of Nel. In the fourth quarter of 2016, Nel reported revenues of NOK 50.6 million, up from NOK 35.5 million in the same quarter in 2015, representing the strongest quarterly performance in 2016. The operating earnings were impacted by the full 2016 non-cash costs related to the company ́s stock option- and share incentive program of NOK 10.2 million, resulting in a negative EBIT of NOK 16.0 million (-5.4). The cash balanced increased NOK 1.8 million to NOK 225.5 million during the quarter.  “The underlying project-development pipeline is strong, and the company continues to experience a high activity level for its prospects and ongoing tender processes. We are well-positioned for the Californian market, both related to fueling stations and renewable hydrogen production”, says Løkke. The Energy Commission in California is expected to announce the Grant Funding Opportunity (GFO) in the first quarter of 2017. The full GFO award is likely to cover around 20 stations, to be installed and developed in 2017 and 2018. “Nel has both a direct and indirect market penetration strategy for California, were our US subsidiary Everfuel has applied directly for funding. In addition, we are offering our H2Station technology to other GFO applicants which have included our equipment into their proposals. California also represents an opportunity within hydrogen production, as 33 percent of the hydrogen must be renewable, compared with today’s situation with no TRUE renewable hydrogen available in this market”, says Løkke. Within renewable hydrogen production, Nel and SunPower Corp. have entered into a framework agreement to develop solar based renewable hydrogen facilities in California, US. The parties are exploring an initial facility in Davis, California, but are also looking at other locations. The target is to market low cost renewable hydrogen from the site at a price of around 4 USD/kg. The presentation will be broadcast live at www.nelhydrogen.com/webcast and can also be viewed at http://webtv.hegnar.no/presentation.php?webcastId=45446527 The fourth quarter 2016 report and presentation will be made available through www.newsweb.no and www.nelhydrogen.com. ENDS Further information: Jon André Løkke, CEO, +47 9074 4949 Bent Skisaker, CFO, +47 4682 1693 About Nel ASA | www.nelhydrogen.com       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

SSAB Results for 2016: Lower cost level and stronger financial position lay foundation for profitable growth

Comments by the CEO SSAB posted a full year operating profit of SEK 1,213 million, up by SEK 1,456 million compared with full year 2015. Improved earnings were driven primarily by the cost reduction program, including synergies from the acquisition of Rautaruukki. Cost reductions were achieved faster than planned and amount to a full annual run rate of SEK 3 billion. Higher volumes and better capacity utilization also contributed to improved earnings for the full year. Our strategic growth initiatives in SSAB Special Steels and Automotive resulted in increased volumes and we continued launching new products at a high pace. Operating profit for the fourth quarter of 2016 was SEK 107 million, down by SEK 600 million compared with the third quarter of 2016. This was largely attributable to SSAB Special Steels, where there was a scheduled maintenance outage in Oxelösund and a production breakdown occurring when restarting the rolling mill in Oxelösund after the outage. The production breakdown was related to a faulty design in the newly installed control system resulting in damaged transformers. The rolling mill is up and running since the beginning of February and discussions have been initiated with the insurance company regarding potential compensation. Lower prices and lower margins in North America also impacted negatively on the fourth quarter. Global demand for high-strength steel remained stable during the fourth quarter. SSAB Special Steels’ shipments for the full year were up by 8% at 1 million tonnes. SSAB Special Steels is growing structurally in the market as a result of customers’ needs for increasingly lighter and stronger products. For SSAB Europe, underlying demand was stable. Market prices rose during the quarter and realized prices for SSAB Europe improved. Import restrictions on Chinese steel have resulted in lower imports and better pricing in Europe. In North America the fourth quarter was adversely affected by lower realized prices. Market prices, however, rose during the quarter, which is expected to impact positively on SSAB’s realized prices and margins from the first quarter of 2017 onwards. SSAB aims to reduce net debt by SEK 10 billion between the start of the first quarter of 2016 and the end of 2017. The rights issue during the second quarter of 2016 raised SEK 4.9 billion net and the net cash flow during the second, third and fourth quarters amounted to approximately SEK 2.2 billion. The remaining amount will be achieved through cash flow generated from operations, a structural reduction in working capital and through possible divestment of non-core assets. The integration between SSAB and Rautaruukki has been completed and the cost reduction program has ended, which resulted in savings of over SEK 3.0 billion and a reduction of over 2,500 employees. Together with our improved financial position, we have created a platform to continue to execute our “Taking the Lead” strategy with the goal to reach industry-leading profitability. We will do this by continuing to drive efficiency through continuous improvement in all our operations, by driving growth within chosen initiatives and by increased focus on the aftermarket. Against this background, I am convinced that we will continue to strengthen our position during 2017. Invitation to SSAB’s year-end report 2016 results briefing SSAB invites you to a presentation of the year-end report 2016 at 09.30am CET on Wednesday February 15, 2017. The press conference will be held in English and webcast live on www.ssab.com. It is also possible to participate in the briefing via telephone. Venue and time of briefing: World Trade Center (WTC) Stockholm, Kungsbron 1, Conference room Manhattan, 09.30am CET. Telephone numbers:+46 8 505 564 74 (Sweden),+44 203 364 5374 (UK),+1 855 753 2230 (USA). Link to webcast: Go to webcast (http://edge.media-server.com/m/p/4ke5hvo8)  For further information, please contact:  Investor Relations: Per Hillström, Head of IR,per.hillstrom@ssab.com, +46 70 2952 912 Media: Viktoria Karsberg, Head of Corporate Communications,viktoria.karsberg@ssab.com, +46 8 454 5734 This information is information that SSAB AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 7.30 am CET on February 15, 2017. 

Finnair Group financial statement release 1 January–31 December 2016

Finnair Plc        Financial Statement Release      15 February 2017 at 9:00 am Comparable full-year operating result more than doubled year on year; positive in Q4 October–December 2016  ·  Revenue increased by 0.4% year-on-year to 569.9 million euros (567.7)*. Excluding the sold travel agencies, revenue growth was 1.2% ·  Available seat kilometres (ASK) grew by 3.5%. ·  Comparable operating result was 1.6 million euros (0.8). ·  Operating result was 18.2 million euros (85.0). The items affecting comparability were mainly related to foreign exchange gains. ·  Comparable EBITDAR was 59.4 million euros (59.5). ·  Net cash flow from operating activities totalled 30.5 million euros (7.1), and net cash flow from investing activities amounted to -264.7 million euros (-7.8).** ·  Unit revenue (RASK) decreased by 3.0% year-on-year.*** ·  Unit cost (CASK) decreased by 3.2% and unit cost at constant currency excluding fuel decreased by 1.6% year-on-year. ·  Ancillary and retail revenue per passenger grew by 10.3% year-on-year to 12.2 euros. ·  Earnings per share were 0.08 euros (0.44). January–December 2016  ·  Revenue increased by 2.8% year-on-year to 2,316.8 million euros (2,254.5) with 6.5% ASK growth. Excluding the sold travel agencies, revenue growth was 3.2%. ·  Comparable operating result was 55.2 million euros (23.7). ·  Operating result was 116.2 million euros (121.7) including the sales gain on one Airbus A350 widebody aircraft (two were sold and leased back in 2015). ·  Comparable EBITDAR was 270.4 million euros (231.2). ·  Net cash flow from operating activities stood at 219.7 million euros (171.0), and net cash flow from investing activities totalled -499.6 million euros (78.6).** ·  Unit revenue (RASK) decreased by 3.5% year-on-year.*** ·  Unit cost (CASK) decreased by 4.8% and unit cost excluding fuel at constant currency increased by 0.3% year-on-year. ·  Ancillary and retail revenue per passenger grew by 15.2% year-on-year to 11.6 euros. ·  Earnings per share were 0.55 euros (0.57). ·  Outlook: Finnair estimates that, in 2017, its capacity will grow 8–10 per cent, weighted towards the second half of 2017. Revenue is expected to grow more slowly than capacity, reflecting both the increasing capacity in the markets and on the other hand Finnair's efforts to grow the ancillary sales. ·  The Board of Directors proposes to the Annual General Meeting that a dividend of 0.10 euros per share be distributed for 2016. * Unless otherwise stated, figures in parentheses refer to the comparison period, i.e. the same period last year.** Net cash flow from investing activities includes 168 million euro investments in money market funds and other financial assets maturing after more than three months. These investments are part of the Group’s liquidity management*** 2015 revenue includes sales from divested subsidiaries; Estravel was sold in December 2015 and SMT in October 2016. Outlook   The demand outlook for passenger and cargo traffic in Finnair’s main markets continues to involve uncertainty. Finnair estimates that, in 2017, due to the fleet renewal and introduction of new aircraft, its capacity will grow 8–10 per cent, weighted strongly towards the second half of 2017. Revenue is expected to grow more slowly than our capacity, reflecting increasing capacity in the relevant markets. In keeping with its disclosure policy, Finnair will issue guidance for its expected full-year operational result in connection with the half-year report in July. CEO Pekka Vauramo: As a whole, 2016 was a year of growth for Finnair. We successfully launched several new destinations, including Fukuoka and Guangzhou, and added frequencies to key routes. We took delivery of four Airbus A350 widebody aircraft and carried half a million more passengers than a year earlier. Considerable progress was made for example in the digitalisation of our technical processes. Due to the growth, we have also recruited and trained considerable numbers of new personnel, mainly pilots and cabin crew, as previously anticipated. We are building a culture of growth. In the last quarter, our comparable result was approximately 2 million euros positive, exceeding last year’s result by one million euros; hence, we achieved our ninth consecutive quarterly result improvement. The front-loaded training and other expenses resulting from the accelerated growth programme amounted to over 20 million euros in 2016. During the last quarter, we had over 100 pilots tied up in trainings. Considering the seasonality of our business and the headwinds we faced towards the end of the year, we can be fairly content with our result. Due to delays in some of the A350 deliveries, the training schedule of our pilots for the new aircraft type was interrupted, which forced us to wetlease additional capacity during the quarter in order to ensure the least amount of inconvenience to our customers. This caused additional expenses during the quarter. In addition, we were forced to cancel some flights towards the end of the year. Finnair’s revenue divided by the capacity, or RASK, showed more resilience than that of some of our peers. Ancillary sales continued healthy growth, and our plan to deploy more tourist capacity to Lapland was a success. As an example, Ivalo and Rovaniemi combined are currently the largest destination for our Chinese passengers. We have specified a target to boost our revenues by 500 million euros by the end of 2019. Ancillary sales, with new revenues streams, will play a key role in achieving this target. We are also expecting the new cargo hub to be completed in 2017, which will enable increased revenue, particularly by providing better facilities for premium services for specialty goods. This year will be an important leap of growth for us. There will be a tangible increase in capacity, four new A350s and active recruitments. At the same time, we are taking serious efforts to develop the customer experience and the internal people experience. I believe this will lay a solid foundation to launch into the year. Financial reporting  The publication dates of Finnair’s financial reports for 2017 are as follows: Interim Report 1 January – 31 March 2017:                               28 April 2017  Half-Year Report 1 January – 30 June 2017:                               20 July 2017  Interim Report 1 January – 31 September 2017:                           25 October 2017  FINNAIR PLC Board of Directors  Briefings  Finnair will hold a result press conference on 15 February 2017 at 11:00 a.m. and an analyst briefing at 12:30 p.m. at its office at Tietotie 9. An English-language telephone conference and webcast will begin at 2:30 p.m. Finnish time. The conference may be attended by dialling your local access number 0800 915 597 (Finland), 0850 510 036 (Sweden), 020 3059 8125 (UK) or +44 20 3059 8125 (all other countries) and quoting “Finnair” to the operator. To join the live webcast, please register at: http://www.investis-live.com/finnair/5889c7ff04323f1100d219ce/7y2ua For further information, please contact:  Chief Financial Officer Pekka Vähähyyppä, tel. +358 9 818 8550, pekka.vahahyyppa@finnair.com  Financial Communications Manager Ilkka Korhonen, tel. +358 9 818 4705, ilkka.korhonen@finnair.com  IRO Kati Kaksonen, tel. +358 9 818 2780, kati.kaksonen@finnair.com  Financial Statement Bulletin 2016 (http://mbpublicbinaryproxy/Public/3718/2189239/b8f3b10c495e9e54.pdf)

Sweco to continue feasibility study of Helsinki-Tallinn tunnel project

The Helsinki-Tallinn tunnel project is advancing to the next phase: a feasibility study focused on preparing an implementation plan to support the project’s decision-making process. This study is a continuation of the pre-feasibility study conducted by Sweco in 2015, which resolved various aspects of project execution, traffic structure and potential socioeconomic impact. In addition to investigating technical solutions, the study will evaluate the project’s economic impact. A fixed link between Helsinki and Tallinn is expected to enhance business opportunities for both capital cities. “New sustainable solutions are needed to improve the flow of freight and passenger traffic across the Gulf of Finland. The Helsinki-Tallinn tunnel would create an important link between Scandinavia and Central Europe. We are investigating the various technical solutions at hand, such as station location, train types and operational solutions for traffic flow. The strategic environmental impact assessment is also now part of the study. Sweco was also involved in the initial pre-feasibility study phase, so we can utilise our previous knowledge of the project’s impact and requirements”, says Sweco Environment Director Juho Siipo. The project team comprises multidisciplinary experts: Sweco Finland and Estonia are joining a consortium with WSP Finland and Sweden and Amberg Engingeering from Switzerland. Amberg Engineering has collaborated with Sweco in several international transport projects, including the Brussels and Paris metros and a high-speed railway line in Sweden. '’Amberg Engineering Ltd is expert in planning, design and site supervision of ultra-long tunnels such as the Gibraltar Strait Tunnel and the Gotthard Base Tunnel. This accumulated knowledge of the specific characteristics of such infrastructures will be very conducive for this feasibility study’’, says the president of the Amberg Group Felix Amberg. The contracting authorities for the project are the Finnish Ministry of Transport and Communications, the Estonian Ministry of Economic Affairs and Communications, the Helsinki-Uusimaa Regional Council, the Harju County Government of Estonia, and the cities of Helsinki and Tallinn. The results of the pre-feasibility study will be available at the end of 2017.

Tobii AB Year-End Report 2016

Tobii AB today reported its results for the fourth quarter and full year 2016. Tobii exceeded SEK 1 billion in annual sales and strengthened its cash position for increased investments in VR and smartphones. Comment by Tobii’s CEO Henrik Eskilsson: “2016 was another exciting and eventful year for Tobii. Tobii Tech passed key milestones in computer gaming, which also contributed to a significant rise in sales for the business unit for the fourth quarter. Together with Huawei, we also took our first step into the smartphone market. The rights issue that we recently carried out provides us with the muscle to further increase the pace of investment and address more areas simultaneously within Tobii Tech. We also continued to invest in market and product development in Tobii Dynavox and Tobii Pro to further grow and increase profitability over the long-term. Adjusted for currency effects and one-off effects, the Group’s net sales increased by 10% compared with the fourth quarter of 2015 and for the full year we exceeded SEK 1 billion in sales.” October – December · The Group’s sales totaled SEK 306 million (287), an increase of 6%. Adjusted for currency effects and one-off effects, the increase was 2% and 10%, respectively. · The gross margin was 71% (76%). · The Group’s operating loss amounted to SEK -10 million (-3). Tobii Dynavox made a positive contribution of SEK 41 million (45) and Tobii Pro of SEK 12 million (11), while investments in Tobii Tech had a negative impact of SEK -64 million (-59) on the Group’s earnings. · Earnings per share amounted to SEK -0.02 (-0.08). January – December · The Group’s sales totaled SEK 1,053 million (967), an increase of 9%. Adjusted for currency effects, the increase was also 9%. · The gross margin was 72% (75%). · The Group’s operating loss amounted to SEK -67 million (-36). Tobii Dynavox made a positive contribution of SEK 125 million (119) and Tobii Pro of SEK 15 million (21), while investments in Tobii Tech had a negative impact of SEK -207 million (-176) on the Group’s earnings. · Earnings per share amounted to SEK -0.57 (-0.30). Events during the third quarter · Tobii carried out a rights issue to finance increased investments in virtual reality and smartphones, which was heavily oversubscribed and generated proceeds of SEK 449 million for the company after issue costs. · Tobii Pro launched the company’s most powerful and advanced eye tracker to date, Tobii Pro Spectrum, and the analytics platform, Tobii Pro Lab. · Tobii announced its first design win in the smartphone area with the launch of Huawei Honor Magic. · Acer announced yet another monitor to come featuring integrated eye tracking from Tobii. Conference call Today at 10:00 a.m. Tobii will arrange a conference call with web cast presentation for media, analyst and investors. Please find dial-in details on Tobii’s website under Year-End Report, Q4 2016 (http://www.tobii.com/group/investors/calendar/year-end-report-q4-2016/). This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, on February 15, 2017, at 8:00 a.m. CET.

THQ Nordic AB (publ) publishes Year-End Report 2016

Fourth quarter 2016 ·  Net sales increased by 30% (38) to SEK 128.2 m (98.4). ·  Owned titles represented SEK 94.0 m (83.0), or 73% (84), of net sales in the quarter. ·  EBITDA was SEK 60.8 m (52.3), corresponding to an EBITDA margin of 47% (53). ·  EBIT was SEK 50.6 m (35.2), corresponding to an EBIT margin of 39% (36). ·  Cash flow from operating activities amounted to SEK 51.3 m (63.3). ·  Earnings per share (diluted) were SEK 0.59 (0.46). ·  Four Acquisitions of IP- and Franchises were finalized in the fourth quarter, including “This is the Police”, “Sphinx and the Cursed Mummy”, “Delta Force”, “Commanche” and many others. ·  Two owned titles and two publishing titles were released in the period. Full year January – December 2016 ·  Net sales increased by 42% (20) to SEK 301.9 m (212.9). ·  Owned titles represented SEK 214.0 m (162.0), or 71% (76), of net sales in the period. ·  EBITDA was SEK 132.4 m (105.1), corresponding to an EBITDA margin of 44% (49). ·  EBIT was SEK 95.0 m (66.6), corresponding to an EBIT margin of 31% (31). ·  Cash flow from operating activities amounted to SEK 99.2 m (109.9). ·  Earnings per share (diluted) were SEK 1.18 (0.85). ·  As of 31 December 2016, cash and cash equivalents were SEK 167.4 m (25.6). The Company also had unutilized credit facilities of SEK 71.2 m (–). ·  The Board proposes no dividend for the financial year 2016. Throughout the Report, all comparatives within parentheses refer to the corresponding period of the previous year, unless otherwise stated. KEY PERFORMANCE Oct Oct-Dec 2015  Jan-Dec 2016  Jan-Dec 2015 INDICATORS, SEK m -DecGROUPMSEK  2016 Net sales 128.2  98.4  301.9  212.9 EBITDA  60.8  52.3  132.4  105.1 Under lying EBIT  50.6  35.2  95.0  66.6 Profit after tax  38.0 27.6  71.9  51.2 Earnings per share, 0.59  0.46  1.18  0.85 SEK Cashflow from 51.3  63.3  99.2  109.9 operating activities Sales growth, %  30  38  42  20 EBITDA margin, %  47  53  44  49 Underlying EBIT 39  36  31  31 margin, % Net sales split: – Owned titles, %  73  84  71  76 – Publishing titles, 27  14  29  22 – Other, % - 2 - 2 For additional information, please contact:Lars Wingefors, Group CEOTel: +46 708 471 978E-post: lwingefors@thqnordic.com About THQ NordicTHQ Nordic acquires, develops and publishes PC and console games. The core business model consists of acquiring established franchises and successively refining them. The portfolio includes more than 75 franchises such as Darksiders, Titan Quest, MX vs ATV, Red Faction, Destroy All Humans, Aquanox, deBlob, Imperium Galactica, Desperados, Impossible Creatures, Jagged Alliance, Spellforce, The Guild and This is the Police. Since its foundation 2011, the Company has created a global presence, with its Group head office in Karlstad, Sweden and its operational head office in Vienna, Austria. THQ Nordics engage more than 370 people and has 4 inhouse development studios based in Germany, USA and Sweden. THQ Nordic shares are listed on Nasdaq Stockholm First North under the ticker THQN B. For more information, please visit http://www.thqnordic-investors.com or www.thqnordic.com. FNCA Sweden AB is THQ Nordic’s Certified Adviser. This information is information that THQ Nordic is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on February 15, 2017.

Double Bond Pharmaceutical expands the cooperation with Alexandrov Cancer Centre to identify biomarkers for Temodex

As previously described, DBP has recently started an extensive partnership agreement with N. N. Alexandrov National Centre of Belarus on Temodex. Now the cooperation is deepened further and includes the identification of potential biomarkers for Temodex. "Biomarkers are absolutely central in the development of modern drugs, especially as so-called personalized medicine becomes increasingly vital in the pharmaceutical world. We see a great potential and opportunities in effective development of biomarkers, - says Igor Lokot, CEO of DBP. - This ensures further the therapeutic value of Temodex on the market and substantially increases the possibility for Temodex to become part of the new standard odf care for operable brain cancer globally. " "Purpose of this cooperation is not only to develop new biomarkers for the treatment of brain cancer. The entire scope of cooperation will gather evidence for our earlier hypothesis that Temodex also works on patients who do not normally respond well to standard systemic treatment with temozolomide" - says Iulia Karlsson, Head of Biomarker and Companion Diagnostics Development in DBP. This information is information that Double Bond Pharmaceutical International AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 15th of February 2017.  More about N.N. Alexandrov National Cancer Centre of Belarus: N.N. Alexandrov National Cancer Centre is the leading cancer centre in Belarus. It provides the whole scope of services in the field of diagnosis and treatment of malignant tumors. N.N. Alexandrov National Cancer Centre is also the greatest medical research institution of the Republic of Belarus. It provides free of charge examination and treatment of Belarusian citizens with malignant tumors and renders paid medical services for foreign citizens and Belarusian citizens without malignant diseases. For more information, read here (http://eng.omr.by/). TemodexTemodex, which is a locally acting formulation of temozolomide, was developed by RI PCP in Minsk, Belarus, and is registered for marketing within Belarus since 2014 as the first-line treatment of glioblastoma. Temodex was acquired by DBP in autumn 2015 and is now being prepared to pass through all the tests and trials required for registration within the EU and globally. Find out more here (http://doublebp.com/sv/produkter/temodexsv).

Atlas Copco awards recognize innovative breaker and compressor monitoring technology

The John Munck Award for technical innovations is presented to Olof Ostensson and Thomas Lilja, who work in technical development for the Construction Tools division in Kalmar, Sweden. They developed the handheld pneumatic breaker RTEX, which cuts energy consumption by half, while being lighter and highly ergonomic. The RTEX has been embraced by customers, who benefit from lower fuel costs, reduced emissions, higher productivity and an improved operator environment. See a three-minute video (https://www.youtube.com/watch?v=TNlPjgfPlAM&t=13s) on the RTEX. The Peter Wallenberg Award goes to a team in the Compressor Technique Service division: Pieter Colen, Bob Rigouts, Louis De Jaegher and Damien Hoyen. They played key roles in advancing and promoting the groundbreaking SMARTLINK data monitoring system for compressors. The system lets Atlas Copco remotely measure the equipment performance and see exactly when service is needed. This gives customers peace of mind, allowing them to focus on their business instead of on the compressors. Thousands of customers globally have benefited from SMARTLINK since its launch in 2013. See a five-minute video (http://www.atlascopco.com/videogallery/detail/fbe7961e-1fd0-4334-a00c-6b424eb15e95) on SMARTLINK. “Our constant focus on increasing customers’ productivity lies behind the development of both the RTEX breaker and the SMARTLINK monitoring system,” said Ronnie Leten, Atlas Copco’s President and CEO. The John Munck Award, established in 1991, is presented each year to a product developer, designer or a team for outstanding contributions to the overall quality of an Atlas Copco product. The Peter Wallenberg Marketing and Sales Award -- named after Atlas Copco’s former Honorary Chair -- recognizes the most innovative successfully implemented method in the field of sales and marketing. The award was established in 1996. The awards will be presented to the winners at the Annual General Meeting on April 26, 2017.  For information on past award winners, please see http://www.atlascopcogroup.com/en/innovation/awards/internal-awards.

Sivers IMA launches new 60 GHz RFIC chip for WiGig

The continued 10x growth in mobile data traffic until 2022* is pushing the boundaries for new and innovative wireless solutions. WiGig, millimeter wave and beamforming will be vital technologies to support this tremendous growth.  “With this new RFIC, Sivers IMA will take a crucial step in becoming a leading supplier of millimeter wave RFICs for data and telecommunication infrastructure solutions. With the state of the art technical performance and very high level of integration, Sivers IMA offers unique value to our customers.” says Anders Storm, CEO of Sivers IMA. TRX-BF01 has 16 Tx +16 Rx digitally controlled beamforming channels, all in one chip. It includes all building blocks in Silicon Germanium, in a small 12,5x12,5 mm eWLB capsule. The built in full PLL and VCO have excellent phase noise and hence offer best in class EVM performance and can be used with the 64 QAM single carrier modulation, compliant to the 802.11ad standard, allowing for speeds up to 7 Gbps in the air. Silicon Germanium offers state of the art performance compared to many CMOS RFICs for millimeter wave, in some cases more than 100 times higher output power per Tx channel.   Prototypes of this new chip will be available to key customers and partners during Q2 2017. For more information:   Anders Storm, CEO Phone: +46 70 262 6390 E-mail: anders.storm@siversima.com  * Ericsson Mobility report (Nov 2016)   Sivers IMA is a leading manufacturer of micro- and millimeter wave products for connecting and quantifying a networked world. Sivers IMA has a long history and is internationally renown as a reliable supplier of high quality components used in telecommunications links, RADAR sensors and test & measurement equipment. Headquarters is located north of Stockholm in Kista, Sweden. Learn more at http://siversima.com.  

Notice to Annual General Meeting

Finnair Plc         Notice to general meeting            15 February 2017 at 10:05 am Notice is given to the shareholders of Finnair Plc to the Annual General Meeting to be held on Thursday 16 March 2017 at 3 p.m. (EET) at Messukeskus Helsinki, Messuaukio 1, Conference Centre entrance. The doors will be opened and reception of persons who have registered for the Meeting will commence at 2 p.m. (EET). Coffee will be served prior to the Meeting. A. MATTERS ON THE AGENDA OF THE GENERAL MEETING At the General Meeting, the following matters will be considered: 1. Opening of the Meeting 2. Calling the Meeting to order 3. Election of persons to scrutinise the minutes and to supervise the counting of votes 4. Recording the legality of the Meeting 5. Recording the attendance at the Meeting and adoption of the list of votes 6. Presentation of the annual accounts including the consolidated annual accounts, the report of the Board of Directors and the auditor's report for the year 2016. - Review by the Chief Executive Officer 7. Adoption of the annual accounts including the consolidated annual accounts 8. Resolution on the use of the profit shown on the balance sheet and the payment of dividend The Board of Directors proposes to the General Meeting that a dividend of EUR 0.10 per share be paid based on the balance sheet adopted for the financial period ended on 31 December 2016. The dividend shall be paid to a shareholder who on the dividend record date 20 March 2017 is registered as a shareholder in the Company's shareholders' register held by Euroclear Finland Ltd. The Board of Directors proposes that the dividend be paid on 4 April 2017. 9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability 10. Resolution on the remuneration of the members of the Board of Directors The Shareholders' Nomination Board proposes to the General Meeting that the annual remuneration of the members of the Board of Directors would remain unchanged and be as follows: ­   Chairperson EUR 61,200 per year; ­   Vice Chairperson EUR 32,400 per year; ­   Chairpersons of the Audit Committee and Compensation and Nomination Committee EUR 32,400 per year, where these individuals are neither the Chairperson nor the Vice Chairperson of the Board of Directors; and ­   Other members EUR 30,000 per year. The Nomination Board further proposes to the General Meeting that each member's fee for a meeting of the Board of Directors or its Committee would be EUR 600 when the meeting takes place in the board member's country of residence. The proposed fee for other meetings would be EUR 2,400 per meeting and for telephone meetings EUR 600 per meeting. In addition, the Board members would be entitled to reimbursement of reasonable travel and representation expenses in accordance with the company's general expenses policy. The Nomination Board also proposes that Board members and their spouses would be entitled to discounted travel on the company's flights in accordance with the company's discount ticket policy regarding the Board of Directors. 11. Resolution on the number of members of the Board of Directors The Shareholders' Nomination Board proposes to the General Meeting that the number of members of the Board of Directors would be confirmed as seven (7). 12. Election of the Chairman and other members of the Board of Directors The Shareholders' Nomination Board proposes to the General Meeting that of the present members of the Board of Directors, Maija-Liisa Friman, Jussi Itävuori, Jouko Karvinen and Jaana Tuominen be re-elected as members of the Board of Directors, and that Colm Barrington, Mengmeng Du and Jonas Mårtensson be elected as new members to the Board of Directors. The Nomination Board further proposes that Mr. Jouko Karvinen be elected as Chairman of the Board. All candidates have given their consent to the position, and all are independent of the company and its significant owners. The current members leaving the Board of Directors, Klaus Heinemann, Gunvor Kronman and Nigel Turner, have informed the nomination board that they will not be available in the election of the Board of Directors in the next Annual General Meeting. All candidates have been presented on the Company's website at www.finnairgroup.com. 13. Resolution on the remuneration of the auditor In accordance with the Audit Committee's recommendation, the Board of Directors proposes that the auditors' fees be paid according to the auditors' reasonable invoice. 14. Election of the auditor In accordance with the Audit Committee's recommendation, the Board of Directors proposes that PricewaterhouseCoopers Oy, a firm of authorised public accountants, which has announced that APA Mikko Nieminen would be acting as the principal auditor, be re-elected as the auditor of the company for the term of office ending at the end of the next Annual General Meeting. 15. Authorising the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of own shares The Board of Directors proposes that the Annual General Meeting would authorise the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of the company's own shares as follows. The amount of own shares to be repurchased and/or accepted as pledge shall not exceed 5,000,000 shares, which corresponds to approximately 3.9 per cent of all the shares in the company. Only the unrestricted equity of the company can be used to repurchase own shares on the basis of the authorisation. Own shares can be repurchased at a price formed in public trading on the date of the repurchase or otherwise at a price formed on the market. The Board of Directors decides how own shares will be repurchased and/or accepted as pledge. Own shares can be repurchased using, inter alia, derivatives. Own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). Own shares may be repurchased and/or accepted as pledge in order to, inter alia, develop the capital structure of Finnair, to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of Finnair's incentive and remuneration schemes. The authorisation would be effective for a period of 18 months from the resolution of the General Meeting and it would cancel the authorisation given by the General Meeting on 17 March 2016 to decide on the repurchase and/or acceptance as pledge of own shares. 16. Authorising the Board of Directors to decide on the disposal of the company's own shares The Board of Directors proposes that the Annual General Meeting would authorize the Board of Directors to decide on the disposal of own shares held by the company as follows. The amount of shares to be disposed based on the authorisation shall not exceed 5,000,000 shares, which corresponds to approximately 3.9 per cent of all the shares in the company. The Board of Directors decides on all the conditions of the disposals, including to whom, at what price and in which manner the company's shares are disposed. The disposals may also be made in deviation from the shareholders' pre-emptive rights for a weighty financial reason, such as using the shares to develop the company's capital structure, to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of Finnair's incentive and remuneration schemes. The authorisation would be effective for a period of 18 months from the resolution of the General Meeting and it would cancel the authorisation given by the General Meeting on 17 March 2016 to decide on the disposal of the company's own shares. 17. Closing of the Meeting B. DOCUMENTS OF THE ANNUAL GENERAL MEETING The proposals for the decisions on the matters on the agenda of the General Meeting as well as this notice to the General Meeting are available on the company's website at www.finnairgroup.com. The annual accounts, the report of the Board of Directors and the auditor's report of Finnair Plc are available on the above-mentioned website on 23 February 2017 at the latest. The proposals for decisions and other above-mentioned documents are also available at the Meeting. Copies of these documents and of this notice will be sent to shareholders upon request. The minutes of the Meeting will be available on the above-mentioned website as from 30 March 2017 at the latest. C. INSTRUCTIONS FOR THE PARTICIPANTS IN THE GENERAL MEETING 1. Shareholders registered in the shareholders' register Each shareholder, who on the record date of the General Meeting, Monday 6 March 2017, is registered in the shareholders' register of the company held by Euroclear Finland Ltd., has the right to participate in the General Meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the shareholders' register of the company. A shareholder, who is registered in the shareholders' register of the company and who wants to participate in the General Meeting, shall register for the Meeting no later than by Monday 13 March 2017 by 10.00 a.m. (EET) by giving a prior notice of participation, which has to be received by the company before the end of the registration period. Such notice can be given: a)      on the company's website at www.finnairgroup.com; b)      by e-mail to agm@finnair.com; c)       by telephone +358 (0)20 770 6866 Monday through Friday from 9:00 to 16:00 (EET); d)      by telefax +358 (0)9 694 0205; or e)      by regular mail to Finnair Plc, Register of Shareholders AAC/502, 01053 FINNAIR. In connection with the registration, a shareholder shall notify his/her name, personal identification number, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Finnair Plc is used only in connection with the General Meeting and with the processing of related registrations. The shareholder, his/her authorised representative or proxy representative shall, where necessary, be able to prove his/her identity and/or right of representation. 2. Holders of nominee registered shares A holder of nominee registered shares has the right to participate in the General Meeting by virtue of such shares, based on which he/she on Monday 6 March 2017 would be entitled to be registered in the shareholders' register of the company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders' register held by Euroclear Finland Ltd. at the latest by Monday 13 March 2017 by 10.00 a.m. (EET). As regards nominee registered shares this constitutes due registration for the General Meeting. A holder of nominee registered shares is advised to request without delay the necessary instructions regarding the registration in the temporary shareholder's register of the company, the issuing of proxy documents and registration for the General Meeting from his/her custodian bank. The account management organization of the custodian bank has to register a holder of nominee registered shares, who wants to participate in the General Meeting, into the temporary shareholders' register of the company at the latest by the time stated above. 3. Proxy representative and powers of attorney A shareholder may participate in the General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the General Meeting. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting. Possible proxy documents should be delivered in originals to Finnair Plc, Register of Shareholders AAC/502, 01053 FINNAIR on Monday 13 March 2017 at the latest. 4. Other information Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be considered at the Meeting. On the date of this notice to the Annual General Meeting, 15 February 2017, the total number of shares and votes in the company is 128,136,115. The company or its subsidiaries hold 788,964 of the company's own shares, which do not have voting rights in the General Meeting. In Helsinki, 15 February 2017 FINNAIR PLCBOARD OF DIRECTORS

SMART WINDSCREEN WIPERS REDUCE ANXIETY WHEN OVERTAKING.

More than half of US drivers surveyed (Semcon/Inizio) stated that they feel anxious before overtaking a truck on a wet road. 50% of those indicated loss of sight as one of the reasons why. ProActive Wipers (PAW) is new software that identifies where other vehicles are and combines this with knowledge about wet roads. The system knows when nearby large vehicles present a risk of sudden water splashes, and activates the wipers. At the same time as the water hits the windscreen, it’s wiped away, giving the driver a clear view. “ProActive Wipers is a good example of how we can use technology that already exists in cars in new and creative ways. This solution uses the car’s camera, radar and rain sensor to make traditional technology, like windscreen wipers, smarter and driving safer for the user,” says Magnus Carlsson, responsible for safety and autonomous driving at Semcon. Information from PAW could also be used in different ways, for example to assess the risk of aquaplaning. Semcon also sees a big potential for the solution when autonomous cars come to market. “Driverless cars are dependant on cameras and other critical sensors behind the windscreen being kept free from dirt and water. The intelligence inside PAW could therefore be used to increase safety and reliability in self-driving cars,” says Magnus Carlsson. PAW is a proprietary and patent pending innovation from Semcon, which uses information from the car’s existing equipment. PAW has been evaluated in real conditions and the software could easily be implemented in today’s cars. See the film about PAW (https://www.youtube.com/watch?v=yFw6sMSgxwI) Download the complete press pack including the FAQs  (https://www.dropbox.com/sh/g9zl99wdomxa24c/AAD9gjMd809ejbuXZTid9VBEa?dl=0) www.semcon.com/paw

Nordea publishes its Annual Report and Sustainability Report

Today, Nordea publishes its Annual Report and Sustainability Report on nordea.com.The Annual Report describes operations in 2016 – an eventful year for Nordea. Besides macroeconomic and regulatory challenges for the sector, Nordea contended with substantial media attention, and commenced the implementation of a sweeping transformation agenda. Two important milestones during the year were the implementation of the new legal structure, and the launch of the first service on the new core banking platform.Despite the challenging market with sustained exceptionally low interest rates, we were pleased to report an improved net interest margin. Inflow to asset management was record-high, Euromoney awarded Nordea Private Banking for having the best Nordic Private Banking offering. We also further cemented our leading position in the Nordics in corporate advisory. However, earnings declined 1% over the full year.During the year, the operations of the former Retail Banking business area were streamlined and two new customer organisations were created – Personal Banking, which serves the household market, and Commercial and Business Banking, serving SMEs. This streamlining enables a sharper focus on improving the customer experience of Nordea, and puts us in a better position to keep working to strengthen the execution capacity in each customer group.The cost progression and credit quality were in line with our forecasts. The CET1 ratio improved by 190 bp in 2016 to 18.4%, and return on equity was 11.5%. Nordea’s board proposes a dividend of EUR 0.65 per share.We expect 2017 to be eventful too, and stand prepared to face the challenges. Our strategic focus is clear. Thanks to our strong balance sheet and robust business model, we can continue to invest in our platform and hence fundamentally change the bank. We continue to focus on creating a fully digital platform, improving customer satisfaction and transforming the organisation. In so doing, we will be best at compliance, with a strong ethics and value culture, and meet our commitments towards society and generate value for our customers and shareholders.In 2016 the bank embarked on a major transformation journey. In order to ensure a sustainable business model, environmental, ethical and social aspects must be integrated into all parts of our business. During the year we established a Business Ethics and Values Committee, chaired by the CEO, and appointed a new Head of Sustainability. We have also held dialogue meetings with a great number of stakeholders, and based on these have identified nine sustainability goals that we will work with in 2017. You can read about these in the Sustainability Report 2016. The Annual Report and Sustainability Report can be downloaded from nordea.com. The Capital and Risk Management (Pillar III) Report 2016 will also be available for downloading from nordea.com/ir. The Sustainability Report and Capital and Risk Management Report are available in English only.For further information:Claes Eliasson, Acting Head of External Communication, +46 72 141 67 12Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15

Stena Line’s four new vessels planned for Belfast routes

-Introducing the world’s most fuel efficient RoPax vessels- Last year Stena announced a newbuild contract of four RoPax ferry vessels with a planned delivery schedule during 2019 and 2020.  The contract also contains an option for another four vessels to be ordered.  The four vessels are being built at the AVIC Shipyard in China and the plan is to locate the vessels on the Irish Sea, specifically on Stena Line’s routes to and from its expanding Belfast hub. “The routes to and from Belfast are strategically very important to Stena Line and during the last number of years we have made significant investments in ports and vessels to improve and develop our capacity offering a frequent high quality service for our customers to and from Belfast. Looking ahead, we intend to continue our ambitious development plan for our business in the region and the new vessels are a part of this strategic plan.   During the last few years we have seen a steady growth in freight and passenger volumes and we believe this will continue. Last year was a record year for us when we for the first time carried over 500,000 freight units through Belfast Port.  These new vessels will be the largest ferries ever to operate between Belfast and Great Britain”, said Stena Line’s CEO Niclas Mårtensson. Joe O’Neil, Commercial Director, Belfast Harbour commented: “We are delighted that Stena Line is planning for Belfast as the location for its next generation of RoPax vessels in what is a significant investment in and enhancement of Northern Ireland’s premier freight and tourism gateway.  Belfast Harbour has worked in close partnership with Stena Line over the last two decades to help it expand its Belfast routes into a flourishing hub and this very welcome investment news comes on the back of a record year for Stena Line’s freight business in Belfast Harbour.  We look forward to welcoming the new vessels and the associated benefits they will bring to Belfast Harbour and the economy of Northern Ireland.”  The new vessels are being constructed in line with Stena Line’s strategic focus on sustainability. “The new RoPax vessels will be among the most fuel efficient in the world with approximately 25% lower CO2 emissions per cargo unit than current RoPax tonnage.  Our aim is to lead the development of sustainability within the shipping industry and set a new industry standard when it comes to operational performance, emissions and cost competiveness.  The vessels will run on traditional fuel, but are designed to the class notation “gas ready” and are also prepared for scrubbers as well as catalytic converters, giving us flexibility for the future”, says Niclas Mårtensson. Stena Line, Gothenburg  15th February 2017

Studsvik’s Year-end Report for January – December 2016

· Sales in the quarter was SEK 246.3 (196.9) million. In local currencies sales increased by 23 per cent. · The operating profit for the quarter amounted to SEK 27.0 (11.4) million. Itemsaffecting comparability impacted earnings for the quarter by SEK –9.3 (0) million. · The free cash flow for the quarter was SEK –22.2 (8.5) million. · The full year net profit increased to SEK 63.0 (2.4) million. The Board of Directors proposes a dividend of SEK 1 per share. +---------------+-----------+-----------+-------------+-------------+| |Oct-Dec2016|Oct-Dec2015|Full year2016|Full year2015|+---------------+-----------+-----------+-------------+-------------+|Sales, SEK |246.3 |196.9 |758.8 |721.2 ||million  | | | | |+---------------+-----------+-----------+-------------+-------------+|Operating |27.0 |11.4  |24.7 |36.6 ||profit, SEK | | | | ||million  | | | | |+---------------+-----------+-----------+-------------+-------------+|Profit after |8.7 |2.8 |17.0 |14.6  ||tax, SEK | | | | ||million  | | | | |+---------------+-----------+-----------+-------------+-------------+|Free cash flow,|–22.2 |8.5 |129.6 |–29.8 ||SEK million* | | | | |+---------------+-----------+-----------+-------------+-------------+|Net debt, SEK |2.9 |134.3  |2.9 |134.3 ||million* | | | | |+---------------+-----------+-----------+-------------+-------------+|Net debt/equity|0.8 |45.0  |0.8 |45.0 ||ratio, %* | | | | |+---------------+-----------+-----------+-------------+-------------+|Profit per |1.06 |0.34 |2.07 |1.78 ||share after | | | | ||tax, SEK | | | | |+---------------+-----------+-----------+-------------+-------------+|Equity per |42.41 |36.30 |42.41 |36.30 ||share, SEK* | | | | |+---------------+-----------+-----------+-------------+-------------+|*Refers to | | | | ||total | | | | ||operations  | | | | |+---------------+-----------+-----------+-------------+-------------+ The interim report will be presented at a telephone conference call according to separate distributed invitation at 2:30 PM CEST today. Please read the full interim report in the attached file. For further information, please contact: Michael Mononen, CEO, +46 155 22 10 86 or, Pål Jarness, CFO, +46 155 22 10 09 Facts about Studsvik Studsvik offers a range of advanced technical services to the global nuclear power industry. Studsvik’s business focus areas are fuel and materials technology, reactor analysis software and consultancy services within waste treatment technology, decommissioning, NORM and solutions for final disposal. The company has 70 years nuclear technology and radiological service experience. Studsvik has 700 employees in 7 countries and the company’s shares are listed on the Nasdaq Stockholm. This information is information that Studsvik AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons above, on February 15, 2017, at 1:30 pm (CEST).  www.studsvik.com   

Michelin solutions on board with McGill’s Buses

McGill’s Buses has signed up to a Michelin solutions tyre management programme for five more years, citing the company’s “fantastic support” as key to its decision to renew. The EFFITIRES™ contract covers 100 per cent of the operator’s more than 400 single- and double-decker buses, and will see Michelin solutions supply, fit and service the operator’s Michelin tyres. Ralph Roberts, Managing Director at McGill’s, says: “We’ve enjoyed fantastic support from Michelin solutions since appointing them to manage our tyres on a pence per kilometre basis in 2010. When the time came to review our tyre strategy, it was clear that extending our current EFFITIRES™ contract was the best decision for the business. “With Michelin solutions, we know our fleet is in expert hands. Plus, as we can keep track of the tyre costs we expect to face throughout the contract, we can focus purely on delivering an outstanding service to our customers.” Roberts adds: “If a bus is off the road with a puncture, our customers’ journeys can be affected, so choosing the correct tyre policy and supplier is key. Michelin tyres have proven to be ideal for our fleet, offering impressive durability, reliability and safety, which helps us to run a reputable, dependable service.” Working with an on-site engineer, Michelin solutions’ dedicated team helps ensure all tyres fitted to the company’s fleet are serviced to the highest standards. Michelin solutions proactively regrooves all tyres across the customer’s fleet to make full use of the additional layers of base rubber built into every new Michelin tyre as standard. This process helps McGill’s to save money on fuel, as regrooving extends the life of the tyre in its most fuel-efficient state. McGill’s also fits Michelin Remix retread tyres that help reduce its environmental footprint, as fewer new tyres need to be manufactured, and therefore fewer raw materials are consumed. McGill’s operates from five depots in Barrhead, Coatbridge, Greenock, Inchinnan and Johnstone. Its 1,000 employees help customers complete more than half a million journeys each week across 110 different routes. The company is a Scottish Business Insider Top 500 company. The 2017 Top 500 saw the company move up an impressive 81 places in the league table, to position 268. ends About Michelin solutions Michelin solutions is part of the Michelin Group and was established in May 2013, replacing the entity previously known in the UK as Michelin Fleet Solutions. It currently employs around 800 people globally and is responsible for in excess of 300,000 vehicles currently on contract. Michelin solutions is dedicated to designing, commercialising and developing solutions for fleets of trucks, buses, coaches, cars and vans. Its solutions are aimed at fleets wanting to improve their efficiency, productivity, and environmental footprint, in a global and customised way. http://fleetstreet.michelin-solutions.com/ http://news.cision.com/michelin-solutions For further press information please contact: James Keeler or Andy Hemphill, Garnett Keeler PR Tel: +44 (0)20 8647 4467 E-mail: james.keeler@garnettkeeler.com and andy.hemphill@garnettkeeler.com MICH_SOL/054/17

Update – JOSAB delivers purification technology to Indian infrastructure for water supply

· JOSAB supplies and finances 150-250 water kiosks including purification technology to Hyderabad in a BOO project. · HMWS&SB (Hyderabad Metropolitan Water Supply and Sewerage Board) is responsible for water supply with access to the Municipal water supply and assign appropriate locations. · Water kiosks are part of the state of Telangana’s regular water supply. · JOSAB estimates that the project generates a revenue over 7 years amounting to between MSEK 65 and 100. The project sum is an estimate based on local calculations and volumes. · Hyderabad is located in India and has 7 million inhabitants. Access to clean water is scarce as the water distributed in the normal municipal network is often contaminated. Since JOSAB has received many questions regarding the project, below is an in-depth information: As informed in a press release distributed November 30, 2016, JOSAB signed on November 29, 2016 a contract with a water treatment project in which JOSAB’s products will purify water in 150-250 water kiosks in Hyderabad, India. The project is a collaboration between JOSAB, the local company Natures Spring Eco Tap Pvt Ltd and the city of Hyderabad in the state of Telangana. Water kiosks will be placed at various locations in the city of Hyderabad. JOSAB is responsible for the  purification technology and production of water kiosks, while Natures Spring Eco Tap Pvt Ltd handles the marketing and public authorities as well as the daily operation of the units. Hyderabad city is responsible for water supply and provides sites with appropriate demographic conditions selected based on the city's internal statistics of previous consumed volumes of water kiosks and water needs. The project is based on a so-called BOO (Build Own Operate), where the payment is done via water tariffs, that is, JOSAB receives part of the revenues for a period of seven years. JOSAB gets paid based on purchased volume according to an integrated meter in each water kiosk. JOSAB owns the water kiosks throughout the project and beyond. The price is determined by the state to 1 rupee per liter of water and customers will fill the water in their own bottles. Bottled water costs 10-20 rupee per liter in stores. Payment is made with cash or a prepaid cards bought in kiosks. As a base of the previously announced sales revenues is the signed agreement, together with a volume assessment by the project partner and the city of Hyderabad. The calculated volume is estimated to be 4 m3 of water per day and machine, and hence no guarantee. The technology in water kiosk allows production of 24 m3 of fresh water per day. The city proposes placement of water kiosks based on the assessed needs in areas where demand is high, such as, for example, train stations, schools and shopping malls. The cost of, and access to, raw water is carried by the city of Hyderabad. JOSAB’s share of revenues under 7 years is estimated to be in the range of MSEK 65-100. JOSAB have been ready to supply the machines starting from December 2016, but delivery of the first machines have been postponed due to delays by the authorities in Hyderabad. The previously announced schedule is estimated to be kept, and according to the agreement all equipment will be deployed before the end of June 2017. Delays due to authority administration are common in India. The inauguration of the first machines will be done in the presence of a minister and is expected to occur shortly. JOSAB manufactures water kiosks using a subcontractor based on a long-term cooperation. Production of up to 250 water kiosks are procured and the units can be delivered within the agreed time schedule. Several Indian newspapers have written about JOSAB and the project. Water kiosks are part of the regular water supply in India and is attracting a lot of interest from the public. The publicity strengthens JOSAB’s brand. So far, two English-language newspapers reported about the project and also interviewed the Mayor who confirms that the project will be rolled out in the near future.1) 2) 1)            http://m.timesofindia.com/city/hyderabad/safe-drinking-water-at-drop-of-coin-250-dispensers-soon/articleshow/56675068.cms 2)            https://www.google.se/amp/telanganatoday.news/eco-friendly-water-purification-tech-for-water-atms/amp JOSAB in India JOSAB is established with its own subsidiary in Pune, India since 2012. JOSAB India has the task of establishing JOSAB’s technology in the Indian market for regular water supply. JOSAB has invested MSEK 5.8 in 2016 in India, of which MSEK 5.2 is financed through project financing from Prime World Ltd and Graceful Win Ltd. The authorities in Telangana announced in 2016 a contract to deploy between 150 and 250 water kiosks in and around the city of Hyderabad and with the requirement that JOSAB’s zeolite-based water treatment method should be used. JOSAB’s ecological purification method has been decisive for the choice of technology. JOSAB lacks tender license in Telangana and hence could not submit bids. In November JOSAB therefor signed a technical partnership with Natures Spring Eco Tap Pvt Ltd, a project company started for the purpose, and which has an agreement with the city of Hyderabad. The contract was signed on 29 November 2016. JOSAB supplies water kiosks containing JOSAB’s patented and ecological water treatment process. Water kiosks are part of the regular water supply in India and the agreement has a strategic value for JOSAB. After four years of testing of JOSAB’s products the state of Kerala introduced JOSAB’s technology as one of five approved water treatment technologies in public procurement in the state. JOSAB India received in March 2016 a tender licensed C that is valid in the state of Kerala and took its first order in the state in spring 2016. Tenders License C allows only participation in smaller projects, but with a number of additional orders in the state of Kerala qualify JOSAB India to apply for the higher bids license B. Offer B license will enable JOSAB to bid in India's states in their own name. Tender License B increases JOSAB’s opportunities to grow in India. Tenders totals in contracts that are made available with tender license B is also significantly greater than those available for holders of tender license C. In the state of Kerala, the World Bank in 2011 allocated MUSD 222 in a program for water and sanitation projects. The program is open to investment financing until 31 December 20183). With the State's approval of JOSAB’s technology and private tenders license in Kerala JOSAB India Pvt Ltd. can participate in procurements during 2017 and 2018, that is ongoing regarding this major project. 3)            http://projects.worldbank.org/P121774/second-kerala-rural-water-supply-sanitation-project-jalanidhi-ii?lang=en The potential in India is very large for JOSAB. Large areas of land, which includes the state of Kerala, has polluted rivers, which are important for the water supply, which is suited to be cleaned with JOSAB’s purification process. India seeks ecological solutions for water treatment and JOSAB’s green profile with ecological water treatment technology is a good fit. Stockholm 15th of February 2017 For more information, please contact: Johan Gillgren                                                               President/CEOJOSAB International AB       +46 (0)8 121 389 00                                                                                                                                                                     johan.gillgren@JOSAB.com  About JOSAB International ABJOSAB International AB manufactures and sells ecological water treatment solutions based on, by the company patented, unique filter material Aqualite™. JOSAB International AB has today four fully owned subsidiaries, JOSAB Hungary Kft, JOSAB India Pvt Ltd, JOSAB China Ecological Water Treatment Systems Co Ltd and JOSINT Financial Services AB.

Full year report 2016

Business highlights fourth quarter 2016  · Positive pivotal phase 3 trial results received for long-acting buprenorphine, CAM2038, for treatment of opioid addiction. · Start of Phase 1-trial of CAM2047, CAM2038 and CAM2058 for treatment of nausea and pain. · Stage 1 of the establishment of Camurus´ European commercial organization and operational structure completed. · Expansion of collaboration and license agreement with Braeburn Pharmaceuticals. · Preclinical development program for CAM2043 for treatment of pulmonary arterial hypertension completed. · Three presentations of long-acting buprenorphine, CAM2038, at ISAM annual meeting 2016 in Montreal. · Capital Markets and R&D Day held at the Royal Swedish Engineering Academy in Stockholm.  Financial summary fourth quarter 2016  · Revenues MSEK 37.1 (36.3). · Operating result before and after items affecting comparability MSEK -35.1 (-4.9) and MSEK -35.1 (‑40.4), respectively. · Result after tax MSEK -27.8 (-31.9). · Earnings per share SEK -0.75 (-1.05), before and after dilution. · Cash position MSEK 508.6 (716.1). Financial summary full year 2016  · Revenues MSEK 113.7 (154.8). · Operating result before and after items affecting comparability MSEK -102.5 (-30.5) and MSEK -102.5 (-204.1) respectively. · Result after tax MSEK -81.0 (-159.5) · Earnings per share SEK -2.17 (-6.02), before and after dilution. · Cash position MSEK 508.6 (716.1). CEO comments The final quarter of 2016 saw us achieve a major milestone for Camurus. Results from our completed Phase 3 study of CAM2038 in opioid dependence demonstrated significantly better treatment effect with our long-acting depots versus standard of care with daily sublingual tablets. With this achievement, we now initiated the work on the market approval applications for both the EMA and FDA. Our long-acting buprenorphine depots, CAM2038, for treatment of opioid dependence, clearly fulfilled efficacy primary endpoints agreed with the European Medicines Agency (EMA) as well as US Food and Drug Administration (FDA). Additionally, secondary analyses demonstrated superior efficacy versus daily sublingual buprenorphine/naloxone tablets. These clear-cut, positive Phase 3 results are particularly impressive in the light of the randomized, controlled double blind, double dummy design, and with regard to the complex patient population that was included directly from the active opioid misuse. Approximately 70% of the 428 study participants were using heroin and more than half of them were injection opioid users. Most of them also used other illicit drugs, including cocaine, amphetamine and marijuana. This group is representative of patients starting their treatment of opioid dependency both in EU and the US. Present daily treatment with buprenorphine or methadone has been clearly demonstrated to be effective in decreasing opioid misuse, reducing mortality and the spreading of infectious diseases. Unfortunately, these treatments have some significant limitations. These include poor treatment adherence, costs and stigma in connection to need of frequent clinic visits and supervised dosing, overdosing, as well as diversion and misuse. Using long-acting medications, these limitations can be significantly reduced, or even eliminated, as pointed out by Prof. Edward Nunes MD, PhD, Columbia University Medical School during his presentation at Camurus’ first Capital Markets and R&D Day in Stockholm, December 14, 2016. Combined with the documented treatment efficacy and favorable safety profile, our long-acting depot products have the potential to transform the treatment of opioid dependence and provide improvement to patients, healthcare providers and society. Process of filing market authorization and new drug applications for CAM2038 to the EMA and FDA mid 2017 are on track. During the period, important advances were also made regarding commercial manufacturing as well as establishment of our commercial organization and operational structure in front of the planned launching of CAM2038 in Europe during 2018. We have been working closely with experts and stakeholders within the various national health systems, as well as performing health economic analyses and modelling. Initial results will be presented at the AMCP Managed Care Specialty Pharmacy Annual Meeting i Denver, Colorado in March 2017. In our collaboration with Novartis, following the announcement of positive Phase 2 results for our subcutaneous long-acting octreotide depot, CAM2029, for treatment of acromegaly and neuroendocrine tumours (NET), a clinical study report has been completed during the quarter. Results will be presented at several conferences during the spring, including ENETS, Barcelona in March and at ENDO, Orlando in April. After completed preparations for GMP-manufacturing of the product during the quarter, GMP manufacturing is now initiated ahead of planned Phase 3 start later in the year. In the collaboration with Rhythm regarding weekly setmelanotide FluidCrystal® investigational product for treatment of genetic obesity disease, GMP-manufacturing was successfully completed and preparations of a clinical trial are ongoing ahead of the start during 2017. In our early development pipeline, we initiated a clinical pharmacokinetic study of new product candidates for treatment of pain as well as nausea and vomiting. Two of the programs are conducted with our US partner Braeburn Pharmaceuticals, after having expanded our license agreement during the period. A new exciting program in our pipeline is a subcutaneous depot of treprostinil, CAM2043, for treatment of pulmonary arterial hypertension. PAH is a rare progressive lung and heart disease with a poor life expectancy of less than 3 years, if left untreated. Based on our preclinical results, we believe that CAM2043 has potential to significantly improve treatment versus available treatments. Presently treprostinil is administrated using continuous infusion, a complex procedure associated with significant and treatment limiting side-effects such as pain and serious infections. The PAH market exceeded USD 4 billion 2015, with treprostinil representing about 25%. Our strong results delivered during the past year have resulted in an increased interest in Camurus and contributed to a positive development of the company value. Behind the success is our team of fantastic coworkers, dedicated partners and clinical investigators, as well as their study teams. Warm thanks to you all! Fredrik TibergPresident and CEO For more information: Fredrik Tiberg, CEO and Head of ResearchTel. +46 (0)46 286 46 92fredrik.tiberg@camurus.com    Rein Piir, VP Investor RelationsTel. +46 (0)70 853 72 92ir@camurus.com  This information is information that Camurus AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the chief executive officer, 07.00 AM CET on 16 February 2017.

QT GROUP PLC FINANCIAL REPORTING 2017

Segment reporting Qt Group comprises of one reportable segment that offers software development tools to its customers. The chief operating decision maker of Qt Group is the CEO together with the Group’s management team. Due to the business model of Qt Group and the nature of its operations and governance structure, Qt Group forms one reportable operating segment, Qt Group. The figures of the reportable segment form the figures of Qt Group. Revenue from products and services Qt Group has previously reported its revenue as one consolidated revenue figure for the Group.   In 2017, Qt Group reports revenue from products and services as follows: license sales and consulting, as well as support and maintenance. License sales and consulting comprises of developer licenses, distribution licenses (runtimes) and consulting. Support and maintenance comprises of maintenance fees. Comparison figures 2016 Revenue by 1-3/2 4-6/2 7-9/2016 10-12/2016 1-12/2016products 016 016andservices ThousandEURLicense 4 435 6 215 4 567 5 855 21 073sales andconsultingSupport and 2 713 2 720 2 900 2 989 11 322maintenance Revenue 7 148 8 935 7 467 8 845 32 395total Revenue from geographical locations In financial statements, Qt Group reports revenue from geographical locations by the location of assets as follows: North America and rest of the world. Qt Group PLC Board of Directors FURTHER INFORMATION CFO Mika Harjuaho, +358 9 8861 8040 Qt Group Plc Qt Group Plc is responsible for Qt development, productization and licensing under commercial and open source licenses. The Qt offering includes a development environment that enables the reuse of software code across numerous different operating systems, platforms and screen types, ranging from desktops and embedded systems to wearables and mobile devices. Qt is used by approximately 1 million developers worldwide and is the leading independent technology behind millions of devices and applications. Qt is the platform of choice for in-vehicle systems, industrial automation devices and other business critical applications manufacturers, and is used by leading global players in 70+ industries. The Qt Company operates in China, Finland, Germany, Japan, Korea, Norway, Russia and USA with about 200 employees worldwide. The Qt Group is headquartered in Espoo, Finland and is listed on Nasdaq Helsinki Stock Exchange. The company’s net sales in year 2015 was 27 MEUR. To learn more visit http://qt.io

Qt Group Plc updates its strategy and long-term goals and is planning to seek additional funding via rights issue

We are surrounded by touch screens and smart devices as digitalization is everywhere—not only in the consumer market but also in industrial equipment. The market penetration of touch screens, and the importance of a great user experience has grown so that the consumers are often making purchase decisions, such as on a car or a smart TV, based on its software content and user experience, and not on the form factor. On the other hand, the same user experience and content should work seamlessly across all the end user devices. Qt technology allows manufacturers to easily create graphical user interfaces for touch screens and software that works across all consumer devices such as desktop computers, smart phones, TVs and cars, as well as in industry, for example, on the factory floor. Today, Qt technology is already in use in more than 70 industries. For example, the automotive industry has in recent years taken Qt as a fundamental technology for the development of digital entertainment and control systems. Qt has business and development activities with most of the major global automobile manufacturers. The Board of Directors of Qt Group Plc wishes to accelerate this growth as witnessed in recent years by investing more in strategic growth areas, such as: · Growing the global sales network and · Product offering in selected industries Many of the key industries in which the company is pursuing growth in market share are undergoing technological transformations that involve making choices of technology platforms for the coming years. As these markets are being divided between the market players right now, it is essential for the company to aggressively capture market share and, most importantly, conclude significant commercial contracts with major OEMs. Contracts with large manufacturers enable scalable growth and continuous revenue streams in Qt’s distribution licensing based revenue model in embedded systems. The more devices are produced with Qt technology, the larger the number of distribution licenses sold. As the product development lifecycles in many industries—such as the automotive industry—are 2–3 years long, the investments being made now are geared towards boosting distribution license revenue particularly from 2019 onwards. Long-term financial goals In accordance with the updated strategy, the Board of Directors has set the following financial targets to be reached by the end of 2021: +--------------------------------+----------------+|Value |Target |+--------------------------------+----------------+|Annual turnover |100 million euro|+--------------------------------+----------------+|Operating profit margin (EBIT-%)|Over 15 % |+--------------------------------+----------------+ Due to investments made into the company’s growth, operating profit is estimated to be negative between 2017 and 2018 because of the upfront investments. In 2019, a positive commercial result is expected, at which time the operating profit margin is estimated to increase and operating profit of more than 15 percent of sales to be realized in 2021. Growth in net sales is primarily based on organic growth by increasing investments into embedded systems and industrial sectors, focusing on product development and expanding the sales network. Selected acquisitions, regarding the technology or services, are a possibility for accelerating the growth. The company's aim is to refrain from the distribution of dividends until further notice. Growing the global sales network Qt Group aims to expand its sales network by increasing the number of its own operating locations as well as the number of retailers. The plan for the company’s own operating locations is to cover the company’s largest geographical markets, which are currently the United States, Germany, China, South Korea and Japan. In the sales of embedded systems in particular, sales cycles are long and they require a local presence. Growth will also be pursued by developing the sales model and organisation with more focus on named strategic customer accounts. The company will seek to grow its network of retailers, particularly in countries with smaller business potential or where the local operating methods or markets deviate significantly from the company’s current operating methods or markets. The aim is also to expand the network of retailers to technology partners that operate globally or have their own distribution networks. The sales network will also be enhanced by increasing online distribution via the Internet. The current view of Qt Group’s Board of Directors is that the self-service based sales channel has limited significance to Qt’s business, but it enables the company to allocate its own sales resources better. Product offering for selected industries Qt provides technology solutions for two main market segments: 1. Platform independent application development for desktop and mobile applications 2. Development of embedded systems Desktop and mobile application development markets are stable for Qt, where the development tool has a good reputation, market share and a large customer base. The company’s Board of Directors believe this market will continue to grow steadily and will continue to bring a steady cash flow. However, these market growth opportunities are restricted by the limited number of software developers. In the embedded systems market the company’s revenue model is, to a large extent, based on the number of products manufactured by means of the distribution license. For this reason, the embedded systems market provides a more scalable target market in comparison to desktop and mobile applications. The Internet of Things (IoT) will revolutionize many industries and change the way in which future devices and systems are developed. As a result of these changes, more and more devices are intelligent, connected to other devices, and connected to the network. The value provided by embedded devices to the user is often based on the user experience, this is also the case in an industrial environment. Although the device will only be used by a trained specialist, for example, in a factory or a hospital environment, it is important that the usability of the device is comparable to the usability of a consumer device, such as a smartphone. Thus with the proliferation of the Internet of Things, above all, the need to create good user interfaces will increase. On the other hand, when the same user experience needs to be available on every device easily and effectively, the need for a platform-agnostic solution like Qt grows. By using Qt, embedded equipment manufacturers can develop software for their devices, and, above all, create user interfaces efficiently. In practice, this means delivering products to the market faster using Qt. In addition, Qt offers device manufacturers with the ability to create their own platforms with external software, such as intelligent-TV or in-car entertainment systems, which offer external services. Qt technology is ideally suited for making embedded systems and platform-independent applications and user interfaces. This competitive advantage will be further developed with a focus on development tools, and thus enhancing customers' development cycles, support for new software and hardware technologies and additional features for creating user interfaces, among other things. Industry-focused approach enables long-term growth—Automotive industry the primary one A specific strategic focus area for the company regarding the embedded systems market is the additional investment in selected industries such as Automotive, Automation and Digital Television sectors. By introducing additional industry-specific solutions and integrations the company can offer better value and grow the market share and revenue in these industries. Especially for the Automotive industry the company will continue its additional investments to grow the market share by developing specific technology solutions and expanding the automotive-specific sales network. Dual-licensed technology A growing trend in the software industry is the utilization of open source code and solutions. Qt technology has been dual-licensed under open source and commercial licenses over the whole 20 years of its history. Because of this, Qt has a wide and vibrant ecosystem of over one million developers. The development of Qt technology itself takes widely place in the open source community together with other companies, organizations and individual code contributors which enhances the product quality, creditability and the ability to introduce new features to the technology. As an open source solution Qt offers device vendors a truly independent solution for creating their own software platforms and ecosystems for their own application developers. For instance automotive OEMs and smart TV vendors can create entertainment systems that enable external 3rdparty content so that the vendors maintain their ownership and control of the end user data. This is a highly important competitive advantage of Qt compared to other application ecosystems. The open source licensing scheme of Qt was updated during 2016 with Qt 5.7 release so that it is clearer when a commercial license is required over an open source license especially when creating commercial end user devices. The Board of Directors believes that this will have a positive impact on the development of the company’s revenue as it improves the commercial conversion during years 2017-2019. Rights Issue to Fund Investments into Growth Qt's Board of Directors has decided to propose 14/03/2017 convening the Company's Annual General Meeting on authorizing the Board to decide on seeking additional funding of approximately EUR 15 million via share issue based on shareholders' pre-emptive subscription-based rights offering (the "Share Issue"). The Board of Directors proposes to the AGM that the AGM authorize the Board to decide on issuing a total maximum of 4,500,000 new shares or treasury shares in one or more Share Issues against payment. The company's four largest shareholders, Ingman Development Oy Ab, Keskinäinen Eläkevakuutusyhtiö Ilmarinen, Jyrki Hallikainen and Kari Karvinen, have preliminarily announced their intention to participate in the Share Issue in proportion to their respective share of ownership. In accordance with the authorization as proposed by the Board of Directors, the Board of Directors will decide on detailed terms and conditions of the Share Issue. Qt Group Plc Qt Group Plc is responsible for Qt development, productization and licensing under commercial and open source licenses. The Qt offering includes a development environment that enables the reuse of software code across numerous different operating systems, platforms and screen types, ranging from desktops and embedded systems to wearables and mobile devices. Qt is used by approximately 1 million developers worldwide and is the leading independent technology behind millions of devices and applications. Qt is the platform of choice for in-vehicle systems, industrial automation devices and other business critical applications manufacturers, and is used by leading global players in 70+ industries. The Qt Company operates in China, Finland, Germany, Japan, Korea, Norway, Russia and USA with about 200 employees worldwide. The Qt Group is headquartered in Espoo, Finland and is listed on Nasdaq Helsinki Stock Exchange. The company’s net sales in year 2015 was 27 MEUR. To learn more visit http://qt.io

Year-end report 1 January – 31 December 2016

3 months ended 31 December 2016 · Local currency sales increased by 8% and Euro sales increased by 5% to €355.1m (€339.5m). · Number of registered actives* decreased by 7% to 3.0m. · EBITDA amounted to €49.0m (€39.7m). · Operating margin was 11.8% (9.6%, adjusted** 11.5%), impacted by -110 bps from currencies, and operating profit was €42.0m (€32.6m, adjusted** €38.9m). The operating margin was favourably impacted by a VAT income related to the Russian tax case, fully offset by Ukrainian and other one-off restructuring costs as well as costs linked to the outsourcing of financial and IT operations to IBM. · Net profit was €25.2m (€8.9m, adjusted** €15.2m) and diluted EPS €0.44 (€0.16, adjusted** €0.27). · Cash flow from operating activities was €61.7m (€68.8m). · The first quarter to date sales development is approximately 11% in local currency. *Replaces the former definition “active consultants” and represents Consultants having placed at least one order during the last 3 months.**Adjusted for non-recurring items of €6.3m in the fourth quarter 2015. 12 months ended 31 December 2016 · Local currency sales increased by 12% and Euro sales increased by 3% to €1,249.4m (€1,211.6m) · EBITDA amounted to €148.2m (€117.4m). · Operating margin was 9.5% (7.5%, adjusted* 8.3%), impacted by -250 bps from currencies, and operating profit was €119.2m (€90.6m, adjusted* €100.2m). · Net profit was €66.7m (€34.2m, adjusted** €43.2m) and diluted EPS €1.18 (€0.62, adjusted** €0.79). · Cash flow from operating activities amounted to €113.1m (€122.2m). · The Board of Directors will propose to the 2017 AGM a total dividend of €1.50 per share for 2016, of which €1.00 (€0.40) per share is to be considered as ordinary and €0.50 to be considered as extra dividend. The ordinary dividend is to be paid in equal quarterly instalments of €0.25 respectively starting in the second quarter 2017, and the extra dividend is to be paid during the second quarter 2017. *Adjusted for non-recurring items of €9.6m during the period 2015.**Adjusted for additional non-recurring items of (€0.5m) during the period 2015. CEO Magnus Brännström comments“2016 was a year when we made significant steps to improve the overall position of Oriflame and when the success from our online leaders and the sales of Skin Care and Wellness sets and routines reached new levels. It was a year when we returned to Euro growth, delivered double-digit local currency growth and increased the profitability each consecutive quarter – despite challenging market conditions and deteriorating macro. 2017 marks the 50th anniversary of Oriflame and we are reaching this milestone stronger than ever before, equipped with a good underlying momentum, solid strategy and strong financial position. At the same time, many of our markets continue to be volatile and face highly uncertain geopolitical and macroeconomic conditions. The first quarter has started in a promising way and we will continue to deliver on our strategy – ready to meet an ever-changing world during the next 50 years.” OtherA Swedish translation is available on www.oriflame.com. Conference call for the financial communityThe company will host a conference call on Thursday, 16 February 2017 at 9.30 CET. Participant access numbers:SE: +46856642698DK: +4535445575FI: +358981710491NO: +4723500252UK: +442030089801US: +18557532235The conference call will also be audio web cast in “listen-only” mode through Oriflame’s website: www.oriflame.com or through http://oriflame-ir.creo.se/170216 16 February 2017 Magnus BrännströmChief Executive Officer For further information, please contact: Magnus Brännström, Chief Executive Officer Tel: +41 798 263 754Gabriel Bennet, Chief Financial Officer Tel: +41 798 263 769Nathalie Redmo, Sr. Manager IR Tel: +41 799 220 173 This information is information that Oriflame Holding AG is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:15 CET on February 16, 2017. Oriflame Holding AGBleicheplatz 3, CH-8200 Schaffhausen, Switzerlandwww.oriflame.comCompany registration no CHE-134.446.883

Year-end report 2016 and quarterly report October – December 2016

Fourth quarter 2016:  · Revenues for the fourth quarter increased by 23.9% to SEK 400 (323) million · Operating profit amounted to SEK 156 (122) million, an increase of 28.1% · Operating margin was 39.0 (37.7)%  · Profit after tax amounted to SEK 150 (116) million, an increase of 29.6% · Earnings per share amounted to SEK 0.62 (0.48) after dilution  · 13 new customer agreements were signed, 12 new customers’ casinos were launched Full year 2016: · Revenues for the full year increased by 28.5% to SEK 1,455 (1,132) million · Operating profit amounted to SEK 536 (402) million, an increase of 33.4% · Operating margin was 36.8 (35.5)% · Profit after tax amounted to SEK 504 (374) million, an increase of 34.9% · Earnings per share amounted to SEK 2.10 (1.56) after dilution · 45 new customer agreements were signed and 34 new customers’ casinos were launched · Proposed cash distribution to shareholders of SEK 2.25 (1.33) per share · At the end of 2016, NetEnt had 31 signed customers that had not yet been launched Important events in the fourth quarter:  · Retail deal signed with Gauselmann for gaming machines market in Italy  · Retail agreement entered with Paddy Power for gaming machines in Great Britain · NetEnt games launched on the regulated markets in Bulgaria and Portugal  · Contract signed with Codere regarding online games distribution in Mexico Comments by Per Eriksson, President and CEO: Another record year for NetEnt2016 was another exciting year for NetEnt with new record levels in revenues, earnings and cash flow. The year featured many new customers, new regulated market entries and successful game launches for NetEnt. Revenues for the full year increased by 28.5 percent to 1,455 SEKm. Operating profit and profit before taxes amounted to SEKm 536 and SEKm 546 respectively, and the operating margin improved to 36.8 percent. We believe in corporate social responsibility as a condition for long-term sustainability of our business, and focus on growing on regulated markets. During the year, we became members of the World Lottery Association (WLA), a member-based organization that promotes the interests of state-authorized lotteries around the world. Following new licenses and certifications, our games were launched on the regulated markets in Romania, Bulgaria and Portugal. We signed a total of 45 new customer agreements, the highest number ever, and we launched our games with 34 new customers. During the year, we made several larger investments – we continued to enhance our platform and developed a mobile solution for Live Casino Roulette, which we think will support future growth for us in this segment. The game trilogy NetEnt Rocks was very successful and Guns N’ Roses was named best game of the year at the EGR Operator Awards in London. We also launched a range of other innovative, best-in-class games such as Aloha, Drive, Warlords and Little Red Riding Hood, all of which became great successes among customers and players. In addition to offering the best games in the industry, we also manage all gaming transactions for our customers through so-called hosting. Our games are available 24/7, all year around. In 2016, we managed almost 36 billion transactions in our systems, which is 19 times more than the total number of transactions on the New York Stock Exchange during the same period. High growth and good profitability in the fourth quarterThe fourth quarter developed well, revenues increased by 23.9 percent in SEK and by 18.5 percent in EUR compared to the very strong fourth quarter of 2015. The operating margin improved to 39.0 percent, mainly due to better scalability in the business. Great Britain continues to offer great growth potential for us and in December, it became our largest geographical market for the first time. Mobile games continue to be an important growth driver and accounted for 43 percent of revenues in the quarter. We signed new retail deals for gaming machines with Gauselmann in Italy and Paddy Power in the UK. We also took our first step into Latin America by extending our partnership with Codere to include the regulated online casino market in Mexico. Future outlookFor the first quarter of 2017, we expect revenues to be in line with the fourth quarter of 2016. For the rest of 2017, we see conditions for continued solid growth supported by a strong pipeline of new games, growing market shares in the UK, mobile growth, new customers to launch, as well as our expansion in North America. We increase the number of employees, enhance our product offering and integrate more customers on new regulated markets. With this in mind, we foresee higher costs and an ongoing need to invest during 2017. These are all projects that will enable continued solid growth for NetEnt going forward. Presentation of earnings reportOn Thursday, February 16, 2017, at 9.00 a.m. the earnings report will be presented by CEO Per Eriksson live via webcast. The presentation can be followed in real-time on NetEnt’s website at https://www.netent.com/en/section/invest/. For additional information please contact:Per ErikssonPresident and CEOPhone: +46 8 5785 4500per.eriksson@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7:30 CET on February 16, 2017.

Profitability target of 12% reached, record high full-year results and cash flow

MUNKSJÖ OYJ, FINANCIAL STATEMENTS BULLETIN, Helsinki, Finland, 16 February 2017 at 07:30 AM CET Profitability target of 12% reached, record high full-year results and cash flow Highlights of the fourth quarter 2016 ·  Net sales were EUR 282.4 (290.0) million. ·  Adjusted EBITDA was EUR 36.1 (22.1) million and the adjusted EBITDA margin was 12.8% (7.6%). Items affecting comparability (IAC) amounted to EUR -6.6 (0.0) million, mainly related to the planned combination.  ·  Operating result was EUR 16.4 (8.5) million and net result EUR 11.8 (7.2) million. ·  Earnings per share (EPS) were EUR 0.23 (0.14). ·  Operating cash flow was EUR 41.3 (44.5) million.  ·  On 7 November 2016, Munksjö announced the plan to combine with Ahlstrom Corporation and create a global leader in sustainable innovative fiber-based solutions.   Highlights of January-December 2016 ·  Net sales were EUR 1,142.9 (1,130.7) million. ·  Adjusted EBITDA was EUR 136.7 (93.6) million and the adjusted EBITDA margin was 12.0% (8.3%). Items affecting comparability (IAC) amounted to EUR -6.6 (-7.3) million, mainly related to the planned combination.  ·  Operating result was EUR 74.9 (32.7) million and net result EUR 43.3 (22.8) million. ·  Earnings per share (EPS) were EUR 0.85 (0.44). ·  Operating cash flow was EUR 114.3 (55.5) million. ·  The Extraordinary General Meeting (EGM) approved the combination with Ahlstrom on 11 January 2017. ·  The EGM also authorised the Board of Directors to resolve on an extra payment of funds from the company's reserve for invested unrestricted equity as return of equity of maximum EUR 0.45 per share. KEY FIGURES Oct-Dec Jan-DecMEUR 2016 2015 Change, % 2016 2015 Change, % Net   sales 282.4 290.0 -3% 1,142.9 1,130.7 1%EBITDA   36.1 22.1 63% 136.7 93.6 46%(adj.*)EBITDA   12.8 7.6 12.0 8.3margin, %(adj.*)EBITDA 29.5 22.1 33% 130.1 86.3 51%EBITDA   10.4 7.6 11.4 7.6margin, %Operating   23.0 8.5 171% 81.5 40.0 104%result (adj.*)Operating   8.1 2.9 7.1 3.5margin, %(adj.*)Operating   16.4 8.5 93% 74.9 32.7 129%resultOperating   5.8 2.9 6.6 2.9margin, %Net   result 11.8 7.2 64% 43.3 22.8 90%Earnings   per 0.23 0.14 66% 0.85 0.44 93%share (EPS),EURInterest 169.5 227.4 -25% 169.5 227.4 -25%-bearing   netdebt *Adjusted for items affecting comparability (IAC)  Unless otherwise indicated, the figures in parentheses refer to the figures for the equivalent period in 2015. This financial report is unaudited. It is published in Swedish, Finnish and English. In case of any discrepancies between the three versions, the Swedish text shall prevail. Comment from Munksjö’s President and CEO, Jan Åström  “I am proud of our team and what we have achieved in 2016. We reached our ambitious target, set in 2013, of an EBITDA margin of 12 per cent. We announced the plan to combine Munksjö and Ahlstrom through a merger to create a global leader in sustainable and innovative fiber-based solutions, and we communicated new expected targets including an EBITDA margin target of above 14 per cent for the combined company. The combination is expected to create significant value for the stakeholders through stronger global growth opportunities and improved operational efficiency. During 2016, the adjusted EBITDA reached EUR 136.7 (93.6) million, an improvement of EUR 43 million or 46 per cent. All four business areas have executed on their respective profitability improvement plans and approximately half of the result improvement is based on our own actions to increase efficiency. The rest was mainly attributable to favourable cost conditions. Market demand has remained stable on a good level in all key businesses. Some geographical markets, such as Brazil, have still been impacted by macroeconomic uncertainty during 2016 but we have been able to compensate this with exports to other markets. Our long-term market growth expectation remains intact at between 2-4 per cent annually, as the demand for several of the end-use applications of our solutions is supported by global megatrends such as urbanization and globalisation. Our strong performance in 2016 has strengthened the company. I am now looking forward to the next big step in the development through the merger with Ahlstrom that is expected to be completed early in the second quarter of 2017. The preparations for the integration process are proceeding according to plan and together we will improve our competitiveness further and create a strong growth platform for the future.” Outlook  The demand outlook for 2017 for Munksjö’s specialty paper products is expected to remain stable at the current good level and to reflect the seasonal pattern.  The annual maintenance and vacation shutdowns in the second and third quarter as well as the seasonal shutdowns at the end of 2017 are expected to be carried out to about the same extent as in 2016. The next maintenance shut down at the pulp production facility in Aspa in Sweden will be carried out in the fourth quarter of 2017. The cash flow effect of current capital expenditure for fixed assets in 2017 is expected to be approximately EUR 40 million and, in addition, the cash flow impact of the strategic investment in the Arches mill is expected to be approximately EUR 14 million. The outlook for the financial year 2017 is given for Munksjö as a stand-alone company with its current operations. The Munksjö Group  Oct-Dec Jan-DecMEUR 2016 2015 Change, % 2016 2015 Change, % Net   sales 282.4 290.0 -3% 1,142.9 1,130.7 1%EBITDA   36.1 22.1 63% 136.7 93.6 46%(adj.*)EBITDA   12.8 7.6 12.0 8.3margin, %(adj.*)EBITDA 29.5 22.1 33% 130.1 86.3 51%EBITDA,   10.4 7.6 11.4 7.6margin %Operating   23.0 8.5 171% 81.5 40.0 104%result (adj.*)Operating   8.1 2.9 7.1 3.5margin, %(adj.*)Operating   16.4 8.5 93% 74.9 32.7 129%resultOperating   5.8 2.9 6.6 2.9margin, %Net   result 11.8 7.2 64% 43.3 22.8 90%Capital   10.7 8.9 20% 39.2 39.8 -2%expenditureEmployees,   2,752 2,749 0% 2,755 2,774 -1%FTE * Adjusted for items affecting comparability (IAC) Fourth quarter 2016  · Total group delivery volumes decreased. The positive volume development in most of the product segments, especially the Brazilian paper business in Business Area Release Liners, did not compensate for the lower volume for the specialty pulp business and the Decor business, where the comparison period was historically strong and included a large year-end delivery. ·  EBITDA adjusted for IAC increased to EUR 36.1 (22.1) million and the adjusted EBITDA margin was 12.8% (7.6%). The positive result effect was driven by profitability improvement actions, lower variable costs and higher production. ·  The seasonal shutdowns in the fourth quarter were shorter compared to 2015 particularly in the Business Area Graphics and Packaging and in the Brazilian paper business in Business Area Release Liners where seasonal shutdowns in 2015 were prolonged. ·  IAC amounted to EUR -6.6 (0.0) million, whereof approximately EUR 4 million were related to the planned merger with Ahlstrom. Furthermore, approximately EUR 2 million were related to the terminated long-term share-value-based incentive program. ·  The operating result was EUR 16.4 (8.5) million and net result EUR 11.8 (7.2) million. ·  In the reporting period the currency hedging result impacting operating profit amounted to EUR -0.8 (-0.2) million. Exchange gains on financial assets and liabilities were EUR 1.6 (1.4) million and are reported in financial items. January-December 2016 · Total group delivery volumes increased in most of the product segments and were stable in decor papers. The delivery volume development was particularly strong in the specialty pulp business and the Brazilian paper business in Business Area Release Liners. · Net sales increased to EUR 1,142.9 (1,130.7) million, as higher volumes compensated for the lower average price, mainly driven by the lower sales price for long fibre specialty pulp and a different product mix compared to last year. ·  EBITDA adjusted for IAC increased to EUR 136.7 (93.6) million and the adjusted EBITDA margin was 12.0% (8.3%). Higher delivery volumes had a positive effect of EUR 10 million. This was offset by EUR 11 million as an effect of the lower average price. Lower variable costs, driven mainly by operational efficiency related actions, the lower energy price and lower raw material prices had a positive result effect of EUR 54 million. Higher fixed costs had a negative result effect of EUR 10 million, mainly as a result of accruals for incentive plans and increased manning related to higher production volumes. ·  Out of the total profitability improvement, amounting to EUR 43 million, approximately half was related to actions related to the plan to reach the profitability target. ·  The annual maintenance and vacation shutdowns in the second and third quarter were carried out to about the same extent as in 2015. The seasonal shutdowns in the fourth quarter were shorter compared to 2015 particularly in the Business Area Graphics and Packaging and in the Brazilian paper business in Business Area Release Liners where seasonal shutdowns in 2015 were prolonged.  ·  IAC amounted to EUR -6.6 (-7.3) million, whereof approximately EUR 4 million were related to the planned merger with Ahlstrom. Furthermore, approximately EUR 2 million were related to the terminated long-term share-value-based incentive program. The IAC in the comparison period 2015 was mainly related to restructuring actions.  ·  The operating result was EUR 74.9 (32.7) million and net result EUR 43.3 (22.8) million. ·  In the reporting period, the currency hedging result impacting operating profit amounted to EUR -1.7 (-4.9) million. Exchange losses on financial assets and liabilities were EUR 1.5 (gains of 9.5) million and are reported in financial items. Combination with Ahlstrom On 7 November 2016, Munksjö Oyj and Ahlstrom Corporation announced a plan to merge the two companies. The combination will create a global leader in sustainable and innovative fiber-based solutions. The combination is expected to create significant value for the stakeholders in the combined company through stronger global growth opportunities and improved operational efficiency. The combined company’s growth ambitions will be supported by a strong balance sheet and strong cash flow generation.  ·  Munksjö and Ahlstrom will merge through an absorption merger whereby Ahlstrom’s shareholders will receive Munksjö shares as merger consideration. ·  Ahlstrom’s shareholders will receive 0.9738 new shares in Munksjö for each share held in Ahlstrom as merger consideration, corresponding to an ownership in the combined company of approximately 47.2% for current Ahlstrom shareholders and approximately 52.8% for current Munksjö shareholders. Unaudited pro forma financials of the combined company and certain other information, such as composition of the management team can be found in the merger prospectus, published on 16 December 2016. Munksjö entered on 10 November 2016 into a facilities agreement for the merger and the combined company with Nordea and SEB as the joint underwriters. The new financing consists of approximately EUR 560 million multicurrency term and revolving credit facilities with maturities ranging between three and five years; and EUR 200 million bridge facility for Ahlstrom, which will be assumed by Munksjö as from the date of completion of the merger with amended terms and commitments reduced to EUR 100 million. The syndication of the term loan facilities and the revolving credit facility was concluded on 23 December 2016 and is provided by SEB, Nordea and Danske Bank as bookrunners. BNP Paribas, OP Corporate Bank and Swedbank joined as Mandated Lead Arrangers and Citi, Commerzbank, Crédit Agricole and DNB Bank joined as Lead Arrangers. Financial targets for the planned combined company are expected to include an EBITDA margin above 14 per cent over a business cycle, a net gearing below 100 per cent, as well as a stable and annually increasing dividend. Profitability target reached  Munksjö’s profitability target, set in 2013, to reach an EBITDA margin of 12 per cent at the end of 2016 was achieved according to plan. The drivers for the profitability improvement included continued operational efficiency, profitable growth, product and service quality leadership and utilising the position as a market and innovation leader. Within operational efficiency, the majority of the planned actions included measures to adjust the cost structure. Of the realised actions in the financial result in January-December 2016, the majority were related to operational efficiency. Further information on the actions related to the profitability improvement plan and their effect on the financial result can be found under the heading Munksjö Group. Events after the end of the reporting period  The Extraordinary General Meetings of both Munksjö Oyj and Ahlstrom Corporation were held in Helsinki on 11 January 2017. Munksjö’s EGM resolved, inter alia, to approve the combination of Ahlstrom’s and Munksjö's business operations through a statutory absorption merger of Ahlstrom into Munksjö and approve the merger plan. The EGM also resolved to authorise the Board of Directors to resolve on an extra payment of funds from the company's reserve for invested unrestricted equity as return of equity of maximum EUR 0.45 per share. The merger, which is expected to be completed at the beginning of the second quarter of 2017, is subject to among other things approval by relevant competition authorities. Webcast and conference call  A combined news conference, conference call and live webcast will be arranged on the publishing day 16 February 2017 at 10:00 a.m. CET (11:00 a.m. EET, 8:00 a.m. GMT) at restaurant Savoy (Eteläesplanadi 14, 7th floor, Helsinki). The report will be presented by President and CEO Jan Åström. The event will be held in English. The conference call and live webcast can be followed on the Internet and an on-demand version of the webcast will be available on the same webpage later the same day. To join the conference call, participants are requested to dial one of the numbers below 5-10 minutes prior to the start of the event. Webcast and conference call information Finnish callers: +358 (0)9 7479 0404Swedish callers: +46 (0)8 5065 3942US callers: +1 719 457 2086UK callers: +44 (0)330 336 9412Conference ID: 7977721 Link to the webcast: http://qsb.webcast.fi/m/munksjo/munksjo_2017_0216_q4/#/webcast For further information, please contact:  Jan Åström, President and CEO, tel. +46 10 250 1001 Pia Aaltonen-Forsell, CFO, tel. +46 10 250 1029

Year-end Report January-December 2016

October – December 2016• Net sales decreased with 6 percent to SEK 579 million (613)• Operating profit before depreciation increased to SEK 28 million (25)• Non-recurring items amounted to SEK -11 million (-12)• Adjusted EBIT before depreciation increased to SEK 39 million (37)• Operating profit increased to SEK 15 million (1)• Earnings after tax amounted to SEK -1 million (-13)• Earnings per share amounted to SEK -0.01 (-0.08)• Cash flow after investing activities amounted to SEK 23 million (5) January – December 2016• Net sales decreased with 9 percent to SEK 2,135 million (2,345)• Operating profit before depreciation decreased to SEK 61 million (70)• Non-recurring items amounted to SEK -18 million (-36)• Adjusted EBIT before depreciation decreased to SEK 79 million (106)• Operating profit increased to SEK 9 million (-5)• Earnings after tax amounted to SEK 297 million (-64)• Earnings per share amounted to SEK 1.42 (-0.41)• Cash flow after investing activities amounted to SEK 30 million (-75) Bong is one of the leading providers of specialty packaging and envelope products in Europe and offers solutions for distribution and packaging of information, advertising materials and lightweight goods. Important growth areas in the Group are packaging within retail and e-commerce and the envelope market within Eastern Europe. The Group has annual sales of approximately SEK 2.1 billion and about 1,500 employees in 15 countries. Bong has strong market positions in most of the important markets in Europe and the Group sees interesting possibilities for continued development. Bong is a public limited company and its shares are listed on Nasdaq Stockholm (Small Cap). For further information, please contact Håkan Gunnarsson, CEO for Bong AB.  Tel (switchboard) 46 44-20 70 00   This information is information that Bong AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8am CET on February 16 2017.   

Nexam Chemical Holding AB (publ) Year End Report 1 January – 31 December 2016

Fourth quarter at a glance Operational: · Receives order of SEK 5.3 million concerning the high performance product NEXIMID®. Largest order in the company history. · Signs supply agreement with Diab concerning the NEXAMITE®-technology for the production of PET-foam. Financials:                                                                                                            · Net sales for the fourth quarter totaled SEK 2,097,000 (2,513,000). · The operating loss for the fourth quarter SEK -6,431,000 (-4,923,000). · In comparison to the beginning of the year, cash and cash equivalents amounted to SEK 133,147,000 (36,305,000). · Cash flow from operating activities was SEK -5,210,000 (-2,936,000). Lund 16 February, 2017 The Board of Directors These financial statements have not been audited by the Company´s auditor. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com This information is information that Nexam Chemical Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on February 16, 2017. ____________________________________________________________________________ About Nexam Chemical Nexam Chemical develops technology and products that make it possible to significantly improve the production process and properties of most types of plastics in a cost-effective manner and with retained production technology. The improved properties include strength, toughness, temperature and chemical resistance as well as service life. The improvements in properties that can be achieved by using Nexam Chemical's technology make it possible to replace metals and other heavier or more expensive materials with plastics in a number of applications. In applications where plastic is already used, Nexam Chemicals products can improve the manufacturing process, reducing material use and enable more environmental friendly alternatives. Example of commercial applications: pipe manufacturing, foam production and high-performance plastics. More information about the business will be found on www.nexamchemical.com (http://file/////TELLUS/styrelsen/A.%20Pressmeddelanden%20och%20nyheter/Pressmeddelanden/Eng/www.nexamchemical.com). The company´s Certified Adviser is FNCA Sweden AB.

Evolution Gaming: Year-end report 2016

Fourth quarter of 2016 (Q4 2015) · Operating revenues increased by 53% to EUR 34.3m (22.4) · EBITDA increased by 39% to EUR 13.0m (9.3), corresponding to a margin of 38% (42) · Profit for the period was EUR 9.0m (6.9) · Earnings per share reached EUR 0.25 EUR (0.19) · Mobile penetration amounted to 46% (28) Full-year 2016 (2015) · Operating revenues increased by 51% to EUR 115.5m (76.4) · EBITDA increased 44% to EUR 44.6m (31.0), corresponding to a margin of 39% (41) · Profit for the period was 31.7 MEUR (20.0) · Earnings per share reached 0.88 EUR (0.56) · The Board of Directors proposes a dividend of EUR 0.45 per share (0.32) Events during the fourth quarter of 2016 · Demand remains strong for tables and environments Events following the balance sheet date · Cecilia Lager new Board Member · Launch of a new game category – Live Lucky Wheel CEO Martin Carlesund comments: 2016 marked Evolution Gaming’s 10thyear in business and I am happy to report that we wrapped up a very successful year with a strong quarter. Sales increased by 53 percent compared with the fourth quarter of 2015. Adjusted for expenses related to the upcoming move to the main market, EBITDA amounted to EUR 13.4 million, corresponding to a margin of 39 percent and an increase of 44% compared to the fourth quarter of 2015. Live Casino continues to strengthen its position among operators as well as players. Our focus on the quality of the user experience, offering the broadest product portfolio for all devices and delivering a leading service to our customers are some of the factors behind our strong results in 2016. The year ended with continued solid demand for our services and a very high pace of delivery. The fourth quarter is also seasonally positive with a high level of activity from our customers. In addition to several new customers, existing customers are continuing to expand their offerings. This quarter, new dedicated environments were launched for 888, Virgin Games and bwin, among others. Existing customers are also choosing to expand into more markets where, for example, the aforementioned bwin launched its offering in Denmark during the quarter. We have also expanded further in our latest studio at Grand Casino Bucharest. Another growth driver is the heavy increase in mobile gaming – in the fourth quarter, almost half of the gaming revenues generated via Evolution’s platform derived from mobile devices. The equivalent number is above 50% among our largest customers. Extensive development is also taking place on the product side. The roll-out of Live Ultimate Texas Hold’em to operators is continuing. We have also launched another derivative of our world leading Live Baccarat product, Baccarat Control Squeeze, where the player is given even more opportunity to actively participate in the course of the game. After the end of the quarter, we have also launched an entirely new game, Dream Catcher, inspired by popular entertainment shows. It is the world’s first game in the Live Lucky Wheel category, which reinforces our position as the market’s prime innovator in the Live segment. At the publishing of this report, this year’s ICE, Europe’s largest gaming trade fair, has just been held. As a temperature gauge on the industry, I can report that this was the most intense exhibition to date, with a very large interest in our services. Apart from premiering the above-mentioned Dream Catcher, Dual Play Baccarat was also one of our main attractions. This is our second Dual Play game, further strengthening our offer to the land-based segment.  2017 will be an exciting year for Evolution. We will continue to work according to our strategy where product innovation, regulated markets and land-based solutions are key areas. In addition to our commercial focus, we are also preparing the company for a move to Nasdaq Stockholm in the second quarter of the year. Together with my colleagues, I want to thank you for the past year. We look forward to Evolution’s continued success with confidence.

Sobi™ publishes its report for the fourth quarter and full year 2016

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) today announces its results for the fourth quarter and full year 2016. Revenues for the full year totalled SEK 5,204 M, an increase of 61 per cent compared to 2015. Revenues for the quarter were SEK 1,292, an increase of 59 per cent. Product sales for the full year amounted to SEK 4,548 M, an increase of 77 per cent, based on strong performance across the portfolio and the launch of our new haemophilia products, Elocta® and Alprolix®. Business highlights Q4 2016 · European Commission approved the transfer of the marketing authorisation for Alprolix to Sobi · European Commission granted SOBI003 orphan designation for the treatment of MPS IIIA (Sanfilippo A Syndrome) · European study of real-life haemophilia treatment emphasises the need to improve standard of care · In collaboration with Bioverativ, data were presented reinforcing the long-term safety and efficacy of Elocta and Alprolix · Sobi entered into a distribution agreement with Horizon Pharma for Ravicti® and Ammonaps® Financial summary Q4 2016 (Q4 2015) · Total revenue of SEK 1,292 M (814), an increase of 59 per cent (54 per cent at CER) · Product revenue of SEK 1,144 M (698), an increase of 64 per cent (58 per cent at CER) · Gross margin of 67 per cent (64) · EBITA of SEK 210 M (90) · Earnings per share 0.37 SEK (-0.04) Financial summary FY 2016 (2015) · Total revenue of SEK 5,204 M (3,228), an increase of 61 per cent · Product revenue of SEK 4,548 M (2,568), an increase of 77 per cent · Gross margin of 70 per cent (62) · EBITA of SEK 1,543 M (433) · Ended the year with a cash position of SEK 786 M · Earnings per share 3.01 SEK (0.24) “2016 was a highly significant year for Sobi. We delivered strong financial performance across the portfolio, we established a platform for transformational growth through the launch of two innovative state-of-the-art treatments for haemophilia in Europe and the Middle East, and we took several important steps forward with our pipeline of innovative therapies for rare diseases”, says Sobi’s CEO and President Geoffrey McDonough. Financial summary Q4 Q4 Full Full year year Amounts in SEK 2016 2015 Change 2016 2015 Change M Total 1,292 814 59% 5,204 3,228 61% revenues(1) Gross profit 860 520 65% 3,651 2,007 82% Gross margin 67% 64% 70% 62% EBITA 210 90 1,543 433 EBIT 100 17 1,133 146 (Operating profit/loss) Profit/loss 100 -10 809 65 for the period (1)Full year 2016 revenues include a one time credit in Q1 of SEK 322 M relating to the first commercial sales of Elocta, and a one time credit in Q2 of SEK 386 M relating to first commercial sales of Alprolix. Outlook 2017* Sobi expects revenues for the full year to be in the range of SEK 5,800 to 6,000 M. Gross margin is expected to be in the range of 66 to 68 per cent. Sobi expects EBITA for the full year to be in the range of SEK 1,600 to 1,700 M. *At current exchange rates  --- Sobi's report for the fourth quarter and FY 2016 can be found on http://www.sobi.com/Investors--Media/Financial-Reports/ About Sobi™ Sobi™ is an international speciality healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. We also market a portfolio of speciality and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and approximately 760 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com.  For more information please contact   Media relations Investor relations Linda Holmström, Senior Jörgen Winroth, ViceCommunications Manager President, Head of Investor Relations +46 70 873 40 95 +1 347-224-0819, +1 212-579 -0506, +46 8 697 2135 linda.holmstrom@sobi.com  jorgen.winroth@sobi.com  This information is information that Swedish Orphan Biovitrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of Linda Holmström, Senior Communications Manager, at 08:00 am CET on 16 February 2017. 

Sobi™ expands haemophilia B development portfolio by adding rFIXFc-XTEN to its collaboration agreement with Bioverativ

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) today announces that it has elected to add a novel product candidate (rFIXFc-XTEN) for the potential treatment of haemophilia B to the company’s collaboration agreement with Bioverativ. Sobi has the right to include the rFIXFc-XTEN fusion molecule into its collaboration agreement with Bioverativ. By making a one-time payment to Bioverativ Sobi gains an opt-in right to participate in the final development and commercialisation of this product candidate. The opt-in right may be exercised by Sobi in connection with the submission of the marketing authorisation application for rFIXFc-XTEN with the European Medicines Agency. In September 2014, Sobi elected to add the rFVIIIFc-VWF-XTEN fusion molecule for the potential treatment of haemophilia A to its collaboration agreement with Bioverativ.  “Sobi is committed to help address the unmet needs for people affected by haemophilia and we are pleased to engage with this innovative product candidate which has been designed for the subcutaneous treatment of haemophilia B,” says Milan Zdravkovic, Senior Vice President, Chief Medical Officer, and Head of Research & Development at Sobi. “We are inspired by the collaboration we have with Bioverativ to support people living with haemophilia. We have a longstanding relationship and this decision further adds to our common aspirations.” - - - About haemophilia BHaemophilia B is caused by having substantially reduced or no factor IX activity, which is needed for normal blood clotting.[i] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_edn1) The World Federation of Hemophilia estimates that approximately 28,000 people are currently diagnosed with haemophilia B worldwide.[ii] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_edn2) People with haemophilia B may experience bleeding episodes in joints and muscles that cause pain, decreased mobility and irreversible joint damage. In the worst cases, these bleeding episodes can cause organ bleeds and life-threatening haemorrhages. Injections of factor IX temporarily replace clotting factors necessary to resolve bleeding and, when used prophylactically, to prevent new bleeding episodes.i About the Sobi™ and Bioverativ collaborationSobi and Bioverativ collaborate on the development and commercialisation of Alprolix and Elocta/ELOCTATE®. Bioverativ has final development and commercialisation rights in North America and all other regions in the world excluding the Sobi territory, and has manufacturing responsibility for ELOCTATE and Alprolix. Sobi has final development and commercialisation rights in the Sobi territory (essentially Europe, North Africa, Russia and most Middle Eastern markets). Bioverativ was created as a spin-off from Biogen’s haemophilia business and separated from Biogen effective February 1, 2017. Bioverativ is an independent, publicly-traded company, headquartered in Waltham, Massachusetts, USA. During a temporary transition period, which includes time to allow Bioverativ to establish certain licenses and consents related to ELOCTATE® and ALPROLIX, each of Bioverativ and Biogen will have a relationship to the products. About Sobi™Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and about 760 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. For more informationplease contact  Media relations   Investor relationsLinda Holmström, Senior Jörgen Winroth, ViceCommunications Manager  President, Head of Investor Relations+ 46 708 73 40 95, + 46 +1 347-224-0819, +1 212-5798 697 31 74   -0506, +46 8 697 2135linda.holmstrom@sobi.com jorgen.winroth@sobi.com  This information is information that Swedish Orphan Biovitrum AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of Linda Holmström, Senior Communications Manager, at 08:15 am CET on 16 February 2017. ---------------------------------------------------------------------- [i] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_ednref1) World Federation of Hemophilia. About Bleeding Disorders – Frequently Asked Questions. Available at: http://www.wfh.org/en/page.aspx?pid=637#Difference_A_B. Accessed on: January, 13, 2017. [ii] (https://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/012_XTEN/012e_XTEN_170216_1.docx#_ednref2) World Federation of Hemophilia. Report on the Annual Global Survey 2013. Available at: http://www1.wfh.org/publications/files/pdf-1591.pdf. Accessed on: January 13, 2017. 

Starbreeze AB (publ) Year-End Report 2016

The full year-end report in Swedish is available at www.starbreeze.com/investor-relations/. The English version of the report will be available within a week. Financial statements in English are available at the end of this document. CHANGED FISCAL YEAR  Note that in accordance with the decision taken on the Annual General Meeting in November 2015, this is the fourth quarterly report after changing the company’s fiscal year to calendar year. The comparative period Q4 2015 corresponds to October-December 2015, previously Q2 2015/2016.  FOURTH QUARTER (OCTOBER - DECEMBER 2016) · Net revenue amounted to SEK 99.4 million (SEK 48.9 million), representing a growth of 103 %. Sum of revenues and capitalized development amounted to SEK 165.5 million (SEK 73.6 million). · During the quarter, PAYDAY 2 represented SEK 37.2 million (SEK 47.7 million) of net revenue. · During the quarter, Dead by Daylight represented SEK 54.6 million (SEK 0.0 million) of net revenue. · Operating income before depreciation and amortization, EBITDA, amounted to SEK 38.8 million (SEK 15.2 million), implying a margin of 23.4 percent. · Income before tax amounted to SEK 32.3 million (SEK 14.0 million). · Net income for the period amounted to SEK 30.2 million (15.4 million). · Earnings per share before dilution were SEK 0.11 (SEK 0.07) and earnings per share after dilution were SEK 0.11 (SEK 0.07). · Cash flow from operating activities amounted to SEK 12.9 million (SEK -3.0 million). · As of December 31, cash and cash equivalents totaled SEK 669.4 million (SEK 85.4 million).  FISCAL YEAR (JANUARY – DECEMBER 2016) · Net revenue amounted to SEK 345.5 million (SEK 218.4 million), representing growth of 58 %. Sum of revenues and capitalized development amounted to SEK 523.0 million (SEK 299.6 million). · Operating income before depreciation and amortization, EBITDA, amounted to SEK 81.2 million (SEK 49.5 million) equivalent to an EBITDA margin of 15.5 %. · Income before tax amounted to SEK 55.9 million (SEK 43.1 million). · Net income for the period amounted to SEK 57.1 million (SEK 39.4 million). · Earnings per share before dilution were SEK 0.22 (SEK 0.20) and earnings per share after dilution were SEK 0.22 (SEK 0.20). KEY EVENTS DURING THE FOURTH QUARTER (OCTOBER – DECEMBER 2016) · In October, Starbreeze carried out a direct share issue to institutional investors, where Första AP-fonden, a major Swedish pension fund, subscribed for a majority of the shares issued. A total of 16,452,991 shares were issued at a price of SEK 23.40, equivalent to a total amount issued of   SEK 385 million. In connection with the new issue, Första AP-fonden also acquired 1,850,000 shares from Indian Nation AB, the company of Starbreeze Chairman Michael Hjorth. · In October, Starbreeze acquired Nozon, a Belgian Visual Effects (VFX) studio and the developer of the PresenZ technology. The PresenZ technology, which was released in 2015, makes it possible to convert 3D films to VR films, and thereby overcome the technical differences between film and game environments. This occurs through interactive parallax in virtual reality and delivers high quality blockbuster computer graphics with true immersive feeling. Since 1998, Nozon has steadily grown to become a well-known, and award winning VFX studio thanks to the company’s creative/artistic approach and technology development. The consideration amounted to EUR 7.1 million, of which EUR 4.6 million was in cash and EUR 2.5 million in newly issued Starbreeze B shares. In addition, the parties also agreed on a 10-year earnout period, based on revenue from the PrezenZ technology. After the acquisition, Starbreeze’s has deepened its analysis of the PresenZ technology, which has resulted in the decision to include all the potential earnout in the calculation of goodwill from the acquisition. The goodwill is estimated at SEK 257.5 million as of December 31, 2016. · In December, Starbreeze agreed to acquire 90.5 percent of the shares in the Indian production company Dhruva Interactive. The total consideration amounted to USD 8.5 million, of which    USD 7.0 million was in cash and USD 1.5 million in newly issued Starbreeze B shares. The deal is planned to be completed in 2017 and had no impact on earnings during 2016. Dhruva Interactive is a highly reputed and best-of-breed art production house, with whom Starbreeze has a long-standing relationship. Founded in 1997, Dhruva is India’s leading game developer with over 320 employees, providing art production services to the global games industry. Dhruva has three studios in India. · During the quarter, Carnegie Investment Bank was appointed as advisor for the company’s relisting to Nasdaq Stockholm’s main market. Starbreeze intends to complete the relisting during 2017. · In November, a new brand was announced in the Publishing division. The new label Starbreeze IndieLabs aims to help projects that are smaller in scope to reach the market. Together with the Croatian studio Lion Game Lion, Starbreeze has agreed that the company will invest USD 300,000 to bring the game AntiSphere to PC and other platforms. Per the agreement Starbreeze will receive 30 percent of revenues, after the initial investment has been fully recouped by Starbreeze. Lion Game Lion and Soap Interactive in turn will retain 100 percent of the IP rights. AntiSphere is a top-down competitive arena battle game in which players use their skills in order to catch each other, and win the match. · In November, Starbreeze entered its second IndieLabs project with the Dutch studio KeokeN Interactive to publish the title “Deliver Us The Moon”. Starbreeze will invest USD 500,000 to bring the game to PC and other platforms. Starbreeze will be able to recoup 120 % of its investment, and will subsequently retain 50 percent of the revenues after distribution fees. KeokeN will retain 100 % of the IP rights. Deliver Us The Moon is set in the near future where the earth’s resources are nearly depleted. A brave astronaut will take the great step and travel to the moon in a do-or-die secret mission to save humanity. AFTER THE QUARTER · In early January, Starbreeze announced that the first pilot center for IMAX VR Experience had opened in Los Angeles, in close proximity to the popular shopping area - The Grove and Farmers Market. In the center, visitors will be able to test high quality VR experiences in StarVR, which is produced in collaboration with Acer. Experiences available for StarVR include John Wick Chronicles: Arcade Edition and the range will be gradually extended as new VR experiences in both film and games become available. StarVR was positively received by visitors and along with John Wick Arcade Edition, is currently one of the most popular VR experiences in the center. · After the opening of the first IMAX VR Experience center in Los Angeles, Starbreeze announced that the company is negotiating with IMAX regarding the continuation of the agreement on premium experiences in IMAX VR Centers, which was announced in May 2016. In light of the decision of IMAX to broaden its offering to include widely available VR experiences during the launch of the center, Starbreeze anticipates that the form of collaboration will be adapted accordingly. · The VR game John Wick: Chronicles was released on Steam for HTC Vive on February 9, in connection with the premiere of the movie John Wick: Chapter 2. The game was available for pre-order for USD 19.99 via the platform from October 6, 2016. · In January, Starbreeze signed an agreement with Behaviour Digital regarding a digital version of Dead by Daylight for PlayStation 4 and Xbox One. To date, more than 1.8 million copies of the game’s PC version have been sold on Steam. The development costs for the modifications required for the console version will be shared equally between the parties. The revenue sharing model follows the existing agreement. In February, Starbreeze signed a distribution agreement with Digital Bros’ subsidiary 505 Games regarding physical distribution of Dead by Daylight for PlayStation 4 and Xbox One. Furthermore, this means that 505 Games will pay an advance royalty of USD 2.5 million, which will be shared between Starbreeze and Behaviour. The agreement does not cover the Asian and Nordic markets. The console version of the game is expected to be released during the second quarter of 2017. · In February, Starbreeze signed an agreement with Double Fine Productions to publish the game Psychonauts 2. Starbreeze will invest USD 8 million to bring the game to PC and console platforms together with Double Fine Productions. The release is expected to occur sometime during 2018. The development of the game was previously funded by Double Fine Productions and through equity crowdfunding via the Fig service. Starbreeze will be able to recoup 100 % of its full investment including marketing costs and will receive an initial revenue share of 85 % after distribution fees and Fig crowdfunding revenue share. Starbreeze share of revenues will become 60 % after the investment is recouped, after distribution fees and Fig crowdfunding revenue share. Psychonauts 2 is a third-person action/adventure game where players control Razputin Aquato   – a newly graduated Psychonaut with powerful psychic abilities. STARBREEZE KEEPS DELIVERING CEO BO ANDERSSON KLINT GIVES HIS COMMENT We’re proud to yet again show a triple digit growth for this quarter and the highest EBITDA since the launch of PAYDAY 2. It is a solid performance that shows our ability to deliver profitability while we are scaling our business to secure future growth. PAYDAY The PAYDAY franchise generated SEK 37.2 million (SEK 47.7 million) in total whereof SEK 0.0 million (SEK 14.4 million) in production support. As the sole owner of the PAYDAY IP, we no longer receive any production support revenues. We’re additionally still awaiting 505 to recoup USD 5 million on console, while we get 100% of the healthy PC sales. Moreover, we expect 505 to have reached their USD 5 million recoup in Q1 2017 as we see impressive PAYDAY performance through digital distribution on consoles following the lastest update. DEAD BY DAYLIGHT We’re over the moon with Dead by Daylight, a complete success both strategically and financially. The game has now sold over 1.8 million units on PC and contributes with SEK 54.6 million to Starbreeze net revenues in Q4, making it the best quarter through the game’s lifetime. An impressive trend that we, together with Behavior, will nurse carefully as we expand the product to consoles in Q2 2017. To date, the game has generated over 267 MSEK in gross sales on Steam. STARBREEZE FINANCES We’re also delighted to see that both our acquisitions, ePawn and Nozon, for the first time are contributing to top-line. Both businesses are now fully integrated and run at full speed within Starbreeze. As we continue our steady growth we need to invest in our key assets PAYDAY, OVERKILL's The Walking Dead, Valhalla engine, StarVR and in our very important publishing business. Consequently, our operating expenses, excluding royalties to publishing partners, have increased with SEK 46.7 million or 78 % compared to Q4 2015. The incremental spend is in all material aspects still derived from employee related expenses as we continue to ramp up the teams for delivering on our plans. Despite the increase in costs we show a remarkable profitability with an EBITDA margin reaching  23.4% underpinned by a strong development of our top line but also boosted by a stronger US dollar.   Boosted by successful financing activities during the third quarter, we’re ending the year with a cash position of SEK 669.4 million (SEK 85.4 million). To be clear, these funds will not be put in the bank to rest, they will continue to build our momentum. Hence we expect it to be reduced over time. Worth noting is also that we now have positive cash flow from our operating activities amounting to         SEK 12.9 million (SEK -3.0 million). When closing the fourth quarter we also close the financial year 2016 where net revenues reached SEK 345.5 MSEK (SEK 218.4 million) which is 62 % better than the financial year when we launched PAYDAY 2. EBITDA reached SEK 81.2 million (SEK 49.5 million) and net profit SEK 57.1 million (SEK 39.4 million). Our core business is doing very well. VR-CENTER IN LOS ANGELES As the first phase of building and operating a pilot VR center, mimicking our VR arcade concept StarCade, with IMAX is underway, we have entered into negotiations with IMAX about the future sale of content and StarVR-headsets into this business. At the VR center, we operate under our original agreement and have two pods equipped with the latest iteration of our StarVR HMD showcasing John Wick Chronicles Arcade Edition in collaboration with Lionsgate. Since January, we have thoroughly enjoyed having customers and potential partners visit the center to experience both the hardware as well as our content, something that has strengthened our view that location-based VR at this time is the best way for consumers to experience high-quality VR. Our goal is to sell StarVR systems to as many different location-based businesses, theme parks and B2B projects as possible. Our aim is to sell a broader range of headsets and systems through our joint venture with Acer under the brand StarVR. STARVR EVOLUTION While we, just as planned, have not yet started shipping larger volumes of StarVR, the current interest from multiple markets and from prominent brands and business sets us up well for the mass production phase beginning later in 2017. We focus on distributing and prioritizing the current development version of the headset to key partners, ensuring that we are compatible with leading industry systems and standards to fully enable us to lead the charge once we deliver the first full production unit. We estimate approximately two more development iterations during the year, where we trust that the third iteration will include Tobii’s proprietary eye tracking. Durability, field of view, hygiene, resolution, refresh rates and weight are all key aspects that we improve constantly and according to plan. The roadmap of StarVR is clear, we’re still targeting B2B partners as our primary business, and we keep delivering as planned at our decided phase. We aim to make the development of StarVR and sales of VR content a significant business for us down the line. We secure this through making early investments and strategic collaborations. This will educate us internally how to master the experience design and optimize our production. Once the market is mature, we’ll be in a pole position. For the fourth quarter StarVR with related activities account for less than 10% of Starbreeze operating expenses. NOZON’S PRESENZ While we’re integrating all of our recent acquisitions with Starbreeze vision to build future ecosystems, Nozon’s Presenz technology is generating quite the buzz in Hollywood. Nozon is now working hard together with our business development team to produce its first showcase VR short movie that we believe will build the foundation for a major cogwheel in our VR offering. Using PresenZ, movie studios can use their CG assets from feature films repurposing them easily for VR movies without losing visual fidelity. We strongly believe that together with the high-resolution of StarVR, this can be a groundbreaking technology for movie and entertainment production everywhere.   PAYDAY MOBILE, BCN STUDIO As a separate note to this report, we also just announced that we’ve opened a new office in Barcelona, Spain. The Barcelona Studio consists of a handful of very talented individuals that have been with us in Stockholm for quite some time. Together with old friends and now new colleagues joining us from a prominent mobile developer, they form our task force to steer our mobile projects with a 100% focus. The bulk of the development will mainly be outsourced but we require a dedicated team from Starbreeze to make sure we are on point and deliver with the same focus as our other products. Starbreeze Barcelona will closely monitor the wrap up of Geminose and also focus its efforts on PAYDAY: Crime War. After a due diligence of the progress on the mobile version of our beloved PAYDAY franchise, we found a lack of focus on our product. As we want to see this game realized as badly as many of our fans, we’ve moved production to another studio, BadFly Interactive. As part of a work-for-hire partnership, BadFly have hit the ground running and we look forward to sharing more from the game in the months to come. The project has already accelerated considerably and is now fully playable in multiplayer with the games backend in place. The following months will be dedicated to building more content and polishing the gameplay format to maximize the fun of the final product. In 2017 we also continue our full productions of RAID, OVERKILLS The Walking Dead, CROSSFIRE Co-Op and Geminose. Our lineup is strong and our teams dedicate their full energy in making the games as high-quality as recent products such as the PAYDAY and Dead by Daylight DLC releases. Our success is of course shared by and thanks to our partners. Lately we had the pleasure to work with Universal on our PAYDAY Scarface DLCs in December. Additionally, we’ve continued our extremely successful partnership with Lionsgate on two DLCs for PAYDAY and the release of the stand-alone VR game John Wick Chronicles on Steam and in the IMAX VR center. These collaborations are tremendously important to us as we establish Starbreeze as a trusted partner for top-tier brands as well as it gives us an ever-growing community of fans from near and far enjoying and talking about Starbreeze products. Our publishing portfolio has grown to secure a steady flow of products, big and small, for the upcoming year. We are proud to have signed up Double Fine with Tim Shafer leading the development of their new AAA game Psychonauts 2. We are constantly looking to attract leading teams to our publishing business and 2017 will see a number of these projects initiated by Starbreeze. It is with great satisfaction that we also can announce that PAYDAY 3 production is officially initiated and at a full design stage. I’d like to especially clarify, that this project will enjoy as much time as we deem needed. It will be done when it’s done. This is our single most important brand today and the cornerstone of our business and we will treat it accordingly. Updates in the near future might be scares and far between. You simply don’t rush PAYDAY 3. With a team of over 550 talented developers, post the acquisition of Dhruva, we are well staffed for the full productions going forward. With this strategic acquisition our capacity is very satisfying, meanwhile we keep recruiting more game developers to secure quality and talent for the future. Our AAA game productions and our innovative VR pipeline is providing our developers with real challenges and exciting careers. At Starbreeze, we look forward to keep delivering on our games, services and strategy for 2017 and beyond. Let’s do this!### This information is information that Starbreeze AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CET on 16 February, 2017 For more information, please contact:Starbreeze Investor Relations Contact: Maeva Sponbergs, +46 (0)8 209 208 or ir@starbreeze.com  About Starbreeze  Starbreeze is an independent creator, publisher and distributor of high quality entertainment products. With studios in Stockholm, Paris, Los Angeles, Barcelona and Brussels, the company creates games and other virtual reality entertainment products, based on proprietary design and licensed content. Starbreeze's most recent games include PAYDAY 2®, John Wick VR shooter and upcoming survival co-op FPS OVERKILL’s The Walking Dead. Under its publishing initiative, Starbreeze has together with Canadian studio Behaviour Digital successfully launched horror thriller Dead by Daylight.x Starbreeze has set out to develop truly immersive virtual reality experiences, by integrating software and hardware in its StarVR® head mounted display, which is produced together with Acer, displaying a unique field of view and a mission to bring top-end VR to large audiences. Together with IMAX, Starbreeze aspires to dominate the location based VR market with the IMAX VR centers. The first IMAX VR center opened in Los Angeles in January 2017.  Headquartered in Stockholm, Sweden, Starbreeze's shares are listed on Nasdaq Stockholm First North Premier under the tickers STAR A and STAR B with the ISIN-codes SE0007158928 (A share) and SE0005992831 (B share).  Remium Nordic is the company's Certified Adviser. For more information, please visit http://www.starbreeze.com, http://www.starvr.com, http://www.overkillsoftware.com  

New White Wolf Games Arrive Today with new Vampire and Mage stories (in the World of Darkness)

STOCKHOLM, SWEDEN (16th of February 2017) White Wolf Publishing today releases Vampire The Masquerade: We Eat Blood and Mage The Ascension: Refuge, two all-new interactive fiction games for Android, iOS, and PC. These classic roleplaying games enter the digital age with two new titles inspired by choose your own adventure books, written and illustrated by award-winning authors and artists. In Vampire The Masquerade: We Eat Blood you’re a young artist who wakes up at night to find you’re no longer human…but exactly what are you and why are you so ravenously hungry for blood?!? Told entirely through an innovate mobile messaging perspective, We Eat Blood is a sharp, mature, and terrifying story about your first nights as unwilling predator and prey. Will you join ancient vampire conspiracies, or will you turn the tables on oppressive authority and seek your own future? The temptation is real. The game is written and illustrated by Zak Sabbath and Sarah Horrocks. In Mage The Ascension: Refuge you play a volunteer at a European camp for Syrian refugees, and suddenly you discover that magic is real, you can use it, and you’re in the middle of a secret magical war for the fate of the world. The game lets you experience today’s social and political upheavals while learning that you can shape reality itself through sheer force of belief. Your actions and choices will have profound consequences on the world and people around you. Safety or sacrifice? Let them in or build the wall? The choice is yours. The game is written by noted Swedish author Karin Tidbeck. “The World of Darkness has always been about mature, intelligent stories,” said White Wolf Creative Director Martin Ericsson. “These new games uphold that tradition, but we put a very modern twist on it: we see our games as a way not only to entertain, but to look closely at contemporary issues, and ask some of the big questions of our time.” “We are absolutely delighted to see the first games from the new White Wolf based on our most popular brands reach our fans on both mobile and Steam,” said White Wolf CEO Tobias Sjögren. “We know we can create great entertainment as well as serve the responsibility any content creators have helping the audience reflect on the world around them. These games show we are keen on trying new formats and that stories in World of Darkness doesn’t shy away from tough questions or contemporary issues.” These game releases are the first digital game releases in over a decade for this acclaimed story world, and this release marks the start of White Wolf’s emergence as a transmedia entertainment company. White Wolf are working on a 5th edition of the Vampire: The Masquerade tabletop RPG books and recently announced a video game adaptation of Werewolf: The Apocalypse. Learn more about Vampire the Masquerade: We Eat Blood and Mage the Ascension: Refuge at White Wolf’s website: www.white-wolf.com.

Public transport supplier Pilotfish Networks AB is acquiring Appello Technologies AB

Pilotfish supplies a combination of a standardised communication platform and a range of services which in various ways improve productivity within the public transport system. At present, public transport in Scandinavia and in Europe in general is undergoing a rapid transition, with major challenges in the form of increased competition, new technology, electric vehicles and new information technologies. Cloud-based applications and services, standardised platforms and efficient autonomous vehicles are important tools for meeting the rapid changes which are currently taking place within the public transport sector. Executive Director of Pilotfish, Tomas Gabinus, says that “Appello has a fantastic team, which with its expertise within the fields of application development, maps and navigation services - used by millions of end-users - is a perfect complement to Pilotfish’s current team”. Tomas adds that “we furthermore intend to continue to develop Appello’s navigation service Wisepilot, which is supplied internationally to a range of telecommunications operators”. Lars Szakaly, Executive Director of Appello, remarks that “we at Appello look forward to working together with Pilotfish on continuing our collective journey as suppliers of modern applications for public transport”. For more information please contact: Tomas Gabinus, Executive Director, Pilotfish Networks AB. Tel.: +46 (0)31 3396674. Email: tomas.gabinus@pilotfish.se Pilotfish’s ambition is to achieve a higher level of competitiveness for bus and train operators within the public transport sector. Pilotfish’s approach is centred on structured digitalisation based around an open communication platform which can be supplemented with various user-friendly applications for utilization via the implementation of strategies aimed at continuous improvements. Pilotfish’s tender is based upon standards and architectures which are administered by the European Committee for Standardization’s ITxPT (Information Technology for Public Transport).

Stora Enso plans to shut down one SC paper machine at Kvarnsveden Mill in Sweden

Stora Enso will start co-determination negotiations with employees at its Kvarnsveden Mill in Sweden regarding a plan to reorganise the mill, including a permanent closure of paper machine (PM) 8. The planned actions would affect a maximum of 140 employees. The paper machine has an annual capacity of 100 000 tonnes of super-calendered uncoated magazine paper (SC) and it is planned to be shut down by the end of the second quarter of 2017. The plan would result in annual cost savings of EUR 12 million. Stora Enso will book restructuring charges of approximately EUR 17 million as an item affecting comparability (IAC) in its Q1/2017 results, of which about EUR 14 million will be cash costs. The planned closure would not have material impact on Stora Enso’s sales or operational EBIT. “We plan to reorganise Kvarnsveden Mill to ensure its competitiveness in the structurally declining paper market. This plan includes the permanent shutdown of PM8, which, due to its small size and technical age, is unfortunately no longer competitive in the current market conditions. We appreciate the efforts taken by the employees, and regret that this plan would be necessary to support the competitiveness of Kvarnsveden Mill going forward,” says Kati ter Horst, EVP Paper division. The closure of PM8 at Kvarnsveden Mill would not impact Stora Enso’s SC paper offering. In Europe, Stora Enso continues to produce SC paper at Kvarnsveden Mill PM12 as well at Maxau Mill in Germany and Langerbrugge Mill in Belgium. The group also serves its SC customers from Dawang Mill in China. No decisions regarding the planned reorganisation or employee impact will be taken until the co-determination negotiations have been concluded. Production at Kvarnsveden Mill would continue on two lines, PM10 for improved newsprint paper and PM12 for SC papers. For further information, please contact:Ulrika Lilja, EVP, Communications, tel. +46 72 221 9228Liisa Nyyssönen, SVP Communications, Paper division, tel. +358 40 544 3491 Investor enquiries:Ulla Paajanen-Sainio, SVP, Investor Relations, tel. +358 40 763 8767Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wooden constructions and paper on global markets. Our aim is to replace fossil based materials by innovating and developing new products and services based on wood and other renewable materials. We employ some 25 000 people in more than 35 countries, and our sales in 2016 were EUR 9.8 billion. Stora Enso shares are listed on Nasdaq Helsinki (STEAV, STERV) and Nasdaq Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY). storaenso.com (http://www.storaenso.com/)

Sectra Tiger approved for NATO SECRET

The ability to transfer information quickly and securely, without the risk of eavesdropping, can be vitally important for authorities, defense organizations and critical societal functions. Sectra Tiger/S 7401 offers the highest level of protection against eavesdropping attacks, even from state actors, and is a unique solution that is approved for both mobile and fixed communication at the NATO SECRET security level. Sectra Tiger/S 7401 was developed by Sectra under guidance from the Netherlands National Communications Security Agency (NL-NCSA). This approval confirms that the long and fruitful cooperation between Sectra and NL-NCSA meets the highest requirement for communication security.  Thanks to cooperation with customers and national security authorities in numerous countries, Sectra’s various solutions for secure communications have now been delivered to more than half of the EU’s member states, for national use and within the context of the EU and NATO. Users include government officials, officials in the diplomatic corps, decision-makers in defense and critical infrastructure, and military personnel in the field. Common to these is that they use security-approved products to communicate securely and that they have high demands on flexibility and mobility.  About Sectra Tiger/S 7401The secure mobile phone Sectra Tiger/S 7401 is the top tier of an ecosystem of security-approved products for secure communications. The system also covers solutions for secure smartphone use and secure fixed telephony. By using Sectra Tiger Ecosystem, an organization can assign secure communication solutions based on an individual’s communication and security requirements. Sectra Tiger/S 7401 also enables secure communications between different security domains. This means a user can securely communicate with colleagues in NATO, the EU and their respective national networks, with a single telephone, which is unique in the crypto industry. Download press images: communications.sectra.com/news-and-media/image-bank 

Airport operator Avinor extends its investment in IFS Applications

By upgrading to IFS Applications 9, Avinor will be able to leverage its layered application architecture and new support model, which will ensure that the company is always benefitting from the latest updates and enhancements in a cost-efficient way. In addition, the upgrade will give Avinor extended capabilities to monitor and document that work processes are carried out in accordance with the industry’s stringent safety requirements. IFS Applications 9 will also empower Avinor employees with the role-based and customizable IFS Lobby™ interface. “We chose to upgrade to IFS Applications 9 because we see great benefit in running evergreen ERP in the future,” Avinor CIO Brede Nielsen said. “Our goal is to remain the leader in terms of service delivery, safety, quality, and cost efficiency. In an increasingly complex industry, a comprehensive ERP suite is one of the most important enablers for achieving operational excellence.” Glenn Arnesen, CEO of IFS in Scandinavia, added, “Avinor plays a pivotal role in ensuring Norway’s airports run smoothly, making process efficiency and safety of the utmost importance. IFS Applications 9 will give Avinor a solid platform for ensuring business transparency and control in an always-updated, flexible environment. We are proud of the renewed trust that Avinor has placed in our solutions and we look forward to continuing our mutually beneficial partnership.” The two companies’ business relationship dates back to 1996, when IFS Applications was chosen as the central maintenance system for Oslo Airport Gardermoen. In 2012 (http://www.ifsworld.com/corp/news-and-events/newsroom/2014/10/21/13/06/2012-12-20-avinor/), Avinor chose to deploy IFS Applications 8 as its central ERP solution to manage and control its varied business processes across a network of 46 airports all over Norway. In 2013 (http://www.ifsworld.com/corp/news-and-events/newsroom/2014/10/21/12/47/2013-07-09-avinor/), the company opted to expand its IFS portfolio with additional functionality for HSEQ (health, safety, environment, quality) reporting. Another area where Avinor already enjoys major benefits, thanks to IFS Applications, is within procurement. The procurement solution is used for achieving a more precise ordering of security personnel, something that used to be a major cost and was sometimes problematic because of the airports’ diverse needs. The solution, together with process improvement, has contributed to substantial savings. Learn more about how IFS supports business in the civil aviation sector: www.ifsworld.com/corp/industries/aerospace-and-defense/civil-aviation-sector/.

Deveo combines forces with a global cloud computing powerhouse

Helsinki, Finland, February 2017: Code hosting and collaboration platform, Deveo, has joined forces with Alibaba Cloud, the cloud computing arm of Alibaba Group, to become   the first repository platform within the Alibaba Cloud Marketplace. With free private repositories, support for Git, Mercurial, and Subversion version control systems, and WebDAV, for storing binary files, Deveo offers a unique private hosting environment. “We are glad to partner with Alibaba Cloud to deliver the best tools for the developers to use in the cloud.” explained Deveo CEO, Ilmari Kontulainen. “The first step was adding Deveo to Alibaba Cloud’s marketplace, but we look forward to discussing a more in-depth collaboration to offer the whole DevOps tool stack on the cloud with a click of a button.”Deveo has been creating proprietary software to assist high-profile enterprises for the last 10 years, as part of the leading Finnish DevOps organization, Eficode. In 2014, the team launched their code hosting and collaboration platform as a standalone application, and while retaining enterprise users, set their sights on the wider industry.“Deveo's sister company has already introduced disruptive innovation in the mobile payment sector.” said Kontulainen. “We are hoping to find disruptive innovations in the DevOps tool sector together with Alibaba Cloud.”   Contact: Ilmari Kontulainen, ilmari@deveo.com, +358 440 715518Deveo Pohjoinen rautatienkatu 25, 00100 Helsinki, FinlandMore about Deveo: https://deveo.comAssets available: http://bit.ly/2fcAhBT   About DeveoBefore Deveo was founded in 2014, the founding team were building custom-tailored software production solutions for customers, including some of the world's largest companies. The small team of 8 work in a fully distributed company, with employees all over Europe, from the UK to Romania. The team are united by 5 core values of simplicity, transparency, customer centricity, curiosity and initiative, and are on a mission to streamline software development.

Summons to the Annual General Meeting of shareholders in Castellum AB (publ)

At the Annual General Meeting of shareholders in Castellum AB (publ), on Thursday, March 23, 2017, following proposals will, inter alia, be presented: · A distribution of SEK 5.00 per share, distributed to the shareholders in two equal payments of SEK 2.50 per share. The first record day for distribution is proposed to be Monday, March 27, 2017 and the second record day for distribution is proposed to be Monday, September 25, 2017. · An amendment of the Articles of Association regarding the term of office at the election of auditor. · Re-election of the existing Board members Charlotte Strömberg, Per Berggren, Anna-Karin Hatt, Christer Jacobson, Nina Linander, Johan Skoglund and Christina Karlsson Kazeem. Charlotte Strömberg is proposed to be re-elected as Chairman of the Board of Directors. Further, remuneration to the members of the Board of Directors is proposed to be the following(2016 remuneration within brackets).   -   The Chairman of the Board of Directors: SEK 825,000 (SEK 720,000). -   Each of the other members of the Board of Directors: SEK 350,000 (SEK 315,000). -   Member of the Remuneration Committee, including the Chairman: SEK 30,000 (SEK 30,000). -   Chairman of the Audit and Finance Committee: SEK 100,000 (SEK 50,000). -   Each of the other members of the Audit and Finance Committee: SEK 50,000 (SEK 35,000). The proposed total remuneration to the members of the Board of Directors, including remuneration for committee work, accordingly amounts to SEK 3,215,000 (SEK 2,820,000). It is proposed that the auditor’s fee shall be paid as per approved accounts. ·  In accordance with the Audit and Finance Committee’s recommendation, Deloitte is proposed as auditor in Castellum for a one-year term of office until the end of the Annual General Meeting 2018. If the Annual General Meeting resolves to elect Deloitte as auditor, Deloitte has announced that the current authorised auditor in the company, Hans Warén, will be the main responsible auditor at Deloitte.  ·  A new Election Committee shall be established in preparation for the Annual General Meeting 2018. For this purpose the Chairman of the Board of Directors will contact the three largest ownership registered or otherwise known share­holders as per the last share trading day in August 2017 and to invite them to each appoint one member of the Election Committee. The names of the members of the Election Committee shall be made public no later than six months prior to the next Annual General Meeting. ·  Authorisation for the Board of Directors to resolve to acquire and transfer the company’s own shares until the next Annual General Meeting of shareholders. Appendix: the Summons  For further information, please contact Charlotte Strömberg, Chairman of the Board of Directors. Phone +46 702 77 04 03 Henrik Saxborn, CEO, Phone +46 31-60 74 50 www.castellum.se  Castellum is one of the major listed real estate companies in Sweden. The fair value of the real estate portfolio amounts to approx. SEK 71 billion, and comprises of commercial properties for office, retail, warehouse and logistics with a total lettable area of approx. 4.3 million sq.m.  Castellum own and manage properties through one common brand in five geographical regions with strong local presence. The five geographical regions are: Central, North, Stockholm, West and Öresund.  Castellum is represented in the Dow Jones Sustainability Indices (DJSI), which includes the companies in all industries in the world with best performance in terms of sustainability. Further Castellum sustainability performance recently has been awarded two top distinctions: First Prize for sustainability reporting in Europe from EPRA and Global Sector Leader, handed out by GRESB which means that Castellum is ranked first in the world within the office- and industrial-properties sector. Further The Castellum share is listed on Nasdaq Stockholm Large Cap.  Castellum AB (publ), Box 2269, SE-403 14 Gothenburg | Org nr/Corp Id no SE 556475-5550 | Phone +46 31 60 74 00 Fax +46 31 13 17 55 

Year-End Report 2016

· Profit after tax for the year increased by SEK 835 million to SEK 5,284 million (4,449). The increase is due mainly to higher unrealized changes in the value of the property holdings. · Gross profit rose by 8 per cent to SEK 1,262 million (1,172). The increase can be attributed mainly to higher rental revenue. · Consolidated net revenue amounted to SEK 1,790 million (1,689), an increase of 6 per cent. · Profit after tax for the year was SEK 4,120 million (3,470), equivalent to SEK 19.98 per share (16.82). · The Board proposes an increase in the dividend to SEK 3.30 per share (3.10). · The fair value of the property holdings was set at SEK 36.5 billion (31.7), resulting in a net asset value of SEK 138 per share (118). The unrealized change in value of the property holdings for the year was SEK 4,160 million (3,427). · The equity ratio was 61 per cent (61), the net loan-to-value ratio was 15 per cent (17) and the interest coverage ratio multiple was 8.6 (9.1). · The rental vacancy level at the year-end was 3.9 per cent (4.5). Excluding projects in progress, the rental vacancy level was 2.6 per cent (3.2). Stockholm, February 16, 2017 HUFVUDSTADEN AB (publ) The Board   Appendix:Year-End Report 2016 Questions can be answered by Ivo Stopner, President, or Åsa Roslund, CFO, telephone +46 (0)8-762 90 00.   The information in this Interim Report is information that Hufvudstaden AB (publ) is obliged to publish under the EU Market Abuse Regulation. The information was published under the auspices of the above contact person on February 16, 2017 at 11:30am.

ALE and Hoist Group Enter Partnership to Address the Hospitality and Healthcare Markets

“Hoist Group is focused on making fully integrated, reliable and competitive solutions available to our customers, ones which ensure high quality services along with end user satisfaction. Combining the knowhow and technology of both ALE and our business will allow us to offer a wider range of solutions, open new areas of development and reinforce our leadership as the one and only hospitality partner for hotels”, says Marc Valentin, CTO at Hoist Group. The partnership creates a full end-to-end solution for the hospitality and healthcare EMEA market combining the Hoist Group Fusion Platform capabilities (guest and internet access, video content, centralised management, TV services, Digital Signage, PMS for hospitality & healthcare) with the Alcatel-Lucent Enterprise network LAN and WiFi, communications phones and cloud offers. As well, the two companies will offer integration and customisation capabilities via an enhanced go-to-market and geographical coverage beyond the original scope of EMEA.  “The hospitality and healthcare markets are key verticals for ALE. We have over 20 years of success with customers in these industries. The partnership with Hoist Group is an essential step forward in further developing our market relevance as well as distribution coverage. It will allow us to create enhanced end-to-end solutions and services for customers in these key vertical markets”, concludes Thierry Bonnin, WW senior Vice President verticals & Strategic partnerships.

Major Shareholder Announcement regarding Nordic Waterproofing Holding A/S

Axcel IV K/S (Danish company registration number 32 90 65 16) has today divested its entire shareholding of 1,821,826 shares in Nordic Waterproofing Holding A/S and therefore no longer holds any shares or voting rights in Nordic Waterproofing Holding A/S. Axcel IV K/S 2 (Danish company registration number 33 42 65 69) has today divested its entire shareholding of 1,447,699 shares in Nordic Waterproofing Holding A/S and therefore no longer holds any shares or voting rights in Nordic Waterproofing Holding A/S. As a result of the divestments, AXIII MPH Invest ApS (Danish company registration number 28 85 73 14) today no longer indirectly controls any shares or voting rights in Nordic Waterproofing Holding A/S. AXIII MPH Invest ApS controls AXIII MP Holding ApS (Danish company registration number 28 86 09 86) who in turn controls Axcel Management A/S (Danish company registration number 28 30 18 55). Axcel Management A/S is the advisor to and exercised the voting rights of Axcel IV K/S, Axcel IV K/S 2, and AX Management Invest II K/S, (Danish company registration number 32 90 66 56), who were the direct holders of the shares. Following the reportable transactions described above as well as a divestment of all shares held in Nordic Waterproofing Holding A/S by AX Management Invest K/S, (Danish company registration number 32 90 66 72) and AX Management Invest II K/S, carried out in relation to the above, Axcel does not hold any shares or voting rights in Nordic Waterproofing Holding A/S. This information is information that Nordic Waterproofing Holding A/S is obliged to disclose pursuant to the Danish Securities Trading Act. The information was released for public disclosure, through the agency of the contact person below.The information was submitted for publication at 12:15 p.m. CET, on 16 February 2017.

ExpreS2ion’s Chief Scientific Officer, Dr. Wian de Jongh, to Speak at ISBiotech 7th Spring Meeting in Washington D.C. – March 6-8

Abstract Drosophila S2 insect cell expression is less known than the extensively used Spodoptera (Sf9/Sf21) or Trichoplusia ni (Hi-5) insect cell based baculovirus expression system (BEVS). Nevertheless, it has been used in research for almost 40 years. The cell line was derived from late stage Drosophila melanogaster (fruit fly) embryos by Schneider in the 1970s, who named the cell line Drosophila Schneider line 2 (synonyms: S2, SL2, D.mel. 2). The S2 expression system has been used for antigen manufacture up to and including Phase II clinical trials, and was used, among others, for production of Dengue antigens tested in a Phase I clinical trial by Merck Inc. ExpreS2ion has developed S2-based production processes for two malaria vaccine clinical trials with The Jenner Institute, Oxford University (Rh5, blood-stage malaria) and Copenhagen University (VAR2CSA, pregnancy-associated malaria). The pregnancy-associated malaria vaccine is currently in a Phase Ia trial in Germany, and will be followed by a Phase Ib trial in Benin. The blood-stage malaria vaccine has recently completed cGMP manufacture and the Phase I/IIa trial started in October 2016. Furthermore, transmission blocking malaria vaccine candidates (Pfs25, Pfs48/45, Pfs230C) are also under development. Antigen expression screening, process development, and GMP manufacture for these malaria programs will be discussed.

Dometic Nomination Committee’s Board proposal for the 2017 Annual Shareholders’ Meeting

The Nomination Committee’s proposal to the 2017 annual shareholders’ meeting is that the number of Board members should continue to be seven. The proposal is for Fredrik Cappelen, Rainer E. Schmückle, Magnus Yngen and Erik Olsson to be re-elected and Heléne Vibbleus, Peter Sjölander och Jacqueline Hoogerbrugge to be elected as new members. The annual shareholders’ meeting will be held in Stockholm on April 7, 2017. For more information, please contact:Simon Blecher, Chairman of the Nomination CommitteeEmail: simon.blecher@carnegiefonder.se Erika Ståhl, Head of Business Control & Investor RelationsTel: +46 8 501 025 24Email: ir@dometicgroup.com This information is information that Dometic Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.20 CET on February 16, 2017. ABOUT DOMETIC GROUP Dometic is a global market leader in branded solutions for mobile living in the areas of Climate, Hygiene & Sanitation and Food & Beverage. Dometic operates in the Americas, EMEA and Asia Pacific, providing products for use in recreational vehicles, trucks and premium cars, pleasure and workboats, and for a variety of other uses. Dometic offer products and solutions that enrich people’s experiences away from home, whether in a motorhome, caravan, boat or a truck. Our motivation is to create smart and reliable products with outstanding design. We operate 22 manufacturing/assembly sites in nine countries, sell our products in approximately 100 countries and manufacture approximately 85% of products sold in-house. We have a global distribution and dealer network in place to serve the aftermarket. Dometic employs approximately 6,500 people worldwide, had net sales of SEK 12.4 billion in 2016 and is headquartered in Solna, Sweden.

Arise announces a fully supported rights issue of convertible bonds to proactively develop its position and strengthen its financial flexibility.

Pursuant to the authorisation of the General Meeting held on 3 May 2016, the Board of Directors of Arise AB (publ) (“Arise” or “the Company”) decided on 17 February 2017 that the Company is to raise a convertible loan of a nominal maximum of approximately MSEK 245 with preferential rights for existing shareholders. Preferential rights issue in brief · The purpose of the preferential rights issue (“the Rights Issue”) is to provide the conditions required to proactively develop the Company’s market position: · Increase growth in development and management, including through acquisitions · Create readiness to exploit consolidation opportunities · Increase value creation potential in the project portfolio as a result of greater financial flexibility The Rights Issue will also strengthen the Company’s financial flexibility and thus provide the opportunity to manage assets based on a position of financial strength and to reduce capital costs · Entitlement to subscribe for the convertible bonds with preferential rights will accrue to the Company’s existing shareholders, but excludes the Company’s treasury holding of 54,194 shares. The Company will, in connection with this, apply to admit subscription rights and the convertible bonds for trading on Nasdaq Stockholm · Existing shareholders Claesson & Anderzén with companies, AB Traction, Briban Invest AB and Peter Gyllenhammar via company, who hold 36.85 % of the shares in the Company, have signed subscription undertakings and underwriting agreements corresponding to approximately MSEK 177.8. In addition, Tredje AP-fonden, who holds approximately 9.99 % of the shares in the Company, has signed a Letter of Intent to subscribe for approximately MSEK 24.5. Furthermore, Swedbank AB (publ) has signed an underwriting agreement corresponding to approximately MSEK 42.4. Accordingly, the Rights Issue is 100 % supported by subscription undertakings, underwriting agreements and the Letter of Intent · The record date for participating in the Rights Issue is 24 February 2017 and the subscription period will be 28 February to 16 March 2017 · The convertible loan carries an annual rate of interest of 5.75 %, with quarterly coupon payments · Holders of convertible bonds are entitled, during the period from two banking days after the convertible bonds have been registered with the Swedish Companies Registration Office up to and including 28 February 2022, to convert all or portions of their convertible bonds to new ordinary shares in Arise at a conversion price of SEK 22 · The loan falls due for payment on 31 March 2022 unless it is converted prior to this date Daniel Johansson, CEO of Arise AB comments: “It is very gratifying that some of our major shareholders have chosen to support this issue. The issue is 100 % supported by the combination of subscription undertakings, a Letter of Intent and underwriting agreements. We will now boost growth together with our customers and the issue provides us with a stronger financial position from which to take action.”  Background and motiveArise is one of Sweden’s leading operators of onshore wind power. At the end of 2016, the Company’s portfolio of managed wind power totalled approximately 655 MW, of which 241 MW is owned by Arise and approximately 415 MW is managed on behalf of external customers. Total production from own and co-owned production in a normal year amounts to 628 GWh. Arise is thereby a significant supplier of renewable power in the Nordic market. Arise also has an extensive project portfolio of approximately 1,000 MW in Sweden. In Scotland, preliminary project planning work is underway on projects with a combined output of about 150 MW for which the company has signed leasehold agreements. Given that production of electricity from wind power is becoming increasingly cost effective and that there is a political desire in Sweden to continue to support the expansion of renewable energy based on the recently published agreement on Swedish energy policy, the Company’s aim is to further expand its project portfolio. Over the past two years, Arise has successfully developed and built a number of wind farms on behalf of investors and also sold several already operational wind farms. Arise’s customers are investors in wind power that either want to acquire wind farms or that require the Company’s assistance with the financial and technical management of wind farms. It has gradually become clear that Arise has the ability and the credibility required for being a successful developer of projects for various types of investors. The purpose of the Rights Issue is to provide the conditions required to proactively develop the Company’s market position: i) enhance growth in development and management, including through acquisitions, ii) create readiness to exploit consolidation opportunities, and iii) increase value creation potential in the project portfolio as a result of greater financial flexibility. The Rights Issue will also strengthen the Company’s financial flexibility and thus provide the opportunity to manage assets based on a position of financial strength and to reduce capital costs. This means that part of the proceeds from the Rights Issue will be used towards final payments on the bond loans that fall due for payment in 2017. The Rights Issue allows Arise to be opportunistic in its project-development business in which the Company sees business opportunities in the prevailing market climate, and in the ownership of wind farms and related financing. Terms of the preferential rights and convertible bonds in briefPursuant to the authorisation of the General Meeting held on 3 May 2016, the Board of Directors of Arise has decided that the Company is to raise a convertible loan of a nominal maximum of approximately MSEK 245. Entitlement to subscribe for convertible bonds with preferential rights will accrue to the Company’s shareholders, with three shares entitling subscription to one convertible, each with a nominal value of SEK 22. Accordingly, the nominal amount of the convertible loan will total a maximum of SEK 244,741,750. The convertible bonds will be issued at a nominal amount. The record date for entitlement to participate in the issue is 24 February 2017. Subscription is to take place between 28 February and 16 March 2017. The convertible subordinated loan carries an annual rate of interest of 5.75 %, with quarterly coupon payments. Holders of convertible bonds are entitled, during the period from two banking days after the convertible bonds have been registered with the Swedish Companies Registration Office up to and including 28 February 2022, to convert all or portions of their convertible bonds to ordinary shares in the Company at a conversion price of SEK 22. The convertible subordinated loan falls due for payment on 31 March 2022 unless it is converted prior to this date. On the condition of full subscription to the Rights Issue and full conversion of the convertible bonds thereby issued, Arise’s share capital will increase by SEK 889,970.00 on the basis of the issue of 11,124,625 ordinary shares. Subscription undertakings and underwriting agreementsAs stated above, existing shareholders who hold 36.85 % of the shares in the Company have signed subscription undertakings and underwriting agreements corresponding to approximately MSEK 177.8. In addition, a shareholder who holds 9.99 % of the shares in the Company has signed a Letter of Intent to subscribe for approximately MSEK 24.5. Furthermore, approximately MSEK 42.4 is underwritten by an external party. Subscription undertakings and underwriting agreements thus total approximately MSEK 220.2, corresponding to 89.99 % of the Rights Issue. Including the Letter of Intent, this corresponds to the total volume of the Rights Issue. The complete terms, conditions and instructions of the convertible bond issue and other information about Arise will be provided in the prospectus that will be published prior to the subscription period. +-----------+--------------------------------------------------------------+|Preliminary|Event   ||timetable | ||Date   | |+-----------+--------------------------------------------------------------+|20 February|Expected publication of the prospectus (but no later than 27 || |February) |+-----------+--------------------------------------------------------------+|22 February|Last day of trading including rights to receive subscription || |rights in the issue of convertible bonds |+-----------+--------------------------------------------------------------+|23 February|First day of trading excluding rights to receive subscription || |rights in the issue of convertible bonds |+-----------+--------------------------------------------------------------+|24 February|The record date for entitlement to participate in the issue of|| |convertible bonds |+-----------+--------------------------------------------------------------+|28 February|Subscription period ||– 16 March | |+-----------+--------------------------------------------------------------+|28 February|Trading in subscription rights ||– 14 March | |+-----------+--------------------------------------------------------------+|28 February|Trading in paid subscribed convertible bonds ||– 27 March | |+-----------+--------------------------------------------------------------+|21 March |Announcement of the final outcome of the issue of convertible || |bonds |+-----------+--------------------------------------------------------------+      AdvisorsSetterwalls Advokatbyrå is acting as legal advisor and Swedbank AB (publ) is financial advisor to Arise in connection with the convertible bond issue. Invitation to a conference call in connection with Arise’s 2016 Year-End ReportArise’s 2016 Year-End Report will be released on Friday, 17 February, 2017 at around 8:00 a.m. CET. At 11:00 a.m. CET on the same day, a conference call will be held, hosted by Daniel Johansson, CEO and Linus Hägg, CFO, who will present the report to the stock market and media. After the presentation, those attending will be invited to ask questions. The dial in number for the conference call is:Sweden                                         08 50 510 036UK: (local):                                    020 3059 8125Other countries:                            + 44 20 3059 8125Password:                                      Arise A presentation will be held during the telephone conference. Presentation material is available at: http://www.investis-live.com/arise/587f532e7b6fba170040b9b8/ioj2a After the meeting, a recording of the presentation will be available at the same link.    Invitation to a conference call due to the Rights Issue on 22 February at 10:00 a.m. CETDue to the Rights Issue, Arise will hold a company presentation via a conference call on 22 February at 10:00 a.m., hosted by Daniel Johansson, CEO and Linus Hägg, CFO. After the presentation, those attending will be invited to ask questions. The dial in number for the conference call is: Sweden:                               +46 (0) 8 535 211 70   For further information, please contact:Daniel Johansson, CEO of Arise, +46 702 24 41 33. This information is information that Arise AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on 17 February 2017.     About ArisArise is one of Sweden´s leading wind power companies, with the business concept to develop, build and manage onshore wind farms for its own account and on behalf of investors. The company is listed on NASDAQ Stockholm. Arise AB (publ), P.O. Box 808, SE-301 18 Halmstad, Sweden, telephone +46 (0)35 20 20 900, corporate id .no. 556274-6726E-mail info@arise.se, www.arise.se  Important informationThis announcement is not and does not form a part of any offer for sale of securities. Copies of this announcement are not being made and may not be distributed or sent into the United States, Canada, Japan, Hong Kong, Singapore, South Africa, New Zealand, Australia or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any offering in the United States or to conduct a public offering of securities in the United States. Any offering of securities referred to in this announcement will only be made by means of the prospectus announced herewith. This announcement is not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus. In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). This communication must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. Matters discussed in this announcement may constitute forward-looking statements. Such statements are statements that are not historical facts and may be identified by words such as “regard”, “estimate”, “expect”, “anticipate”, “assume”, “predict”, “intend”, “may”, "continue", “should” and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

Alligator Bioscience AB Full Year 2016 Report

Summary · During the quarter were the company’s shares listed for trading on Nasdaq Stockholm Mid Cap. In connection with this were new shares issued that provided the company 350 000 TSEK before underwriting expenses. · The company's project portfolio has continued to develop according to plan including the start of dosing in a second phase I clinical trial that is done by Janssen Biotech. · The Board of Directors proposes that no dividend shall be paid for the year 2016. Conference call for investors, analysts and the mediaThe 2016 Financial Statement will be presented by Alligator’s CEO, Per Norlén and members of the management group on Friday February 17, 2017, at 10.00 (CET).Phone numbers for participants from:Europe: +44 (0) 2030089803, Sweden: +46 856642696, US: +1 8558315946The recorded conference call will be available on Alligators website after completion of the conference, www.alligatorbioscience.com Fourth quarter 2016 in summary  · During the quarter, the company's shares were listed on the Nasdaq Stockholm Mid Cap. · In connection with this, a new share issue which provided the company TSEK 350 000 before underwriting expenses was done. · In October began dosing in a second phase I clinical trial with ADC-1013. This second study includes intravenous dose escalation and is done by Janssen Research & Development LLC. · Net sales for the period amounted to TSEK 6 433 (512). · Result for the period amounted to TSEK -19 352 (-39 450) which corresponds to a result per share before and after dilution with SEK -0,31 (0,67). · Cash flow amounted to TSEK 310 886 (-28 690) and cash and cash equivalents at the end of the quarter amounted to TSEK 659 136 (365 605). January - December 2016 in summary · Alligator’s clinical study with ADC-1013 was expanded in the first quarter resulting in a milestone payment of 5 MUSD following the terms in the partnership agreement with Janssen Biotech Inc. · Janssen started in October a phase I clinical trial with ADC-1013. · Cell-line development for manufacturing of clinical materials for ATOR-1015 began in January. · Result for the period amounted to TSEK -48 356 (207 377), which is equivalent to earnings per share before and after dilution of SEK -0,80 (3,81 and 3,70 respectively). · Cash flow for the period amounted to TSEK 287 135 (326 232). · During the second quarter, the participation in the Biosynergy project was written down with TSEK 22 120. · During 2016 has Alligator increased the share of expenses invested in R&D to 64,3% (54,6%). · The number of employees has increased during 2016, mainly within R&D, and the company is well prepared for further development in 2017. Events after the end of the period · In January 2017 has 700 000 warrants been converted to an equal number of shares. Financial summary (Group)  +---------------------------+-------+--------+-------+--------+| |October-December|January-December|+---------------------------+-------+--------+-------+--------+| |   2016|   2015 |   2016|   2015 |+---------------------------+-------+--------+-------+--------+|Net sales, TSEK (SEK | 6 433| 512| 58 240| 289 797||thousand) | | | | |+---------------------------+-------+--------+-------+--------+|Profit/loss for the period,|-19 352| -39 450|-48 356| 207 377||TSEK | | | | |+---------------------------+-------+--------+-------+--------+|Cash flow for the period, |310 886| -28 690|287 135| 326 232||TSEK | | | | |+---------------------------+-------+--------+-------+--------+|Cash and cash equivalents, |659 136| 365 605|659 136| 365 605||TSEK | | | | |+---------------------------+-------+--------+-------+--------+|Equity ratio, % | 96%| 95%| 96%| 95%|+---------------------------+-------+--------+-------+--------+|R&D costs as % of operating| 68,5%| 47,3%| 64,3%| 54,6%||costs excluding impairments| | | | |+---------------------------+-------+--------+-------+--------+|Earnings per share before | -0,31| -0,67| -0,80| 3,81||dilution, SEK | | | | |+---------------------------+-------+--------+-------+--------+|Earnings per share after | -0,31| -0,67| -0,80| 3,70||dilution, SEK | | | | |+---------------------------+-------+--------+-------+--------+|Average number of employees| 35| 26| 31| 27|+---------------------------+-------+--------+-------+--------+  For further information, please contact:Rein Piir, VP IR, rein.piir@alligatorbioscience.com, +46 (0) 46 286 42 80Per Norlén, CEO, per.norlen@alligatorbioscience.com, +46 (0) 46 286 42 80Per-Olof Schrewelius, CFO, per-olof.schrewelius@alligatorbioscience.com, +46 (0) 46 286 42 85 This information is such information as Alligator Bioscience AB (publ) is obligated to disclose in accordance with EU market abuse regulation. The information was submitted, through the above contact persons, for publication on 17 February 2017 at 08:00 (CET)

Lynparza positive in metastatic BRCA breast cancer

This announcement contains inside information 17 February 2017, 07:00 GMT LYNPARZA MEETS PRIMARY ENDPOINT IN PHASE III TRIAL IN BRCA-MUTATED METASTATIC BREAST CANCER Lynparza provided a statistically-significant improvement in progression-free survival compared to chemotherapy First positive randomised trial to evaluate the efficacy and safety of a PARP inhibitor beyond ovarian cancer AstraZeneca today announced positive results from its Phase III OLYMPIAD trial comparing Lynparza (olaparib) tablets (300mg twice daily) to physician's choice of a standard of care chemotherapy in the treatment of patients with HER2-negative metastatic breast cancer harbouring germline BRCA1 or BRCA2 mutations. Patients treated with Lynparza showed a statistically-significant and clinically-meaningful improvement in progression-free survival (PFS) compared with those who received chemotherapy (capecitabine, vinorelbine or eribulin). Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer at AstraZeneca, said: "These results are positive news for patients with BRCA-mutated metastatic breast cancer, a disease with a high unmet need, and are the first positive Phase III data for a PARP inhibitor beyond ovarian cancer. This is highly encouraging for the development of our broad portfolio which aims to treat multiple cancers by targeting DNA damage response pathways." Initial findings from the OLYMPIAD study indicate that the safety profile of Lynparza was consistent with previous studies.   A full evaluation of the OLYMPIAD data is ongoing and the results will be submitted for presentation at a forthcoming medical meeting. AstraZeneca will be working with regulatory authorities to make Lynparza available to patients with this type of breast cancer. About Metastatic Breast Cancer Approximately one in eight women are diagnosed with breast cancer. Of these patients, approximately one-third are either diagnosed with or progress to the metastatic stage of the disease.[i] Despite treatment options increasing during the past three decades there is currently no cure for patients diagnosed with metastatic breast cancer. Thus, the primary aim of treatment is to slow progression of the disease for as long as possible, improving or at least maintaining a patient's quality of life. About OLYMPIAD OLYMPIAD is a randomised, multi-center Phase III trial assessing the efficacy and safety of Lynparza (300 mg twice daily) to 'physician's choice' chemotherapy (capecitabine, vinorelbine, eribulin) in 302 patients with HER2-negative metastatic breast cancer with germline BRCA1 or BRCA2 mutations, which are predicted or suspected to be deleterious. The international study was conducted in 19 countries from across Europe, Asia, North America and South America. The primary endpoint of the trial was progression-free survival (PFS) as measured by a Blinded Independent Central Review (BICR). Secondary endpoints include overall survival (OS), time to second progression or death (PFS2), objective response rate (ORR), and effect on health-related quality of life (HRQoL). About Germline BRCA mutations BRCA1 and BRCA2 are human genes that produce proteins responsible for repairing damaged DNA and play an important role maintaining the genetic stability of cells. When either of these genes is mutated, or altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired properly. As a result, cells are more likely to develop additional genetic alterations that can lead to cancer.[ii] Specific inherited mutations in BRCA1 and BRCA2 increase the risk of female breast and ovarian cancers, and they have been associated with increased risks of several additional types of cancer. Together, BRCA1 and BRCA2 mutations account for about 20 to 25 percent of hereditary breast cancers[iii] and about 5 to 10 percent of all breast cancers[iv]. In addition, mutations in BRCA1 and BRCA2 account for around 15 percent of ovarian cancers overall[v]. Breast and ovarian cancers associated with BRCA1 and BRCA2 mutations tend to develop at younger ages than their nonhereditary counterparts. About Lynparza Lynparza (olaparib) is an innovative, first-in-class oral poly ADP-ribose polymerase (PARP) inhibitor that may exploit tumour DNA damage response (DDR) pathway deficiencies to preferentially kill cancer cells. Lynparza is the foundation of AstraZeneca's industry-leading portfolio of compounds targeting DNA damage response (DDR) mechanisms in cancer cells. Lynparza is currently approved by regulatory health authorities in the EU for use as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. It is also approved in the US as monotherapy in patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA- test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy. Lynparza is currently being investigated in another separate non-metastatic breast cancer Phase III study called OLYMPIA. This study is still open and recruiting patients internationally. About AstraZeneca in Oncology AstraZeneca has a deep-rooted heritage in Oncology and offers a quickly growing portfolio of new medicines that have the potential to transform patients' lives and the Company's future. With at least 6 new medicines to be launched between 2014 and 2020 and a broad pipeline of small molecules and biologics in development, we are committed to advancing Oncology as one of AstraZeneca's six Growth Platforms focused on lung, ovarian, breast and blood cancers. In addition to our core capabilities, we actively pursue innovative partnerships and investments that accelerate the delivery of our strategy, as illustrated by our investment in Acerta Pharma in haematology. By harnessing the power of four scientific platforms -- immuno-oncology, the genetic drivers of cancer and resistance, DNA damage response and antibody drug conjugates -- and by championing the development of personalised combinations, AstraZeneca has the vision to redefine cancer treatment and one day eliminate cancer as a cause of death. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca. Media EnquiriesEsra Erkal-Paler UK/Global +44 203 749 5638Vanessa Rhodes UK/Global +44 203 749 5736Karen Birmingham UK/Global +44 203 749 5634Rob Skelding UK/Global +44 203 749 5821Jacob Lund Sweden +46 8 553 260 20Michele Meixell US +1 302 885 2677Investor RelationsThomas Kudsk Larsen +44 203 749 5712Craig Marks Finance, Fixed Income, M&A +44 7881 615 764Henry Wheeler Oncology +44 203 749 5797Mitchell Chan Oncology +1 240 477 3771Lindsey Trickett Cardiovascular & Metabolic Diseases +1 240 543 7970Nick Stone Respiratory +44 203 749 5716Christer Gruvris Autoimmunity, Neuroscience & Infection +44 203 749 5711US toll free +1 866 381 7277 Adrian Kemp Company Secretary, AstraZeneca PLC ---------------------------------------------------------------------- [i] Dr Joyce O'Shaughnessy; Extending Survival with Chemotherapy in MBC" The Oncologist 2005:10 [ii] NCI website - BRCA Fact-sheet … https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet Last accessed January 2017 [iii] Easton DF. How many more breast cancer predisposition genes are there? Breast Cancer Research 1999; 1(1):14-17. [iv] Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: New genetic developments, new therapeutic avenues. Human Genetics 2008; 124(1):31-42. [v] Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005; 104(12):2807-16.

MEDIVIR AB – FINANCIAL STATEMENT, JANUARY – DECEMBER 2016

Significant events during the fourth quarter · Medivir focuses research and development operations exclusively on oncology and reorganises in order to achieve significant cost savings. As a result of the operative transformation a non-recurring sum of SEK 49.1 million was charged to the profit/loss for the period and of SEK 52.6 million for the full year. · Medivir divests its pharmaceutical company, BioPhausia (Nordic Brands), to Karo Pharma for SEK 908 million and reports a consolidated capital gain of SEK 534.8 million, thereby applying IFRS 5 (see p. 12). · Medivir strengthens its clinical pipeline by entering into an agreement on the acquisition of a portfolio of clinical phase oncology programmes, which has increased its intangible fixed assets by SEK 89 million and current receivables by SEK 22 million. October – December 2016 · Net turnover for the continuing operations totalled SEK 9.9 million (34.5 m), SEK 5.6 million (31.1 m) of which comprised royalties for simeprevir. · Revenues from Medivir’s continuing pharmaceutical sales totalled SEK 2.9 million (2.9 m), of which SEK 2.9 million (2.7 m) derived from sales of OLYSIO®. · The profit after tax for the continuing operations was SEK -121.3 million (-56.9 m). · Basic and diluted earnings per share totalled SEK -4.50 (-2.11) and SEK -4.50 (-2.11), respectively. · The cash flow from operating activities amounted to SEK -69.6 million (-37.6 m). January – December 2016 · Net turnover for the continuing operations totalled SEK 93.0 million (474.3 m), SEK 60.3 million (418.6 m) of which comprised full year royalties for simeprevir. · Revenues from Medivir’s continuing pharmaceutical sales totalled SEK 12.3 million (53.9 m), of which SEK 12.0 million (53.0 m) derived from sales of OLYSIO®. · The profit after tax for the continuing operations was SEK -294.9 million (31.7 m). · Basic and diluted earnings per share totalled SEK -10.94 (1.09) and SEK -10.94 (1.08), respectively. · The cash flow from operating activities amounted to SEK -180.1 million (307.4 m). +-------------------------------+--------+-------+-------+-------+|Summary of the Group’s figures | Q4 | Q1-Q4 ||(SEK m) | | |+-------------------------------+--------+-------+-------+-------+|Continuing operations | 2016| 2015| 2016| 2015|+-------------------------------+--------+-------+-------+-------+|Net turnover | 9.9| 34.5| 93.0| 474.3|+-------------------------------+--------+-------+-------+-------+|Gross profit | 7.7| 30.0| 77.1| 436.0|+-------------------------------+--------+-------+-------+-------+|Operating profit before | -120.7| -51.9| -278.9| 95.7||depreciation and amortisation | | | | ||(EBITDA) | | | | |+-------------------------------+--------+-------+-------+-------+|Operating profit (EBIT) | -128.9| -60.4| -312.4| 55.4|+-------------------------------+--------+-------+-------+-------+|Profit/loss before tax | -129.9| -67.8| -306.7| 46.2|+-------------------------------+--------+-------+-------+-------+|Profit/loss after tax | -121.3| -56.9| -294.9| 31.7|+-------------------------------+--------+-------+-------+-------+|Operating margin, % |-1,306.1| -175.3| -335.7| 11.7|+-------------------------------+--------+-------+-------+-------+|Basic earnings per share, SEK | -4.50| -2.12| -10.94| 1.09|+-------------------------------+--------+-------+-------+-------+|Diluted earnings per share, SEK| -4.50| -2.12| -10.94| 1.08|+-------------------------------+--------+-------+-------+-------+|Net worth per share, SEK | 64.38| 54.04| 64.38| 54.04|+-------------------------------+--------+-------+-------+-------+|Return on equity | -30.5| -15.5| -18.5| 1.8|+-------------------------------+--------+-------+-------+-------+|Cash flow from operating | -69.6| -37.6| -180.1| 307.4||activities | | | | |+-------------------------------+--------+-------+-------+-------+|Cash and cash equivalents at | 1,698.5|1,077.9|1,698.5|1,077.9||period end | | | | |+-------------------------------+--------+-------+-------+-------+|R&D spending/total opex, % | 65.9| 77.8| 78.8| 73.1|+-------------------------------+--------+-------+-------+-------+ Conference call for investors, analysts and the mediaThe financial statement for January – December 2016 will be presented by Medivir’s President & CEO, Niklas Prager.Time: Friday, 17 February 2017, at 14.00 (CET).Phone numbers for participants from:Sweden 08- 566 426 91Europe +44 20 3008 9804USA +1 855 753 2235The conference call will also be streamed via a link on the website: www.medivir.comThe presentation will be available on Medivir’s website after completion of the conference. CEO’s commentsWe took several significant steps in the restructuring of Medivir during the fourth quarter. In all essentials, we completed the transformation of the company that had been in progress throughout the year. A key part of this transformation was the focusing of the company’s operations exclusively onto research and development in the field of oncology. This focus was given extra emphasis with the acquisition of two oncology projects in late development phases, both of which have considerable potential. The acquisition strengthens and balances our research portfolio and gives us a wider range of projects in different phases, shifting the company’s primary focus from early stage research to clinical development.As a further step in this process, we also divested BioPhausia with its drug portfolio Nordic Brands. After having considered and prepared a separate stock exchange listing of BioPhausia, we judged that a sale to Karo Pharma AB was the best alternative for our shareholders. An Extraordinary General Meeting in early February 2017 endorsed the Board’s proposal that the net proceeds from the sale of SEK 870 million should be distributed to Medivir’s shareholders in the form of a voluntary redemption programme.We also reorganised the company’s early stage research and administrative functions during the quarter. It is estimated that this will give annual savings totalling approximately SEK 110 million.Furthermore, we continued to make progress in our research projects during the quarter, both in our internal portfolio and in partner projects. I would like to make particular mention of the fact that we selected two new candidate drugs from our own research portfolio that have now proceeded to preclinical development: MIV-323 for the treatment of RSV infections and MIV-818 for the treatment of liver cancer. In keeping with our new exclusive oncology focus, we will continue to pursue the development of MIV-818 in-house, while for that of MIV-323 we will be seeking a partner.Along with MIV-802 for the treatment of hepatitis C, which we licensed out to Trek Therapeutics in the third quarter of 2016, these projects are clear indications of the improved productivity of our early stage research operations and ability to continue to produce new, well-differentiated candidate drugs in areas of great unmet medical needs on the basis of our own technology platform.The osteoarthritis trial MIV-711 proceeded according to plan and is now fully enrolled. As before, we expect to report data from the study during the third quarter of 2017.In November our partner, Janssen Research & Development, announced that they are building on earlier interesting results by initiating a phase IIb study with the combination of simeprevir, odalasvir and AL-335 for the treatment of hepatitis C.Q4 royalties attributable to the hepatitis C drug OLYSIO® (simeprevir) amounted to SEK 5.6 million as a result of the decline in global net sales.The extensive transformation we have now achieved gives me great hope for the future. Our strong, balanced research and development portfolio with a focus on oncology, based on our exciting technology platforms for protease inhibitors and nucleosides/nucleotides, has considerable potential to create long-term value for the shareholders and will generate a continuous news flow in 2017 and the years to come. It is therefore with a sense of pride and great confidence that I feel spring 2017 is the right time to hand over the baton to a new CEO, Christine Lind. I would like to take this opportunity to thank all our engaged shareholders, the Board of Medivir, all our employees and business partners for the stimulating and intense years at the helm of Medivir and I wish the company every success in the future. As a shareholder, I will be following the progress with great interest! Niklas PragerPresident and CEO  Upcoming reporting dates:Interim Report (January – March 2017)28 April 20172017 Annual General Meeting3 May 2017Interim Report (January – June 2017)25 July 2017Interim Report (January – September 2017)26 October 2017 For further information, please contact:Niklas Prager, President & CEO, phone: +46 (0) 8 407 64 30Ola Burmark, CFO, mobile: +46 (0)725-480 580.This information is information that Medivir AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.30 CET on 17 February 2017.About MedivirMedivir is a research-based pharmaceutical company with a focus on oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical needs. Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Summa Equity’s first fund closes at SEK 4.5 billion

Summa Equity was founded in 2016 by five partners brought together by a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market. The firm focuses on capturing the investment opportunity provided by thematic megatrends that are expected to drive long term growth. Reynir Indahl, Managing Partner, Summa Equity comments: “Our investment strategy is designed to address the challenges associated with generating long-term profitability in a volatile market underpinned by low economic growth. In the process we hope to be part of developing innovative solutions to some of the most pressing challenges of our time. The closing of our first fund brings us closer to realising this vision and marks the beginning of an exciting journey.” Summa Equity Fund I is backed by a broad investor base comprising endowments, foundations, pension funds, insurance firms and funds of funds across the Nordics, Europe and North America. The Fund’s strategy will focus on investments related to four themes: resource scarcity, energy efficiency, changing demographics and tech-enabled businesses. The firm has offices in Stockholm and Oslo and the partners are Reynir Indahl, Jenny Keisu, Johannes Lien, Christian Melby and Tommi Unkuri. Two deals, Sortera and eGain, have already been completed for the fund: · Sortera is the market leader in collection and recycling of building material waste in Sweden’s largest urban areas. · eGain is a leading Nordic technology/service provider of remote optimisation and climate-based control of heating in multi-apartment buildings. Jenny Keisu, Partner and COO of Summa Equity, continues: “Sortera and eGain are great examples of the investment opportunities we see. They both have megatrend driven, resilient business models uncoupled from GDP growth and we have already identified a number of value creation initiatives that are being implemented to stimulate their respective growth strategies. A third investment is finalised and will be announced shortly providing a solid foundation for the fund.” Summa Equity’s investment philosophy also contributes to a strong environmental, social and governance (ESG) profile with the goal to generate long-term sustainable growth and profitability. As part of this commitment the firm will be the first Nordic Private Equity firm to report towards the UN Sustainable Development Goals. Summa Equity was advised by London-based Rede Partners, an independent fund raising and secondary adviser to the private equity industry. The legal advisors in connection with the fund raising were Mannheimer Swartling and Ropes & Gray. The new fund is domiciled in Sweden and is regulated as an AIF (Alternative Investment Fund) by the Swedish Financial Supervisory Authority. Ends Notes to Editors For more information, please contact: Jenny Keisu, Partner and COO, +46 72 24 24 144 About Summa Equity Summa Equity was formed in 2016 by partners with a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market, positioned to capture the investment opportunity provided by the thematic megatrends expected to drive growth over the long term. The Firm focuses on sectors related to four megatrend driven themes: resource scarcity, energy efficiency, changing demographics and tech-enabled businesses. Summa Equity closed its first fund in February 2017 with commitments of SEK 4.5 billion.

Viking Line to invest in its Helsinki–Tallinn route, tripling departuresin July

The Helsinki–Tallinn route is by far one of the most popular with cruise passengers on the Baltic Sea. Many travel to Tallinn on business trips or to shop. In past years, aside from the usual service on the Viking XPRS, additional sailings were provided by the M/S Mariella and M/S Gabriella. This year, Viking Line also wanted to offer customers the chance to get to Tallinn even faster than before. The large amount of departures means it is possible to visit Tallinn easier than before. “Some people like to spend time on the vessel, while others want to get where they are going as fast as possible. So we decided to rent a vessel to make express sailings. This year we also want to start up the additional sailings beginning in the spring and continue them well into the autumn. There is such a great demand, and we do not want to leave anyone on shore”, says Kaj Takolander,Vice President Marketing and Sales at Viking Line. To Tallinn in less than two hours Travel time on the Viking FSTR from Helsinki to Tallinn is 1 hour and 45 minutes. Passengers can conveniently work on board since window seats on the upper deck are equipped with outlets for charging computers. Although the vessel travels the distance quickly, people have an opportunity to shop on board or relax in the restaurant and pub. The vessel has capacity for about 850 passengers and 120 cars. It also features an additional class, Club Lounge, where food and beverages are included in the ticket price. People can continue their journey by car from Tallinn to attractive Estonian destinations such as Vihula Manor, where they can enjoy a spa weekend, or the remote sandy beaches of the Baltic Sea. Naturally, Tallinn also offers city holidays with relaxation, shopping, culture and food experiences all day long. The last departures to Helsinki are in the evening. During the spring and autumn, the Viking FSTR will make four to six daily sailings in addition to the Viking XPRS’ usual four departures. In July, there will be a full 12 daily departures on the Helsinki–Tallinn route since the vessels that serve the Helsinki–Stockholm route will also make one return sailing to Tallinn during the day. The new departures will be bookable from March 15, 2017. The preliminary timetable, Viking Line reserves the right to changes:

Cloetta acquires Candyking

”The acquisition of Candyking will significantly strengthen Cloetta’s position in Denmark, Norway and the United Kingdom. Cloetta will be able to develop the Candyking brand and product offering, in order to offer an attractive customer and consumer experience. The acquisition will also strengthen our position in natural snacks with the Parrot brand. In addition, there are substantial cost synergies that make the acquisition attractive,” says Danko Maras, CFO and outgoing CEO a.i., of Cloetta. Candyking offers stores a complete concept in pick and mix candy including products, displays and accompanying store and logistic services. Candyking itself does not manufacture any products, instead they purchases products from different suppliers. The company currently supplies approx. 8,000 retail outlets in seven countries. Sweden, the United Kingdom, Norway and Denmark are the largest markets. Other markets are Finland, Ireland and Poland. In total Candyking have approx. 370 employees. Candyking’s total sales (including Danish tax) amounted to approx. SEK 1,300m on a rolling twelve month basis per the third quarter of 2016. Underlying EBITDA was approx. SEK 70m and underlying EBIT approx. SEK 30m. Candyking’s trademarks in confectionary are Candyking, Karamellkungen and Candyking Favourites. The company is also a leading pick and mix supplier within natural snacks in Sweden and Finland under the Parrot brand. The acquisition is expected to create substantial synergies that will gradually be realized during the years 2017 – 2020. Synergies will be created within administration, procurement, logistics, sales and through insourcing of production. The final outcome of the synergies is dependent on volume development. Cloetta intends to, following completion of the transaction, revert with information regarding expected synergies and non-recurring costs. The Cloetta group’s target of an underlying EBIT margin of 14 per cent stands firm. The transactionCloetta has agreed to acquire 100 per cent of the shares in Candyking as well as 100 percent of Candyking’s outstanding bond and other debt. The initial purchase price amounts to SEK 325m on a cash and debt free basis with a potential additional purchase price of maximum SEK 225m based on the result of Cloetta’s and Candyking’s combined sales volume of pick and mix in confectionary and natural snacks in the Nordic countries, the United Kingdom and Poland during 2018. The seller of the shares is Candyking’s CEO, Dani Evanoff. The majority of the initial purchase price and the potential additional purchase price will be allocated to the holders of Candyking’s SEK 750m bond loan. In connection with closing of the acquisition, Candyking’s bonds will be delisted from Nasdaq Stockholm. At the same time Cloetta will issue an earn-out instrument to the current bondholders that entitles to the future potential additional purchase price. The instrument will be registered at Euroclear in order to facilitate the distribution of any additional purchase price to the current bondholders. The transaction is subject to approval from the Swedish Competition Authority. FinancingThe acquisition will be financed by Cloetta using cash and its existing credit facilities. AdvisorsHandelsbanken Capital Markets has been financial advisor to Cloetta and Advokatfirman Cederquist has been legal advisor. KPMG contributed with support regarding financial due diligence. Conference call and web presentationA conference call and web presentation with Danko Maras, CFO and outgoing CEO a.i., will be held today at 15.00 p.m. Those who wish to participate are invited to dial in on telephone numbers. Phone numbersSE: +46856642690DK: +4535445575FI: +358981710493UK: +44 2030089802NO: +4723500254  Web presentationLink to the live broadcast will be published on www.cloetta.com The presentation will be in English. Make sure that you are connected to the conference by dialling in and register a few minutes before the conference begins. An audio recording of the conference call will be published on www.cloetta.com This information is such that Cloetta AB (publ) is required to disclose pursuant to the EU Market Abuse Regulation. The information was submitted, through the agency of the contact person set out below, for publication at 13.30 CET on 17 February 2017.

Candyking gets new owner

-          Shortly after my acquisition of Candyking, after a thorough dialogue with the creditors of the Company, the conclusion was that we needed to find a strong and long-term owner to the company. With this insight, dialogues with several potential purchasers on the market were initiated and Cloetta was deemed to be the best candidate in this process. A professional player with a strong interest for pick and mix confectionary and a strong focus on further developing its concept business within its group. I am convinced that Candyking will create added value for Cloetta, customers and our Nordic suppliers who during all years have supported Candyking for better or worse. Personally, I feel proud and relived to through this transaction perpetuate Karamellkungen which was founded in 1984 by Christer Forsman, says Dani Evanoff. The transaction is carried out on the basis of the discussions that have taken place between Candyking Holding AB (publ) (the “Company” or “Candyking”) and holders of the Company’s outstanding bond-loan in a nominal amount of MSEK 750 (the “Bonds”) regarding Candyking’s long-term financing (please refer to the press release on 13 January 2017 regarding the divestment of Candyking from Accent to Dani Evanoff). The agreement in relation to the acquisition has been entered into between a wholly owned subsidiary of Cloetta AB (publ) (“Cloetta”), a group of bondholders (together representing a qualified majority of more than 2/3 of the Bonds) and Dani Evanoff through his wholly owned company. Cloetta acquires, inter alia, all shares in Candyking and the Company’s mezzanine loan from Dani Evanoff as well as all outstanding Bonds from the bondholders.   The initial purchase price amounts to MSEK 325 on a cash and debt free basis and will be payable in connection with closing of the transaction. The purchase price after adjustments for cash and debt is estimated to approximately MSEK 307 in the agreement and will be finally determined in connection with closing. Based upon Cloetta’s and Candyking’s combined sales volume of pick and mix in confectionary and natural snacks in the Nordics, the United Kingdom and Poland during 2018, an additional purchase price of maximum SEK 225 million may become payable. The major part of the purchase price will be allocated to the bondholders. In connection with closing, Cloetta will issue an instrument relating to the right to the potential additional purchase price, which will be issued to the current bondholders in exchange for the existing Bonds (a so called “Mandatory Exchange” in accordance with the terms and conditions for the Bonds). Thereafter, the Bonds will be de-listed from Nasdaq Stockholm. The new instrument will be registered with Euroclear in order to facilitate the payment of the potential additional purchase price to the bondholders. Resolutions to approve the transaction, the exchange of instruments and other resolutions necessary in connection therewith will be resolved upon at a bondholders’ meeting which will be called upon shortly in accordance with the terms and conditions for the Bonds. Bondholders together representing a qualified majority of more than 2/3 of the Bonds have undertaken towards Cloetta to vote in favour of such resolutions. More information in relation to the transaction that may be of importance to the bondholders will be included in the notice. The transaction in subject to approval from the Swedish Competition Authority and approval of the bondholders at a bondholders’ meeting. Gernandt & Danielsson Advokatbyrå KB and Baker McKenzie are advisors to the bondholders, the Company and Dani Evanoff in connection with the transaction. In case of questions, please contact: Dani Evanoff +46 73-503 97 97 About this information Candyking Holding AB (publ) publishes this information in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 13.30 CET on 17 February 2017.   About Candyking Candyking was founded in 1984 and is a leading concept supplier of pick and mix candy in the Nordic countries, the United Kingdom, Ireland and Poland. Today, Candyking has more than 8,000 points of sale and offer stores an integrated concept which includes products, displays and accompanying store and logistic services. Candyking’s trademarks in confectionary are Candyking, Karamellkungen and Candyking Favourites. The company is also a leading pick and mix supplier within natural snacks in Sweden and Finland under the Parrot brand. More information is available at www.candyking.com.

UPDATE ON STATUS OF THE REFINANCING OF FINANCIAL OBLIGATIONS

The Board of Directors (the “Board”) of EMAS Offshore Limited (the “Company”, together with its subsidiaries, the “Group”) refers to the announcement released by the Company dated 13 December 2016 (the “Announcement”) where the Company announced that the Group has signed a term sheet with all its financial lenders to refinance its financial obligations (“Refinancing”) over a period of 5 years from 12 December 2016 and the Refinancing will be subject to documentation and conditions that would be set out in definitive agreements (the “Definitive Agreements”) to be entered into between the parties within sixty (60) days from 12 December 2016. Unless otherwise defined, capitalised terms used herein shall have the same meanings ascribed to them in the Announcement.  The Board wishes to announce that the Company and all its financial lenders are still in the process of negotiating and finalising the Definitive Agreements. The Company has requested its financial lenders to grant an extension of time to finalise the Definitive Agreements within sixty (60) days from 10 February 2017. The Company will make further announcements in compliance with the listing requirements of the Oslo Bors, upon the execution of the Definitive Agreements and/or when there are material developments in respect of the Ongoing Initiatives. Shareholders of the Company (the “Shareholders”) are advised to exercise caution when trading in the Company’s shares as there is no certainty or assurance as at the date of this Announcement that the Definitive Agreements will be entered into or the Ongoing Initiatives will be undertaken or completed at all. When in doubt as to the action they should take, shareholders and potential investors should consult their financial, tax or other advisers. By Order of the Board Shannon OngCompany Secretary17 February 2017

Nel ASA: Awarded frame contract for multiple hydrogen fueling stations in California

(Oslo, 20 February 2017) Nel Hydrogen Solutions, a division of Nel ASA (Nel, OSE:NEL), has entered into a framework contract for the supply, construction and maintenance of H2Station® hydrogen fueling stations in California, following the California Energy Commissions Notice of Proposed Awards for the Grant Funding Opportunity GFO-15-605. “This framework contract represents a major milestone for Nel, and open significant opportunities in the fast developing US hydrogen market. We are very proud to have been exclusively chosen to deliver H2Stations to our customer in California. We look forward to working with our partner to roll out their Californian hydrogen fueling network”, says Mikael Sloth, Director of Business Development in Nel. On Friday 17 February 2017, the California Energy Commission (CEC) announced the Notice of Proposed Awards (NOPA) for the Grant Funding Opportunity GFO-15-605 on the construction and operation of fueling stations in California. Following the NOPA announcement, Nel and its partner finalized the framework contract for the exclusive supply, construction and maintenance for H2Station® hydrogen fueling stations in California. Rather than getting a direct allocation through Nel’s subsidiary Everfuel Inc., the allocation for H2Stations® came through a third party partner of Nel. The name of the partner will remain undisclosed until the details in the allocation document has been assessed. The exact value of the contract and delivery details will also be disclosed later. “This is our largest single order for fueling stations ever, and represents the best possible start of our entry into the Californian market. We look forward to supplying our partner with technology as well as support through service and maintenance. We are also in good dialogue with other applicants and are therefore in position to deliver even additional H2Station technology to other grants recipients”, says Jon André Løkke, Chief Executive Officer of Nel. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 9074 4949 About Nel| www.nelhydrogen.com       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

Summa Equity acquires Lin Education

Tommi Unkuri, Partner at Summa Equity, said: “We are very excited about concluding Summa Equity’ third investment, and the first one within the investment theme Changing Demographics. This investment also fits within another of our four themes, Tech-enabled business, where Education is a core segment. Through Lin Education we will contribute to the digitalisation of the Swedish educational system. In a time when learning is more important than ever, this is a field offering important challenges, but also huge opportunities. Being part of innovative solutions to some of the pressing challenges of our time, is a fundament in Summa Equity’s investment philosophy”. Josef Lind, Founder and CEO of Lin Education, said: “We are very pleased to have Summa Equity as our new majority owner and partner, as this will help Lin Education take the next steps in our development. We are looking forward to a collaboration whereby we will strengthen our offering, press ahead to lead the development in educational content, and further develop our organisation. In Summa Equity we find a fit not only for our business, but also for our people and stakeholders.” Lin Education was founded in 2007 by Josef Lind, and today has several hundred thousand digital tools and IT hardware (i.e. computers, laptops, tablets, etc.) in schools and preschools all over Sweden. Lin Education also offers learning, development and digitalisation training for its customers. Many thousand people are using the Lin Education’s proprietary digital content tools for learning. The company has some 90 employees working out of offices in Gothenburg, Stockholm, Malmö, Karlstad and Umeå. Revenue was SEK 569m in 2016. Summa Equity will support the continued development of Lin Education and assist the Company in further growth through investments to develop existing as well as new products. Lin Education is expected to benefit from the trend towards increasing digitalisation of learning, in schools and in other environments. Ends For more information, please contact: Tommi Unkuri, Lead Partner, Summa Equity, +46 70 508 1196, tommi.unkuri@summaequity.com Josef Lind, CEO, Lin Education, +46) 704 385 827, josef.lind@lineducation.se About Lin Education Lin Education is a Swedish Education Technology company founded in 2007 as distributor of IT hardware (i.e. computers, laptops, tablets) to Swedish schools. The Company has since also expanded into segments for digital content, training and supplementary services for a digital learning environment, and today has a position as a leader in the Swedish market for digitalisation of the educational system. Lin Education has demonstrated strong double digit revenue growth annually over the past three years. About Summa Equity Summa Equity was formed in 2016 by partners with a shared vision of building a leading specialised private equity firm in the Nordic lower mid-market, positioned to capture the investment opportunity provided by the thematic megatrends expected to drive growth over the long term. The Firm focuses on sectors related to four megatrend driven themes: resource scarcity, energy efficiency, changing demographics and tech-enabled businesses. Summa Equity closed its first fund in February 2017 with commitments of SEK 4.5 billion.

Autoliv declares increased dividend

The dividend will be payable on Thursday, June 1, 2017 to Autoliv shareholders of record on the close of business on Wednesday, May 17. The ex-date will be Monday, May 15 for holders of the common stock listed on the New York Stock Exchange and Tuesday, May 16 for holders of Swedish Depository Receipts (SDRs) listed on NASDAQ Stockholm. Shareholders AGM As previously announced, the Board of Directors has set Tuesday, May 9, 2017, as the date for the Annual General Meeting of Shareholders to be held in Chicago, IL, USA. Only shareholders of record at the close of business on March 13, 2017, will be entitled to be present and vote at the 2017 Annual General Meeting. Notice of the 2017 Annual General Meeting will be delivered to the holders of record in late March. All of the directors with terms expiring at the 2017 Annual Meeting (Robert Alspaugh, Jan Carlson, Aicha Evans, Leif Johansson, David Kepler, Franz-Josef Kortüm, Xiaozhi Liu, James Ringler, Kazuhiko Sakamoto and Wolfgang Ziebart) will be nominated for re-election at the 2017 Annual Meeting, with the exception of George Lorch, who has informed the Company that he will  not stand for re-election at the 2017 Annual Meeting, as he has reached the retirement age set forth in the Company’s Corporate Governance Guidelines. George Lorch has served as a director of the Company since 2003 and as Lead Independent Director since May 2014. At the conclusion of Mr. Lorch’s service, the Board will appoint a new Lead Independent Director. The Board will not fill the vacancy resulting from Mr. Lorch’s retirement and will accordingly reduce the size of the Board to ten directors, effective immediately following the closing of the polls for the election of directors at the 2017 Annual Meeting. Inquiries: Thomas Jönsson, Vice President Corporate Communications, Tel: +46 8 58 72 06 27 This information is information that Autoliv, Inc. is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the contact person set out above, at 08.30 AM CET on February 20, 2017.

Brighter signs agreement with Sonat for global logistics solution.

Brighter has selected Sonat as its development partner for the upcoming launch of Actiste®, Brighter’s connected diabetes solution. Sonat specializes in developing, managing and running logistics processes, and will together with Brighter develop a strong logistics platform that facilitates growth and international expansion. Under the agreement, Sonat will take on a partner role and drive the development of a logistics platform that enables rapid growth and expansion to new markets. Sonat will also act as an outsourced logistics function, which includes responsibility for forecasts, inventory control, availability, order planning, transportation administration, delivery monitoring and ongoing problem solving. “The Actiste launch is approaching, and it is crucial that we have professional partners in all of the relevant areas. Just like our production partner Sanmina, Sonat adds valuable expertise. That in combination with our agreements with Telia and Indosat Ooredoo will ensure a successful launch on applicable markets. Sonat’s clients include Apoteket, Svenska Retursystem and Varner Ibrahimovic, among others, and they have many times demonstrated their capability in terms of supplying world-class logistics solutions,” says Truls Sjöstedt, CEO and founder of Brighter. Cooperation with Sonat will be initiated immediately. With this partnership, Brighter, which is currently in the industrialization phase, has ensured all of the partnerships it requires for the initial launch of Actiste on selected markets. In July 2016, Brighter teamed up with Sanmina, its global manufacturing partner, and shortly after Brighter signed an agreement with Telia for subscription services in Sweden, with an option for the Nordic countries. Brighter has also signed an agreement with Indosat Ooredoo, an Indonesian mobile network operator. In addition, Brighter has an on-going close partnership with Ericsson regarding its Device Connection Platform. “This is an extremely invigorating assignment that we are looking forward to implementing. Over the course of 17 years, we have accumulated an enormous amount of expertise and experience. With Brighter, we have an opportunity to combine the hands-on aspect of our 4PL operations with our extensive strategic know-how. We have extensive experience from both large and small companies, some in the start-up phase and some more established, but all with the same growth aspirations as Brighter,” says Kjell Rundqvist, CEO of Sonat. For more information, please contact:Truls Sjöstedt, CEO     Tel: +46 709 73 46 00     Email: truls.sjostedt@brighter.se  Henrik Norström, COO     Tel: +46 733 40 30 45     Email: henrik.norstrom@brighter.se About Brighter AB.Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms. The Company's shares are listed on NASDAQOMX FIRST NORTH/BRIG. Brighter's Certified Adviser is Remium Nordic AB, +46 (0)8 454 32 50, CorporateFinance@remium.com, www.remium.com. This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on February 20, 2017.

Sivers IMA enters partnership with Integrated Device Technology

This new 60 GHz RFIC contains a beam forming transceiver including 16 Tx and 16 Rx channels. Sivers IMA will also be able to deliver a high gain patch antenna as part of the full solution. The partnership will produce a carrier-grade, high-speed mmWave V-band solution targeting data and telecommunication infrastructure applications for the networks of today and tomorrow. The leading use cases for this ground breaking technology are fixed wireless access (FWA), meshed networking and backhaul. ”We are very pleased and excited to join forces with IDT in conquering the growing IEEE 802.11ad infrastructure market and I am impressed by the joint work and cooperation performed by our teams so far,” says Anders Storm, CEO of Sivers IMA. “The combination of capabilities from the Sivers IMA and IDT products will create a solution exhibiting very high throughput, immunity against interference and outstanding link budget that will add value to any potential customer wanting to explore the use of the wide license free 60 GHz spectrum.” “This collaboration with Sivers IMA is a reflection of IDT’s strategic focus, investments, and commitment to mmWave enablement within wireless infrastructure,” said Sean Fan, vice president and general manager of IDT’s Computing and Communications Division. “We see great opportunities for utilizing the mmWave bands for access and backhaul applications.” The IDT and Sivers IMA combined solution will provide an optimized infrastructure solution unlike anything existing on the market today. For example, IDT’s RapidWave RWM6050 dual modem is designed in 28nm CMOS technology and offers unprecedented integration including  dual modems in a single chip, enabling many data and telecommunication infrastructure uses cases. Sivers IMA’s RFIC is developed in Silicon-Germanium technology, offering state-of-the-art RF performance packaged in an eWBL capsule for easy surface mounting. The Sivers IMA RFIC and the IDT RapidWave  RWM6050 is expected to sample to key customers in Q2 2017. Under the partnership, IDT will have access to resell the Sivers IMA RFIC, and Sivers IMA will sell the RWM6050 module solution to select customers. For more information: Anders Storm, CEO Tel: +46 70 262 6390 E-mail: anders.storm@siversima.com  Integrated Device Technology, Inc. develops system-level solutions that optimize its customers' applications. IDT's market-leading products in RF, real-world interconnect, wireless power transfer, serial switching, interfaces, automotive ASICs, battery management ICs, sensor signal conditioner ICs and environmental sensors are among the company's broad array of complete mixed-signal solutions for the communications, computing, consumer, automotive and industrial segments. Headquartered in San Jose, Calif., IDT has design, manufacturing, sales facilities and distribution partners throughout the world. IDT stock is traded on the NASDAQ Global Select Stock Market® under the symbol "IDTI." Additional information about IDT can be found at www.IDT.com. Follow IDT on Facebook, LinkedIn, Twitter, YouTube and Google+. Sivers IMA is a leading manufacturer of micro- and millimeter wave products for connecting and quantifying a networked world. Sivers IMA has a long history and is internationally renown as a reliable supplier of high quality components used in telecommunications links, RADAR sensors and test & measurement equipment. Headquarters is located north of Stockholm in Kista, Sweden. Learn more at http://siversima.com.

Eltel’s Q4 and FY 2016 operative EBITA significantly below previous guidance – Q4 report to be published one day earlier

Due to these circumstances, Eltel will publish its full-year 2016 and fourth quarter interim report one day earlier than communicated, on Tuesday 21 February 2017 at 7.00 CET. Eltel’s CEO Håkan Kirstein, interim CFO Lars Nilsson and Chairman of the Board Ulf Lundahl will host a presentation via audiocast in English starting at 9.00 CET. The interim report and the presentation will include structural measures and strategic revisions. The presentation will be audiocasted live on www.eltelgroup.com. For those who would like to participate on the telephone conference in connection with the presentation, the telephone numbers are: · SE: +46 8 56 64 26 94 · FI: +358 9 81 71 04 92 · UK: +44 20 30 08 98 03 Please, call well in advance to register. After the presentation there will be an opportunity to ask questions via audiocast or telephone conference. The presentation material will also be available at that time and on demand at www.eltelgroup.com. For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com This information is information that Eltel AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 11.00 CET on 20 February 2017. About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

SCHMITZ CARGOBULL INVESTS IN RIGID BODY SECTOR GROWTH WITH NEW APPOINTMENT

Schmitz Cargobull has invested in its future growth in the rigid market, with the appointment of a new National Sales Representative - Truck Bodies, to further develop the company’s presence in the rapidly growing sector. Tom Stott, 23, brings more than six years of experience from Cartwright, with a strong emphasis on customer service. In his new role, Stott will help customers of all sizes save money, with rigid truck bodies offering a low total cost of ownership. Stott says: “With urban delivery now a booming market in the UK and Ireland, the rigid body market has huge potential for expansion, and we’re committed to supporting operators in this competitive sector.” He adds: “Schmitz Cargobull’s trailers lead the market thanks to cost-effective features developed in-house, backed by outstanding customer service. Our rigid bodies also offer those advantages, which will benefit customers requiring world-class, high-tech assets combined with the functionality of a rigid. Supported by our range of value-added services, hauliers can get everything they need to maximise the cost-effectiveness of their operations from a single source.” Ideally designed for urban deliveries, Schmitz Cargobull’s rigid bodies incorporate a variety of advanced technologies, including a double-decker pallet stacking system that doubles carrying capacity for non-stackable goods, and flooring that is lighter, more slip-resistant and easier to clean than conventional flooring, as well as being PIEK-certified for low-noise operations. Schmitz Cargobull also offers a range of services designed to reduce the total cost of ownership of each rigid body, including telematics for optimal route planning and temperature control, and full-service contracts for repair and maintenance Europe-wide. The rigid bodies also maintain a higher residual value than comparable products in the market. Stott will be based at Schmitz Cargobull UK and Ireland’s head office in Warrington, reporting to Managing Director Alan Hunt. ends Editor’s notes: Schmitz Cargobull UK and Ireland is a subsidiary company of the German-owned Schmitz Cargobull Group. With an annual production of some 50,000 vehicles and around 5,100 employees, Schmitz Cargobull AG is Europe's leading manufacturer of semi-trailers, truck bodies and trailers for temperature-controlled freight, general cargo and bulk goods. A turnover of € 1.779 billion was reported in the 2015/2016 business year. As a pioneer in the industry, Schmitz Cargobull AG developed a comprehensive brand strategy early on and has consistently established quality standards spanning every level: from research and development, to production, to specialist services such as trailer telematics, financing, spare parts and used trailers. Visit Schmitz Cargobull UK’s dedicated online press room at http://news.cision.com/schmitz-cargobull  Press Contact UK:        James BoleyGarnett Keeler PR                                                        Tel: 020 8647 4467Email: james.boley@garnettkeeler.com   Company Contact Europe:Gerd Rohrsen, Corporate Public RelationsSilke Hesener, Manager Public RelationsTel: +49 02558 811501Email: silke.hesener@cargobull.com  SCB/183/17

Hearts of Iron IV Sells Half a Million Copies

Paradox Development Studio is thrilled to announce that Hearts of Iron IV, its World War II themed strategy wargame, has sold 500,000 copies worldwide since its release in June 2016. This milestone follows record sales for Stellaris, Europa Universalis IV and Crusader Kings II, once again confirming Paradox as the premier developer of computer strategy games.Fredrik Wester, CEO of Paradox Interactive, underlines how the continued success of Paradox games justifies the company philosophy.“The PC remains the primary platform for games of this nature,” Wester says. “Even genres that have traditionally been seen as niche can find a large audience, if a developer is dedicated to quality, variety and learning from both previous experiences and the community at large.” Hearts of Iron IV recently saw the release of Together for Victory, the first major expansion to the game. Lead Designer Dan Lind is very pleased with the ongoing development of the game, and the team remains committed to continually improving the HoI experience."As a result of this success we are able to take advantage of extra time to add tweaks and polish to the game. Our community has high standards, and we will work hard to to live up to their expectations in the coming weeks and months. We really want HoI to be the best it can be for our fans."Hearts of Iron IV is currently 33% off at the official Paradox Store. (https://www.paradoxplaza.com/hearts-of-iron-iv) The game is also available on Steam. 

Itiviti Group Holding AB (publ) calls for early redemption of notes with ISIN SE0004872851

Itiviti Group Holding AB (publ) (previously Cidron Delfi Intressenter AB (publ)) has today given notice of exercise of its option for early redemption of all outstanding notes with ISIN SE0004872851 (the "Notes") to all noteholders as of 20 February 2017.The date on which the redemption will occur will be 27 March 2017. The Notes will be redeemed at an amount equal to the sum of:a) 100 per cent. of the nominal amount (i.e. EUR 100,000 per Note);b) 25 per cent. of the interest rate; andc) accrued but unpaid interest.The redemption amount amounts to EUR 63,499,167 in aggregate and EUR 105,831.94 per Note. The record date for redemption is 20 March 2017. In conjunction with the redemption, the Notes will be delisted from the corporate bond list at Nasdaq Stockholm.This information was prior to this release inside information and is information that Itiviti Group Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 4.00 p.m. CET on 20 February 2017.For further information, please contact:Itiviti Group Holding AB (publ)Tony Falck, CFO, tel. +46 8 506 477 24About ItivitiItiviti is a world-leading technology provider for the capital markets industry. Trading firms, banks, brokers and institutional clients rely on Itiviti technology, solutions and expertise for streamlining daily operations, while gaining sustainable competitive edge in global markets.With 13 offices and serving more than 400 customers worldwide, Itiviti was formed by uniting Orc Group, a leader in trading and electronic execution, and CameronTec Group, the global standard in financial messaging infrastructure and connectivity. From its foundation in 2016, Itiviti has a staff of 400 and an estimated annual revenue of SEK 700 million.Itiviti is committed to continuous innovation to deliver trading infrastructure built for today’s dynamic markets, offering highly adaptable platforms and solutions, enabling clients to stay ahead of competitive and regulatory challenges.Itiviti is owned by Nordic Capital Fund VII.www.itiviti.com

Eltel Group: Full-year report January–December 2016

January–December 2016 · Net sales amounted to EUR 1,399.8 million (1,254.9), up 13.5% in local currencies, organic net sales increased by 1.8%* · Operative EBITA amounted to EUR 2.1 million (62.2) or 0.1% of net sales (5.0) · Write-downs and provisions in operative EBITA amounted to EUR 49.8 million · Goodwill impairment of EUR 55.0 million recognised relating to the power transmission business · EBIT amounted to EUR -67.4 million (46.6) · Net financial expenses amounted to EUR -12.6 million (-14.4) · The net result amounted to EUR -82.2 million (43.2) · Earnings per share was EUR -1.33 (0.69) · Operative cash flow was negative at EUR 8.0 million (+45.8), cash conversion was -387.4% on a rolling 12-month basis · The Board proposes that no dividend be paid for the year 2016 (0.24) October–December 2016 · Net sales amounted to EUR 387.1 million (397.3), down 1.8% in local currencies, organic net sales decreased by 2.8%* · Operative EBITA amounted to EUR -14.6 million (20.5) or -3.8% of net sales (5.2) · Write-downs and provisions in operative EBITA amounted to EUR 34.1 million · Goodwill impairment of EUR 55.0 million recognised relating to the power transmission business · EBIT amounted to EUR -73.2 million (16.5) · Net financial expenses amounted to EUR -4.5 million (-2.2) · The net result amounted to EUR -80.3 million (17.3) · Earnings per share was EUR -1.29 (0.27)  · Operative cash flow was positive at EUR 22.5 million (90.4)  Unless otherwise stated, figures in brackets refer to the same period in the preceding year.* Organic net sales excludes the U-SERV acquisition in 2016 and the Norwegian Communication business until 1 September 2016 (Eltel Sønnico) and is presented using comparable exchange rates.  Important decisions and events at the Board meeting on 20 February 2017 Decisions by the Board of Directors to focus and stabilise the operations: · Eltel’s management and Board of Directors have decided on strategic focus on Eltel’s core businesses in Power and Communication · Geographically, the markets in the Nordics and Poland will be prioritised, as will further growth opportunities in Germany · Combined net sales of operations in Power and Communication amounted to approximately EUR 1.2 billion, corresponding to 87% of Group total net sales in 2016 · Following this decision, operations excluding Eltel’s core businesses will be divested, with the intention to find new owners with relevant core expertise in the respective business areas. The decision covers the following businesses:– The power transmission business in Africa– The rail business– The power distribution business in the Baltics · Net sales of businesses intended to be divested amounted to approximately EUR 180 million in 2016 · Eltel and its creditors have agreed on revised covenants for 2016 · The Board of Directors decided to initiate a process for a preferential rights issue to enable required restructuring and growth in core markets · Eltel’s largest shareholders, Zeres Capital, Solero Luxco S.á.r.l., The Fourth Swedish National Pension Fund (AP4), Swedbank Robur Funds and The First Swedish National Pension Fund (AP1), representing 49.02% of Eltel’s share capital as of 31 January 2017, support the decision of a preferential rights issue · The Board has decided to appoint a special investigator regarding the liabilities of potential historical inaccuracies in the accounting of the project business Comments by the CEO  Strategy to achieve stable growth in our core area After taking on my position as CEO of Eltel on 19 September 2016, we initiated an operational review of the project business. Next, a Group Project function was established to execute certain operational improvement actions within the project business, including project governance, risk assessment and reporting. A decision was made to implement an in-depth investigation, led by external auditors, of projects with high risk profile and focus mainly in Africa. In parallel, Eltel’s management, in close cooperation with the Board, has continued to review the remaining business. Our conclusions following the review are clear. Eltel’s core competence is in Power and Communication in our domestic markets in the Nordics and in Poland. Furthermore, there are growth opportunities in Germany – a market that is close to the Nordics both in cultural and structural terms. Expansion in other markets has not been successful. Eltel has had difficulties to achieve critical mass and consequently profitability. In light of the above analysis and Eltel’s financial situation, management has developed a strategy and action plan which the Board has decided to implement in 2017. We will focus Eltel’s operations on our stable and profitable businesses within Power and Communication in the Nordics and Poland, and evaluate our continued growth opportunities in Germany. This is where we have long-term ability to generate stable profitability. These markets also offer attractive market potential, stable customers and an interesting development in fibre and smart meters. In 2016, the operations in Power and Communication in the Nordics, Poland and Germany recorded net sales of approximately EUR 1.2 billion, corresponding to 87% of Group net sales. As a consequence of the decision, Eltel’s operations, excluding the core business, will be divested to new owners with core expertise in the business area concerned. The decision is in line with our ambition to reduce the risk level in our operations and release resources for our core business. As a consequence of the decision, the intention is to initiate sales processes regarding the power transmission business in Africa, the rail business and our power distribution business in the Baltics. In 2016, net sales of these operations amounted to approximately EUR 180 million. To enable execution of stated actions, Eltel and its banks have agreed on revised covenants for 2016. However, in order to create long-term shareholder value, a balance sheet allowing for a balanced debt structure combined with investments in growth in our core markets, is required. The Board has consequently decided to initiate a process for a preferential rights issue. Eltel’s largest shareholders, Zeres Capital, Solero Luxco S.á.r.l., The Fourth Swedish National Pension Fund (AP4), Swedbank Robur Funds and The First Swedish National Pension Fund (AP1), representing 49% of Eltel’s share capital as of 31 January 2017, support the decision of a preferential rights issue. This Board decision and the expressed support by the main owners are important cornerstones for the turnaround now put in action. The outcome of our investigation led by external auditors and covering certain projects shows larger deficiencies than earlier anticipated. This resulted in larger than expected write-downs compared to estimates provided in the profit warning in January. Revenue recognition in power transmission has proven to have been more aggressive than previously anticipated, mainly in projects in Africa. The work, initiated as I started as CEO, to investigate the project business and implementation of new governance and control continues. Eltel’s Board has decided to appoint a special investigator regarding the liabilities of potential historical inaccuracies in the accounting of the project business. Considering the development in the fourth quarter, net sales decreased by 1.8% to EUR 387.1 million. For the full-year 2016, net sales amounted to EUR 1.4 billion, growth by 13.5%, mainly driven by acquisitions in the Communication segment. In the fourth quarter, operative EBITA was negative at EUR -14.6 million and positive at EUR 2.1 million for full-year 2016. In 2016, Group operative EBITA was negatively impacted by EUR 49.8 million of provisions and write-downs mainly related to the project business in power transmission in Africa and the rail business in Norway. Of these, EUR 34.1 million were recorded in the fourth quarter. The weak result is concerning, although there are clear explanations. At the same time, I feel great confidence in us now taking right actions. Eltel’s operations are fundamentally solid with highly skilled employees and loyal customers. We have a strong and solution-focused culture and a long track record of delivering value-adding services. Our decision to refocus on our core businesses and markets goes back a long way, and we know our customers and markets well. Together with our Board and our owners, we will now channel all our efforts on implementing this action plan to restore Eltel to become a stable company that will have what it takes to capitalise on the clear growth opportunities in our core business. –Håkan Kirstein, President and CEO For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com  This information is information that Eltel AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07.00 CET on 21 February 2017. About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2016, Eltel net sales amounted to EUR 1.4 billion. The current number of employees is approximately 9,500. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Nel ASA: Awarded frame contract for multiple hydrogen fueling stations in California by Royal Dutch Shell Plc

(Oslo, 21 February 2017) Nel Hydrogen Solutions, a division of Nel ASA (Nel, OSE:NEL), has entered into a framework contract for the supply, construction and maintenance of H2Station® hydrogen fueling stations in California for Royal Dutch Shell Plc (“Shell”) in a partnership with Toyota Motor Corp. “Being exclusively chosen by Shell and Toyota for this framework contract is a great honor and proves that our technology is state of the art. We look forward to working with our partner to roll out their Californian hydrogen fueling network”, says Mikael Sloth, Vice President Business Development in Nel. On Friday 17th of February 2017, the California Energy Commission (CEC) announced the Notice of Proposed Awards (NOPA) for the Grant Funding Opportunity. Following the NOPA announcement, Nel and Shell finalized the framework contract for the exclusive supply, construction and maintenance for H2Station® hydrogen fueling stations in California. Through this project, Shell will build seven fueling stations for hydrogen cars in California through a partnership with Toyota Motor Corp, these stations will support the target for 100 hydrogen fueling stations by 2020 in the state. The California Energy Commission is considering $16.4 million in grants toward these stations, with Shell and Toyota contributing their part. The contract between Nel and Shell has a potential value in excess of NOK 140 million depending of number of H2Stations and scope of equipment and services that Shell choses to execute under the framework contract. “As communicated yesterday, this is our largest single order for fueling stations ever. Working with great partners like Shell and Toyota is a privilege and we will do our best to ensure that this project becomes a success for other to follow.”, says Jon André Løkke, Chief Executive Officer of Nel. Nel Hydrogen installed the first H2Station® for Shell in 2014 at a conventional gas station in Hamburg, Germany, and will use this experience for the deliveries to Shell in California. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 9074 4949 About Nel| www.nelhydrogen.com       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

REPORT FOR THE FOURTH QUARTER 2016 AND PRELIMINARY RESULT FOR 2016

Financial and operating highlights 4Q 2016 (4Q 2015 in brackets):  · Operating revenues were NOK 2 630 million (NOK 3 613 million) · EBITDA (operating result before depreciation, impairment and finance) was NOK 1 065 million (NOK 1 419 million) · Impairments were NOK 213 million (NOK 1 376 million · EBIT (operating result) was NOK 92 million (NOK - 922 million · Net finance was NOK -14 million (NOK -302 million). · Net result after tax was NOK 31 million (NOK -1 098 million Post quarter event: · Proposed dividend for 2016: NOK 2.00 per share Offshore drilling · EBITDA NOK 810 mill. (NOK 1 227 mill.) · Challenging markets · 3 units in operation · Waiver of loan covenants Renewable energy · EBITDA NOK 212 mill. (NOK 261 mill.) · Like-for-like generation down 18% · Including Fäboliden and Crystal Rig III, down 11% · Crystal Rig III commenced production · Higher prices throughout all markets · 20% weakening of GBP/NOK Shipping / Offshore wind · EBITDA NOK 35 mill. (NOK -35 mill.) · Utilization for installation vessels 64% (39%) · Impairment of CTVs NOK 103 mill. · Contract pipeline into 2019 covered 42% by firm contracts and 14% options Cruise · EBITDA NOK 18 mill. (NOK -10 mill.) · 20% weakening of GBP / NOK · 18% weakening of GBP/USD · Strong bookings · Passenger days up 6%  · Net ticket income per diems up 10% Financial information The Group‘s operating revenues amounted to NOK 2 630 million (NOK 3 613 million). Offshore drilling had operating revenues of NOK 1 310 million (NOK 2 262 million), Renewable energy NOK 306 million (NOK 372 million), Shipping / Offshore wind NOK 264 million (NOK 219 million) and Cruise NOK 401 million (NOK 433 million). Within Other investments NHST Media Group had operating revenues of NOK 337 million (NOK 332 million). EBITDA (operating result before depreciation, impairment, result from associates, financial items and tax) was NOK 1 065 million (NOK 1 419 million). Offshore drilling achieved EBITDA of NOK 810 million (NOK 1 227 million), Renewable energy NOK 212 million (NOK 261 million), Shipping/Offshore wind NOK 35 million (NOK -35 million), while Cruise achieved EBITDA of NOK 18 million (NOK -10 million). Within Other investments EBITDA were NOK -10 million (NOK -24 million). Depreciation in the quarter was NOK 760 million (NOK 966 million). Impairments were NOK 213 million (NOK 1 376 million) of which offshore drilling units amounted to NOK 90 million (NOK 1 375 million), Crew Transfer Vessels within Shipping/Offshore Wind NOK 103 million (0) and write down of development projects within Renewable energy of NOK 20 million (0). EBIT (operating result after depreciation and impairment before result from associates, financial items and tax) was NOK 92 million (NOK -922 million). Net financial items in the quarter were NOK - 13 million (NOK - 302 million). Net interest expenses were NOK 131 million (NOK 192 million) and net currency gain amounted to NOK 73 million (NOK 62 million) Net unrealized gains related to fair value adjustment of financial instruments were NOK 62 million(NOK - 33 million). Dividends received in the quarter was 35 million (NOK 1 million). Other financial items (inclusive impairment of investments) amounted to NOK - 53 million (NOK - 140 million). Net result in the quarter was NOK 31 million (NOK -1 098 million), of which NOK 11 million are attributable to the shareholders of the parent company (NOK -573 million). The non-controlling interests´ share of net result in the quarter was thus NOK 20 million (NOK -525 million). Revenues in 2016 were NOK 12 415 million (NOK 14 640 million), EBITDA was NOK 5 072 million (NOK 6 243 million) and EBIT was NOK - 294 million (NOK – 2 361 million). EBIT was heavily influenced by impairments of total NOK 2 037 million whereof offshore units were impaired with NOK 1 914 million (NOK 4 903 million). Net financial items were NOK - 410 million (NOK - 535 million). Net result after estimated tax was NOK -1 021 million (NOK – 2 804 million), of which NOK - 499 million (NOK - 1 261 million) are attributable to the shareholders of the parent company. Annual General meeting / Dividend With regard to the Annual General Meeting in 2017, the board will propose a dividend of NOK 2.00 per share. For the company NOK 85.1 million. The annual general meeting is scheduled for Wednesday 24 May 2017.

Sobi™ enters into new distribution agreement with Valeant for Ammonul®

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) today announces that the company has entered into a 3-year agreement with Valeant Pharmaceuticals Ireland for the distribution of Ammonul® (sodium phenyl acetate and sodium benzoate) injection in Europe, the Middle East and North Africa. The new agreement replaces the current distribution agreement with Valeant Pharmaceuticals North America LLC for the same territory. Under the new agreement, Sobi will have exclusive rights and license for sales and distribution of Ammonul in Europe, the Middle East and North Africa until 31 December 2019 for named patient use (NPU) programmes. “We are very pleased to extend our long-term partnership with Valeant to continue to provide access to Ammonul in the territory,” says Alan Raffensperger, Chief Operating Officer at Sobi. “This agreement complements Sobi’s portfolio within the area of Urea Cycle Disorders and creates a wider range of treatment alternatives for patients suffering from these rare conditions”.  Ammonul is approved by the US Food and Drug Administration (FDA) for the treatment of acute Urea Cycle Disorders (UCDs). The product is not registered in the European Union, Middle East or North Africa but is only available under NPU programmes. --- About Ammonul®Ammonul is approved in the US and indicated as adjunctive therapy in paediatric and adult patients for the treatment of acute hyperammonaemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. During acute hyperammonaemic episodes, ammonia-lowering therapies should be considered. For full safety information please see fda.gov. (http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020645lbl.pdf)  About Sobi™Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and   Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and about 760 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com.   For more informationplease contact:Media relations Investor relationsLinda Holmström, Senior Jörgen Winroth, ViceCommunications Manager  President, Head of Investor RelationsT: + 46 708 73 40 95, + T: +1 347-224-0819, +1 21246 8 697 31 74   -579-0506, +46 8 697 2135linda.holmstrom@sobi.com jorgen.winroth@sobi.com

Coor Service Management announces proposed new Board of Directors

Ahead of the Annual General Meeting, Coor Service Management’s Nomination Committee proposes to decrease the Board of Directors with one Director. Søren Christensen and Anders Narvinger (currently Chairman of the Coor Board) have declined re-election, and as new Board member Anders Ehrling (for more information, see below) is proposed. The following Board members are proposed for re-election: Mats Granryd, Mats Jönsson, Monica Lindstedt, Kristina Schauman, Heidi Skaaret and Mikael Stöhr. The Nomination Committee also proposes Mats Granryd as the Chairman of the Board, as previously communicated. The Nomination Committee’s goal has been to provide the Board of Directors with the overall competence and experience required to continue to lead and develop the company’s operations optimally, and to ensure continued profitable growth. The proposal also takes into account versatility, as well as, breadth of experience and background, and complies with the stipulations of the Swedish Code of Corporate Governance regarding non-affiliation. Anders Ehrling (born in 1959) was most recently CEO & President of BRA—Braathens Regional Airlines. Previous positions include: CEO of Scandic Hotels, and held several senior positions with SAS, including President of SAS Sverige AB. Mr. Ehrling is a Director of Parks & Resorts Scandinavia AB, and Chairman of the Board of Nordic Cinema Group. The Annual General Meeting will be held in Kista Entré, Knarrarnäsgatan 7, Kista (Stockholm), Sweden on May, 4, 2017 at 15:00 CET. The Nomination Committee of Coor Service Management consists of Jan Andersson (Swedbank Robur Fonder), Malin Björkmo (Handelsbanken Funds), Ulrika Danielson (Second AP Fund), Jan Särlvik (Nordea Funds), and Anders Narvinger (Chairman Coor). For more information, images etc., please visit www.coor.com or contact: Jan Andersson, Chairman of the Nomination Committee, +46 76 139 55 00, jan.andersson@crossmore-adsors.com Erik Strümpel, General Counsel at Coor, +46 734 101 389, erik.strumpel@coor.com Åsvor Brynnel, Sustainability and Communications Director at Coor, +46 10 559 59 83, asvor.brynnel@coor.com